Depression:the possible roles of BPRP and the gender differences in stress response and recovery by Lin, Yanhua
  
 University of Groningen
Depression
Lin, Yanhua
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2007
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Lin, Y. (2007). Depression: the possible roles of BPRP and the gender differences in stress response and
recovery. PrintPartners Ipskamp B.V., Enschede, The Netherlands.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019




THE POSSIBLE ROLES OF BPRP 
AND THE GENDER DIFFERENCES 










YANHUA LIN                            
2007                              





The studies described in this thesis were performed at the Department of Psychiatry, 
University of Groningen, Groningen, The Netherlands; and the Department of 
Pharmacology, Peking University, Beijing, China. 
Publication of this thesis was financially supported by the Graduate School of 
Behavioral and Cognitive Neurosciences (BCN) and the University of Groningen.  
Cover designed by: Aihua Liu                                       
Printed by: PrintPartners Ipskamp B.V., Enschede, The Netherlands              
© Yanhua Lin, 2007. 
 
 
ISBN number: 978-90-367-3184-3 











the possible roles of BPRP and 





ter verkrijging van het doctoraat in de 
Medische Wetenschappen 
aan de Rijksuniversiteit Groningen 
op gezag van de 
Rector Magnificus, dr. F. Zwarts, 
in het openbaar te verdedigen op 
maandag 1 oktober 2007 







geboren op 12 september 1979 
JiangXi, China 
                                 
              
Promotores: Prof. dr. G. J. ter Horst  
Copromotores: Prof. dr. X.J. Li 
 Dr. C. Westenbroek 
  
  
Beoordelingscommissie: Prof. dr. H. W. G. M. Boddeke 
 Prof. dr. P. G. M. Luiten 
 Prof. dr. A. J.W. Scheurink 
                                                          
Contents 
 
Chapter 1  Introduction / 7  
Chapter 2  Effects of chronic unpredictable mild stress on  
Brain-Pancreas Relative Protein in rat brain and    
pancreas / 57 
Chapter 3  Effects of glucose, insulin and supernatant from 
pancreatic β- cells on Brain-Pancreas Relative  
Protein in rat hippocampus / 77 
Chapter 4  Effects of long-term stress and recovery on the 
prefrontal cortex and dentate gyrus in male and 
female rats / 93 
Chaper 5   General discussion / 123 
Summary  / 143 
Nederlandse samenvatting  / 147 
Abbreviations  / 151 
Publications    / 153 











































8 / Introduction 
Part Ⅰ Stress and stress response 
 
Stress   
    The concept of stress has been the subject of a countless number of studies 
involving a wide range of different approaches, each one presenting its own way of 
interpreting and assessing the phenomenon. Besides its great diversity, the literature on 
this subject often associates stress to concepts of psychological nature such as well-being, 
suffering, emotionality, fearfulness and anxiety. Since most of these concepts involve a 
subjective component, researchers are challenged by the lack of direct measures, being 
therefore obliged to infer such psychological states from their measurable manifestations, 
such as physiology, endocrinology and behavior.  
    Cannon was the first to introduce the term "homeostasis" to describe the 
"coordinated physiological processes which maintain most of the steady states in the 
organism" (Cannon, 1929). However, Cannon never used the term "stress."  It is Hans 
Selye who introduced and popularized stress as a medical and scientific idea. The 
starting point for the elaboration of his stress theory was his report, published as a letter 
to Nature in 1936 (Selye, 1936), describing a pathological triad (adrenal enlargement, 
gastrointestinal ulceration, and thymicolymphatic involution) elicited by any of a variety 
of stressors. Selye defined stress as the nonspecific response of the body to any demand, 
emphasizing that the same pathological triad - "stress syndrome" - would result from 
exposure to any stressor. Selye also introduced the term "general adaptation syndrome" 
with its three successive phases: the alarm, resistance, and exhaustion stages. 
Ramos described stress more in details. According to Ramos and Mormede, stress 
is considered as the response of an organism to environmental stimuli (stressors) which 
threaten its internal equilibrium, also called homeostasis. Such stimuli, which are 
perceived and evaluated by a cognitive/emotional system, may induce a variety of 
neuroendocrine, metabolic and behavioral changes in an attempt to maximize the 
probability of success over a demand. Once the intensity of the challenge reaches a level 
beyond which the specific homeostatic mechanisms may no longer ensure the 
maintenance of the internal equilibrium, a series of non-specific adjustments occur. The 
attainment of this non-specific stage of response may also result from a high emotional 
activation, produced by the interaction of environmental and psychological factors (e.g. 
stimulus intensity, perception/evaluation of the challenge and chances of adaptation) 
(Ramos and Mormede, 1998).  
     In general, stressors can be divided into four main categories: 1) physical stressors 
that have either a negative or, in some situations, a positive psychological component 
(pain or immobilization); 2) psychological stressors that reflect a learned response to 
previously experienced adverse conditions (fear, anxiety or exposure to a novel or 
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uncontrollable environment); 3) social stressors reflecting disturbed interactions among 
individuals; and 4) stressors that challenge cardiovascular and metabolic homeostasis 
(hemorrhage, exercise or heat) (Pacak et al, 1998). The intensity and the nature of the 
response to stressors depend on the characteristics of each individual, and their 
influences on the individual’s health and well-being depend on the efficiency of the 
coping process. The response to mild, brief (acute) and controllable challenges could be 
perceived as pleasant or exciting stimuli, which is adaptive and beneficial for the 
survival of the animal and could be a positive input for the emotional and intellectual 
development (Selye, 1936; Selye et al, 1950), while the more intense, persistent (chronic) 
and uncontrollable situations of threat, or distress may lead to maladaptive responses 
(Selye, 1976a, 1976b; Van de Kar et al, 1999), and may cause negative feedback 
mechanisms start to fail, causing inadequate regulation of the hypothalamus- 
pituitary-adrenal-axis (HPA-axis) (De Kloet et al, 1987; Mizoguchi et al, 2001). 
Evidence pointing to harmful effects of stress on the immune system, the 
neuroendocrine balance, the wellbeing and several pathological states of humans and 
animals, has led scientists of different disciplines to investigate the biological processes 
underlying stress.  
    Submitting groups of subjects to different types of stressful conditions has revealed 
a great variability of response among individuals from the same species. This 
inter-individual variation has been demonstrated for several species of animals and for 
humans, involving different aspects of the stress response (Bertagna, et al, 1994; Lozoff 
et al, 1995). Although it is generally accepted that such variability is caused by both 
genetic and environmental factors, little is known about its biological and molecular 
mechanisms of control. Studies providing this kind of knowledge will certainly improve 




    Exposure to stressors results in a series of coordinated responses referred to as the 
“stress response” which is composed of altered behavior, immunologic and autonomic 
function and the secretion of multiple hormones including adrenocorticotropin hormone 
(ACTH), cortisol/corticosterone, and adrenal catecholamines. These coordinated 
responses are organized to enhance the probability of survival (Van de Kar et al, 1999, 
McEwen, 2000a, 2000b). 
Stress leads to an immediate sympathetic activation, upon which the adrenal 
medulla releases adrenaline and noradrenaline in the bloodstream. Increased adrenaline 
and noradrenaline activity results in increased heart rate and blood pressure by the 
stimulation of the α- and β-adrenergic receptors on the heart muscle and vessel walls. 
10 / Introduction 
The increased blood flow to the brain and muscles allow a fast performance of a 
fight-or-flight reaction to cope with potential harmful events (Westenbroek et al, 2004a). 
A slower reaction takes place via the activation of the HPA-axis (Fig. 1). Negative 
feedback to prevent excessive HPA-axis activation is exerted at the level of the pituitary, 
paraventricular nucleus of the hypothalamus (PVN) and extra-hypothalamic nuclei of the 
limbic system. Glucocorticoids inhibit their own release by inhibiting release and 
synthesis of ACTH in the pituitary and inhibiting corticotropin-releasing hormone (CRH) 
release at the level of the PVN (Swaab et al, 2005) (Fig. 1). The key elements of the 
























Figure 1. Hypothalamus-pituitary-adrenal-axis schema 
 
z The paraventricular nucleus of the hypothalamus, which 
contains neurons that synthesize and secrete corticotropin- 
releasing hormone (CRH). This peptide regulates  
z The anterior lobe of the pituitary gland. In particular, CRH and 
vasopressin stimulate the secretion of adrenocorticotropic 
hormone (ACTH). ACTH in turn acts on  
z The adrenal cortices, which produces glucocorticoid 
hormones response to stimulation by ACTH. Glucocorticoids 
in turn act back at the hypothalamus and pituitary (negative 
feedback). 
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Under stressful conditions, there is a strong increase in the corticosteroids secretion 
achieved within 10 to 30 minutes (Paris et al, 1987). Corticosteroids play a principal role 
in elevating blood glucose levels and mobilizing energy, growth processes, immune 
function and processes in the central nervous system including learning and memory 
(Carrasco et al, 2003). The receptor system that mediates the slow genomic actions of 
corticosteroids has several remarkable features. First, it consists of two related receptor 
molecules, the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR), 
which bind the same hormone (primarily cortisol in humans and corticosterone in 
rodents) in the brain, albeit with a tenfold difference in affinity (Reul and de Kloet, 1985; 
Reul et al, 1998). MR affinity seems sufficiently high to maintain receptor activation 
throughout 1-h intervals between hormone secretory bursts of 20-min duration. By 
contrast, the lower affinity GR seems to respond largely in phase with the ultradian 
rhythm. This receptor becomes progressively activated during stress- and circadian- 
induced increases in the frequency and amplitude of corticosteroid secretory bursts 
(Young et al, 2004; Kitchener et al, 2004). Second, GR distribution is ubiquitous, 
although uneven, in neurons and glial cells. GR density is highest in the parvocellular 
PVN of the HPA axis, in neurons of ascending aminergic pathways and in limbic 
neurons that modulate PVN function trans-synaptically through pathways that impinge 
on an inhibitory hypothalamic GABA (γ-aminobutyric acid) network that surrounds the 
PVN (Miklos and Kovacs, 2002; Herman et al, 2003). Limbic neurons also express MRs 
abundantly. Considerable MR and GR co-expression is found in hippocampal pyramidal 
cell fields (except the adult CA3, which shows minimal GR expression) as well as the 
dentate gyrus, the amygdaloid and lateral septal nuclei, and some cortical areas. MR and 
GR co-localization is found in the hippocampus of almost all species (Patel et al, 2000). 
Third, the two receptor systems function in a binary fashion at the cellular level (Young 
et al, 2004). In general, the effects of MR activity on cellular communication maintain 
the excitability and stability of networks. Conversely, GR (in addition to MR) activation 
leads to delayed suppression or normalization of network activity (Cole et al, 2000; de 
Kloet, 2003; Spencer et al, 1998). Fourth, in the hippocampus, the activation of MRs or 
GRs led to the altered expression of 70-100 genes, of which roughly 50% were 
upregulated. One-third of the genes were responsive to both receptor types. These 
findings indicated that corticosteroids coordinate the expression of high- and 
medium-abundant genes that underlie aspects of cell metabolism, structure and synaptic 
transmission. Some of the genes included known GR targets, such as enzymes and 
receptors for biogenic amines and neuropeptides, growth factors and cell-adhesion 
factors (de Kloet et al, 2005). 
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Gender differences in stress response 
    Male and female rats show differences in magnitude of the stress response. In 
rodents, females are generally more behaviorally reactive to stressors than males, 
although such effects appear to be strain-dependent (Altemus, 2006). Female rats react 
with a much higher rise in corticosterone and greater changes of ACTH (Rivier, 1999) to 
a stressor than males do (Weinstock et al, 1998; Tinnikov, 1999). Such effects have been 
reported in different rat strains (Stohr et al, 2000) in response to acute and chronic 
stressors (Tinnikov, 1999; Campbell et al, 2003). However, in human, it was reported 
that healthy male subjects demonstrated a more robust ACTH and cortisol response to a 
psychological stress compared to females (Uhart et al, 2006). The intensity of the stress 
response in females is also dependent on the levels of circulating gonadal hormones, and 
differs during different stages of the estrous cycle (Figueiredo et al, 2002; Viau and 
Meaney, 1991). So, especially in acute stress responses the stage of the estrous cycle of 
the female can be a confounding factor (Westenbroek et al, 2004b).  
 
 
Brain regions involved in stress response 
     Multiple brain structures are involved in the organization of responses to aversive 
or stressful stimuli. The hippocampus and frontal regions of the cerebral cortex have 
received the most attention and are expected to be particularly associated with cognitive 
abnormalities that are seen in many patients with depression, such as memory 
impairments and feelings of worthlessness, hopelessness, guilt, doom and suicidality.  
The striatum (particularly the ventral striatum and nucleus accumbens) and amygdala, 
and related brain areas are important in mediating aversive and rewarding responses to 
emotional stimuli, and, as a result, could mediate the anhedonia, anxiety and decreased 
motivation and energy levels that predominate in many patients with depression. Given 
the prominence of so-called neurovegetative symptoms of depression, including too 
much or too little sleep, appetite and energy, as well as a loss of interest in sex and other 
pleasurable activities, a role for the hypothalamus has also been speculated (Drevets, 
2001; Mayberg et al, 2003). Similarly, studies of the brains of patients with depression 
obtained at autopsy have reported abnormalities in many of these same brain regions 
(Drevets, 2001; Bissette et al, 2003; Rajkowska, 2003). The ventral tegmental area 
(VTA) which provides dopaminergic input to the NAc as well as to most of the other 
brain areas, locus coeruleus which provides the majority of noradrenaline, and dorsal 
raphe and other raphe nuclei which provide the majority of serotonin are also involved in 
stress response (Van de Kar and Blair, 1999; Amat et al, 2005).  
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Fos as neuronal activation marker 
     The protein Fos is the product of the c-fos proto-oncogene, one of the immediate 
early genes (IEG). These genes are expressed immediately after an extra cellular 
stimulus and play a role in signal transduction and transcriptional regulation. Fos forms 
heterodimers with Jun proteins, the product of another IEG. A Fos/Jun complex is 
referred to as AP-1, which can bind to AP-1 binding sites and are thought to contribute 
to the transcription of genes bearing these sites in their promotor region. Fos mRNA is 
expressed immediately (within a few minutes) after a stimulus. Expression of the protein 
Fos is maximal between 1 and 3 hrs after a stimulation (Kovacs, 1998). 
 Fos has been mostly studied as a marker for neuronal activation after a wide 
variety of stimuli. However Fos-ir does not always represent an activated neuron. Fos 
induction can be evoked without any changes in neuronal firing, and some neurons seem 
to always express Fos or do not use Fos when stimulated. Even though Fos-ir might not 
give an accurate measure of the total number of activated neurons, it does provide a 
sensitive marker to distinguish patterns of activation between different treatments. Acute 
stress results in a widely distributed pattern of Fos mRNA and Fos expression in the rat 
brain (Li et al, 1998; Cullinan et al, 1995; Stamp and Herbert, 2001). However if 
habituation to a stimulus occurs, brain regions fail to show a Fos-response (Stamp and 
Herbert, 2001; 1999).  
 
 
Part Ⅱ Neuroplasticity and depression 
 
Concept of neuroplasticity 
  Neuroplasticity is a life-long process that mediates the structural and functional 
reaction of dendrites, axons, and synapses to experience, attrition and injury. The 
manifestations of neuroplasticity in the adult CNS include alterations of dendritic 
ramifications, synaptic remodeling, long-term potentiation (LTP), axonal sprouting, 
neurite extension, synaptogenesis and neurogenesis. Experience-induced modifications 
of synaptic strengths, for example, enable the accumulation of a knowledge base that is 
unique to each individual and provide the critical substrates for adaptation and 
individuation. Self-stimulation, learning new associations and exposure to enriched 
environments can induce synaptogenesis, synaptic remodeling, and neurogenesis in the 
adult rodent brain (Black et al, 1989; Kempermann et al, 1998; Klintsova et al, 1999; 
Rao et al, 1999). Simply put, neuroplasticity is the ability to acquire information and 
make the appropriate responses to the same or related future stimuli. This includes 
sensory, cognitive, emotional, social, as well as endocrine inputs and combinations of 
this information (Duman, 2002).  
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Concept of Neurogenesis 
     Neurogenesis is a process that involves cell proliferation, migration and 
differentiation. During proliferation neural stem cells (NSCs) divide asymmetrically and 
give rise to progenitor cells which are also capable of proliferating. Progenitor cells 
migrate from proliferation area and begin to differentiate. Neural stem cells (NSCs) are 
distinguished by their two functional properties: a seemingly unlimited capacity for 
self-renewal by symmetric division and the ability to generate multiple mature NSC 
types (multipotent). Switch from a pattern of symmetric to asymmetric division 
generates a progenitor cell. A single NCS is capable of generating various kinds of cells 
within the central nervous system, including neurons and glial cells (astrocytes, 
oligodendrocytes). In contrast, progenitors of neurons and glial cells are the cells capable 
of proliferation but possessing a limited capacity for self-renewal and are often unipotent. 
During differentiation process the immature cell are transformed to mature neuronal or 
glial cells. Adult neurogenesis is mainly restricted to the subventricular zone (SVZ) and 
the subgranular zone of the dentate gyrus in the hippocampus (SGZ) in rodents. In 
humans, adult neurogenesis has been conclusively demonstrated only in the 
hippocampus (Eriksson et al, 1998). However, other brain regions, such as cortex or 
substantia nigra cannot be excluded.  
The investigation of neurogenesis requires methods detecting cell proliferation, the 
initial phase of neurogenesis, and subsequently should be capable of determining 
phenotype of the newly born cell using cell class specific markers. There are several 
exogenous and endogenous markers of cell division and also various cellular antigens 
which can be used to specify the phenotype (neuronal or glial) of the cells. 
Representative markers of cell proliferation and differentiation are listed in Table 1.  
 
 
Factors regulating adult neuroplasticity 
 Recent studies indicate that the rate of neuroplasticity can be regulated by several 
factors. It is also known that neuroplasticity can be controlled in both a positive and 
negative manner by internal (genetics, age, growth factors, hormones, neurotransmitters) 
and external factors (environmental or pharmacological stimuli). Table 2 describes 











Table 1. The list of representative markers expressed by proliferating  

























Adult neuroplasticity and brain diseases 
There are several findings indicating that stress decreases neuroplasticity and the 
impairment of adult neuroplasticity may be involved in the pathophysiology of some 
brain diseases, such as depression, epilepsy, ischemia or neurodegenerative disorders. 













PCNA (proliferating cell nuclear antigen) 
Ki-67 








PSA-NCAM (polysialylated neural cell 
adhesion molecule) 
CRMP-4 (collapsing response mediator 
protein-4) 
DCX (doublecortin) 
NeuN (neuronal nuclear pretein) 




GFAP (glial fibrillary acidic protein) 
S-100β 
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Proliferation: C57BL/6 mice> BalB/c, CD1 and 129/SVJ mice 
Number of newly generated neurons: CD1> C57BL/6 , BalB/c, 129/SVJ 
Enrichment of environment promotes survival of progenitor cells but does 




brain-derived neurotrophic factor (BDNF), insulin-like growth factor-I 
(IGF-I), fibroblast growth factor (FGF-2), epidermal growth factor (EGF), 






Administration of NMDA decreases neuroplasticity, while increased by 
NMDA receptor antagonist (MK-801, CGP 43487); Lesion of the 
entorhinal cortex, which provides a major glutamatergic input, increase 
neuroplasticity; AMPA receptor potentiator (LY451646) and group II 
metabotropic glutamate receptor antagonist (MGS0039) increases 
neuroplasticity 
Serotonin[5-HT]:  
Lesion of the 5-HT system, inhibition of 5-HT synthesis and WAY 
100635(a 5-HT1A antagonist) decreases neuroplasticity; d-fenfluramine 
(an agent releasing 5-HT) and 8-hydroxy- 2-dipropylaminotetralin (5-HT1A 
agonist) increase neuroplasticity; 5-HT may also regulate neurogenesis 
through other 5-HT receptor subtypes, such as 5-HT2A or 5-HT7 
Norepinephrine:  
Depletion of norepinephrine decreases neuroplasticity; Blockade of 
α2-adrenergic receptor by antagonist dexefaroxan increases neuron 
survival  
Dopamine: 
Depletion of dopamine decreases neuroplasticity; Agonist of D2-like 
receptors, stimulation of D3 receptors enhance neuroplasticity 
Endocannabinoids: The results are not clear even controversial; 
CB1R–knockout mice show reduction in neuroplasticity; activation of CB1 
receptor by endocannabinoid, anandamide, decreases adult 




Adrenal steroids: Decrease neuroplasticity by acting through an NMDA 
receptor-mediated pathway; Removal of adrenal steroids stimulates 
neuroplasticity  
Estrogen: Increase neuroplasticity; Removal of circulating estrogen 
decrease neuroplasticity 
Peptide hormones (prolactin): increases neuroplasticity 
Age 
 
Advanced age decreases neuroplasticity, which is related to the elevated 




Enriched environment such as exercise, learning and memory training 
increases neuroplasticity 
Acute or chronic restraint stress decreased neuroplasticity, which 
appears to result from the stress-induced activation of the HPA axis, 






Drugs of abuse: nicotine, ethanol, opiates (morphine, heroin) decrease 
neuroplasticity 
Antidepressants: long-term antidepressant treatment, electroconvulsive 
treatment, long-term lithium administration increase neuroplasticity  
Antipsychotic drugs: effect of antipsychotic drug on adult neuroplasticity 
depends on pharmacological profile of antipsychotic drugs; present 
findings show an increase, but also a decrease, even no effect 
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Depression 
    Major depression is a chronic, recurring and potentially life-threatening illness that 
affects up to 20% of the population across the globe (Gillespie et al, 2005). It is one of 
the top ten causes of morbidity and mortality worldwide based on a survey by the World 
Health Organization. It is highly heritable, with roughly 40-50% of the risk for 
depression being genetic, although the specific genes that underlie this risk have not yet 
been identified. The remaining 50-60% of the non-genetic risk also remains poorly 
defined, with suggestions that early childhood trauma, emotional stress, physical illness, 
and even viral infections might be involved. Most experts agree that depression should 
be viewed as a syndrome, not a disease. Therefore, the highly variable compilation of 
symptoms that is used to define depression (Table 3), and the highly variable course of 
the illness and its response to various treatments, indicate that depression subsumes 
numerous disease states of distinct aetiology, and perhaps distinct pathophysiology 
(Berton and Nestler, 2006). The symptoms of depression fall into three primary 
categories, including changes in mood (e.g., sadness, anhedonia, irritability), basic 
drives (e.g., sleep, eating), and cognitive disturbances (e.g., ruminations, guilt, 
indecisiveness, persistent thoughts of suicide) (Table 3).  
    Depression (officially termed major depression) is diagnosed according to criteria 
in the Diagnostic Statistical Manual of Mental Disorders (Diagnostic Statistical Manual 
of Mental Disorders), which defines a “major depressive episode” as being characterized 
by at least five of the symptoms listed in Table 3. Each must be evident daily or almost 
every day for at least 2 weeks. Severity is judged as mild, moderate or severe, based on 
the degree of impairment in daily occupational and social functioning. Melancholic 
subtype describes particularly severe cases, with prominent circadian variations in 
symptoms. Some patients with depression may show symptoms of psychosis or loss of 
touch with reality (for example, hallucinations or delusions). Symptoms of anxiety are 
also seen in many individuals with depression, whereas other patients are blunted in 
terms of their emotional reactivity. Individuals with relatively mild but prolonged 
symptoms, which persist for at least 2 years, are considered to have “dysthymia”. 
“Depressed disorder not otherwise specified” describes individuals with impaired 
function due to depressive symptoms who do not meet the aforementioned criteria. 
‘Adjustment disorder with depressed mood’ describes depressive symptoms that occur 
after a significant trauma (for example, death of a loved one), although this can evolve 
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Gender differences in depression 
   More and more evidence indicates that there is gender difference in depression 
(Altemus, 2006), depression occurs more frequently in females than in males by a ratio 
of 2:1 (in the case of atypical depression the ratio is closer to 3:1). Such an outcome may 
occur for any number of reasons, including differences in stressor experiences, less 
availability of resources to cope with stressors, greater stress-relevant neurochemical 
disturbances in females, the influence of particular sex hormones, the endorsement of 
less adaptive coping strategies to deal with stressors, or psychosocial or personality 
factors that favor the development of depression (Matheson and Anisman, 2003). 
Whatever the case, it is obviously incumbent on researchers to attend to the influence of 




 Antidepressants are the effective agents for the treatment of depression and have 
been used clinically for more than 50 years. A list of therapeutic manipulations currently 
used to treat depressed patients is provided in Table 4. Prior to Selective serotonin 
reuptake inhibitors (SSRIs), almost all psychotropic medications were the results of 
chance observations. Tricyclic antidepressants (TCAs) for instance were the results of an 
unsuccessful attempt to improve the antipsychotic effectiveness of phenothiazines (Kuhn, 
1958), while Monoamine oxidase inhibitors (MAOIs) came from a failed attempt to  
 
• Depressed or irritable mood 
• Decreased interest in pleasurable activities  
 and ability to experience pleasure 
• Significant weight gain or loss (>5% change/month) 
• Insomnia or hypersomnia 
• Psychomotor agitation or retardation 
• Fatigue or loss of energy 
• Feelings of worthlessness or excessive guilt 
• Diminished ability to think or concentrate 
• Recurrent thoughts of death or suicide 
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develop effective antitubercular medications (Crane, 1957). SSRIs however were a 
rationally designed class of psychotropic medications which hence launched a new era in 
psychotropic drug development (Berton and Nestler, 2006). After imipramine, the 
Type of treatment Mode of action Examples 
Medication 




























Inhibition of monoamine oxidase A (MAOA). 







Lithium has many molecular actions (for 
example, inhibition of phosphatidylinositol 
phosphatases, adenylyl cyclases, glycogen 
synthase kinase 3β and G proteins) but which of 
its actions is responsible for its antimanic and 





Unknown. Although these drugs have purported 
monoamine-based mechanisms (for example, 
bupropion inhibits dopamine reuptake, 
mirtazapine is an α2-adrenergic receptor 
antagonist and tianeptine an activator of 
monoamine reuptake), these actions are not 
necessarily the mechanisms that underlie the 













General brain stimulation? A magnetic field is 
thought to affect the brain by inducing electric 




Unknown   
Psychotherapies 
 
Exact mechanism is uncertain, but is thought to 





Deep brain stimulation In severely ill patients, stimulation of a region of 
the cingulate cortex found to function 
abnormally in brain imaging scans reportedly 
has antidepressant effects 
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development of subsequent SSRIs occurred over a relatively short period. Eventually 
five SSRIs (citalopram by Lundbeck, fluvoxamine by Solvay, fluoxetine by Lilly, 
paroxetine by SmithKline-Beecham and sertaline by Pfizer) were launched in many 
countries world wide, indicative of the shift from a chance-dependent discovery process 
to one of rational drug development. Unfortunately, after this milestone discovery, 
development of newer drugs has seen little progress. The following years consisted 
mostly of optimization of older drugs (Table 5). The reason for this is due to the fact 
that to date no clear consensus has been reached regarding the precise molecular and 
cellular mechanisms of action of these drugs. 
 
 









Animal model of depression  
 Animal models of depression are used for a variety of purposes: as screening tests 
to discover and develop novel antidepressant drug therapies; as simulations for 
investigating aspects of the neurobiology of depressive illness; and as experimental 
models within which the neuropharmacological mechanisms associated with 
antidepressant treatments, including electroconvulsive shock (ECS), may be investigated 
(Jesberger and Richardson, 1986; Henn and McKinney, 1987; McKinney, 1984; Willner, 
1990). While it is recognized that animal models of affective illness may not be entirely 
congruent with the human conditions, it is generally agreed that there are minimal 
number of criteria that must be met for an animal model to be considered valid. These 
have been iterated in numerous reviews (Newport et al, 2002; Willner and Mitchell, 
2002). At the very least, animal models must resemble the human conditions in several 
respects, including: (a) face validity: similarity in the symptom profile presented; (b) 
predictive validity: amelioration or attenuation by treatments effective in treating the 
1950s 
 
Accident discovery of leading drugs        
Iproniazide(MAOI) and imipramine (TCA)  
Synaptic pharmacology as therapeutic target 
Proposal of the “monoamine hypothesis” 
1970s-1980s Optimization of older drugs   
Newer antidepressants (SSRI, NRI, SNRI, RIMA etc) 
2000s Strategic drug development  
and rational drug design 
Discovery novel therapeutic targets 
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human condition, and conversely not be affected by those treatments that are ineffective 
in attenuating the human disorder (McKinney and Bunney, 1969); (c) etiological validity: 
provocation by events thought to be important in eliciting the human disorder; (d) 
construct validity: involvement of similar neurochemical processes  (Newport et al, 
2002; Willner, 1985). Although among these respects construct validity is regarded as 
the most important one, assessment of the validity of a model is generally based on 
elements of all four dimensions. 
 




























Till now, a variety of models have been developed (Table 6). Among these 
models, chronic mild stress (CMS) model has a great many positive features, and is 
Model type 
 
Sensitive to acute drug 
treatment 




















5-HT transporter knockout 
CRH receptor subtypes 
knockouts 


























 Chronic severe stress 





Social dominance models 
Social separation  Neonatal isolation 
Adult isolation 
Social defeat  Social defeat 
Agonistic behaviour  Resident-intruder 
Social hierarchy 
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probably the most valid animal model of depression currently available. Stressors, such 
as reversal of the light/dark cycle, periods of food and water deprivation, small 
temperature reductions, changes of cage mates and cage tilting, electric shocks, and 
other similarly individually innocuous, but unpredictable events. Chronic stress impairs 
the ability to anticipate reward in some studies (Matthews et al, 1995; Harris et al, 1997; 
Willner, 2005). This condition resembles anhedonia and can be reversed by 
antidepressants (Willner, 1997). In addition, these rats also demonstrate various sleep 
disturbances, another characteristic of depression (Cheeta et al, 1997; Willner et al, 
1996). An advantage of the chronic mild stress model is the applicability in both male 
and female rats, in contrast to the social stress models which are applied to males only. 
Disadvantages of this model are, so far unexplained, lack of reproducibility between 




Part Ⅲ Exploring the effects of stress and 
antidepressants on neuroplasticity from the 
cellular and molecular perspectives 
 
     Despite years of study, the biological basis of depression and the precise 
mechanisms of stress and antidepressant efficacy remains poorly understood. Early 
research on depression focused on the changes in neurotransmitter concentrations and 
receptor levels. Depression has been associated with abnormalities of the central nervous 
system (CNS) monoaminergic systems and antidepressants target monoaminergic 
function by preventing the reuptake of monoamines presynaptically or blocking their 
metabolism. Although antidepressants seem to exert their initial effect by immediately 
increasing monoaminergic levels intrasynaptically, their clinical antidepressant effect 
occurs only after chronic administration. These findings suggest that enhanced 
monoaminergic neurotransmission per se is not sufficient to explain the clinical actions 
of antidepressants. The molecular and cellular mechanisms that (i) contribute to the 
damage which is implicated in the pathogenesis of depression and (ii) the repair that has 
been hypothesized to contribute to the therapeutic effects of antidepressant treatments 
remain unclear. More recent efforts have focused on intracellular cascades and the 
regulation of gene expression. Exploring the role of signalling cascades and transcription 
factors dysregulated in depression and recruited by antidepressant therapies will most 
likely yield valuable data, since these molecules can affect the expression of diverse 
downstream target molecules. Evidence linking stress, depression and antidepressants 
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action suggests that depression may result from an impairment of neurons to make 
appropriate adaptations and/or synaptic connections. 
  
 
Structural impairments in brain associated with stress and 
depression 
 Most of these researches are focused on the hippocampus as this brain region is 
particularly susceptible to the structural impairments induced by stress (Sapolsky, 2000; 
McEwen, 2000a; Sairanen et al, 2007). In adult rodents, chronic stress or glucocorticoid 
administration resulted in distinct remodeling of the apical dendrites of hippocampal 
CA3 pyramidal neurons (Magarinos et al, 1996). This was manifested as a decrease in 
the number and length of apical dendrites (McEwen, 2000a; Radley et al, 2006). Besides 
the changes in dendritic remodeling, stress and stress hormones decreased the ongoing 
rate of cell birth and cell proliferation in the dentate gyrus granule cell layer of the adult 
hippocampus by an undetermined mechanism (Gould et al, 1992; Gould et al, 1997; 
Dranovsky and Hen R, 2006). It appears that permanent damage may occur in the brain 
only under extreme conditions (McEwen, 2000a). The above evidence suggests that 
dendritic restructuring, decreased neurogenesis and decreased cell survival occurs in 
stress, and may provide a cellular basis for the impairments seen in the brains of patients 
with depression.  
Depressed patients exhibit distinct pathological changes in limbic regions 
(hippocampus, basal ganglia and amygdala) and cortical brain regions (Manji et al, 
2001). Postmortem studies of patients with depression indicate a reduction in neuronal 
size in the orbitofrontal cortex, a reduction in glial number and size in prefrontal and 
orbitofrontal cortex and a decrease in cortical thickness and volume of prefrontal cortical, 
ventral striatal and hippocampus (Manji et al, 2001; Ongur et al, 1998; Rajkowska et al, 
1999; Rajkowska et al, 2000; Cotter et al, 2001; Videbech and Ravnkilde, 2004). 
Imaging studies also indicate impairments in cerebral blood flow and glucose 
metabolism in limbic and cortical structures (Drevets, 2000). The fact that depression 
has a genetic component does not exclude the possibility that neuroendocrine changes 
and stressful life experiences can lead to a depressive episode (Kessler, 1997; Heim and 
Nemeroff, 2001). Several clinical studies indicated that a subset of patients with 
depression had glucocorticoid hypersecretion or exhibit a hyperactivity of the HPA axis 
(Gold et al, 1995; Sapolsky, 2000; Arborelius et al, 1999; Duval et al, 2006). Moreover, 
distinct reductions in hippocampal volume were seen in patients with HPA hyperactivity 
(Colla et al, 2006). 
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Activation of necrotic and/or apoptotic cellular death pathways that 
underlie the structural impairments associated with stress and 
depression 
 A mechanism has been proposed wherein stress and elevated glucocorticoids, 
results in glutamate excitotoxicity, disturbed calcium homeostasis, an inhibition of 
glucose transport and an increase in oxygen radical generation (Sapolsky, 2000). 
However, only in the most extreme cases, does chronic stress lead to cellular death or 
compromises hippocampal neurons in their ability to respond to other insults. 
Hippocampal neuronal death after insults involving oxidative stress and perturbed 
calcium homeostasis has traditionally been considered necrotic, wherein the neuron dies 
via swelling, disruption of its cellular membrane and release of its contents into the 
extracellular space (Sapolsky, 2000; Joels et al, 2004). The emerging view that glia play 
a critical role in synaptic neurotransmission (Bezzi and Volterra, 2001) and the glial cell 
loss observed in cortical regions of patients with depression (Manji et al, 2001; Cotter et 
al, 2001; Hasler et al, 2007) suggests that glial glutamate may also contribute to the 
necrotic process and cellular death. 
 Research in the last decade has shown that neurons in the adult brain also die via 
another process called apoptosis. Apoptosis is a normal physiological process during 
development wherein excess cells are removed from the brain (Yuan and Yankner, 
2000). In the adult brain, however, this process plays an important role in the cell death 
observed in acute and chronic neurodegenerative diseases. In contrast to necrosis, 
apoptosis is programmed and critically controlled by the levels of proapoptotic (BAX, 
BAD) and antiapoptotic (BCL-2 and BCL-xL) proteins within the cell. In response to 
death-inducing stimuli, these proteins regulate the release of cytochrome c from the 
mitochondria into the cytoplasm (Yuan and Yankner, 2000). This process, in turn, 
sequentially activates cysteine proteases called caspases. Caspases are the main 
executors of apoptosis, responsible for the morphological and biochemical changes (i.e., 
DNA fragmentation and membrane blebbing) associated with it. There is some evidence 
that apoptosis might occur in depression. Postmortem studies revealed apoptosis in 
limbic structures, particularly in the entorhinal cortex, subiculum, dentate gyrus and 
CA1 hippocampal subfields, although there was no major cell loss in these regions 
(Lucassen et al, 2001; Lucassen et al, 2006). Because apoptosis is a measure of ongoing 
cell death at the time of death, it might not be an indication of the structural impairments 
that occur over a lifetime (D’Sa and Duman, 2002). Whether a neuron dies via apoptosis 
or necrosis, ultimately depends on its glucose availability and calcium homeostasis 
(Sapolsky, 2000). It is possible that both types of degeneration processes play a role in 
cellular death. 
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Impairments in neurogenesis involved in the cellular changes induced 
by stress 
As mentioned above, regional reductions in cell numbers observed in depression is 
primarily due to cell death. However, the demonstration that neurogenesis occurs in the 
human brain into senescence (Eriksson et al, 1998), raises the possibility that ongoing 
impairment of neurogenesis may also play a role (Henn and Vollmayr, 2004). The 
greatest density of new cell birth is observed in the subventricular zone and the 
subgranular layer of the hippocampus. Recent studies have shown that decreased 
neurogenesis occurs in response to both acute and chronic stress, effects which appear to 
be mediated by glucocorticoids (Miller and McEwen, 2006). Thus, it is an interesting 
possibility that the reduced hippocampal volumes that have been observed in conditions 
associated with elevated glucocorticoid levels may be due, at least in part, to an 
impairment of neurogenesis (Dranovsky and Hen, 2006). At present, it is not clear to 
what extent ongoing neurogenesis may contribute to the appearance of new neurons in 
other brain regions, and if these newborn neurons are also regulated by glucocorticoids 
in a similar manner. Age-related increases in glucocorticoid levels have also been 
postulated to be responsible for the reduced rate of neurogenesis observed in aged 
mammals, since lowering of glucocorticoid levels in these animals restores neurogenesis 
to levels observed in younger animals (Cameron and McKay, 1999). These observations 
raise the intriguing possibility that corticotropin-releasing factor (CRF) antagonists, 
currently being developed for the treatment of mood and anxiety disorders, may have 
particular utility in the treatment of elderly depressed patients. 
 
 
Involvement of the cytoskeletal microtubular system in neuronal 
plasticity, stress and antidepressant effects 
     As mentioned above, the property of adult neurons to change their structure and 
function in response to new stimuli is called neuronal plasticity and includes changes in 
dendritic ramifications, synaptic remodelling, LTP, axonal sprouting, neurite extension, 
synaptogenesis and neurogenesis. Structural neuronal plasticity, which is involved in the 
pathophysiology of stress and depression, requires cytoskeletal molecular changes in the 
components of the microtubular system, which is a complex cellular machine formed by 
multiple components. In the brain the main elements of the microtubular system are 
Tubulin α and β isotypes (α1/α2, α4, βI/βII, βIII, βIVa/b), Tubulin modifications 
(Phosphorylation, Glutamilation, Acetylation, Tyrosination/ detyrosination) and 
microtubule-associated proteins (MAPs) (MAP-1A, MAP-1B, MAP-2a/b, MAP-2c, 
MAP-4, TAU). Different components of the microtubular system seem to be involved in 
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the regulation of microtubule dynamics in neurones and, therefore, in the regulation of 
neuronal plasticity (Bianchi et al, 2003).  
     The close relationship between the microtubular system and the control of 
structural neuronal plasticity suggests the possibility of microtubular alterations in the 
hippocampus following both stress and exposure to glucocorticoids. First evidence of 
microtubular changes following stress and glucocorticoids was that local hippocampal 
infusion with the excitotoxin kainate increased TAU while decreased MAP-2 
immunoreactivity in the CA3 subregion of the hippocampus (Stein-Behrens et al, 1994). 
In addition, alterations in MAPs induced by the neurotoxic effect of kainate infusion 
could be significantly exacerbated if the animals were also submitted to a 3-day 
combination of stressors (Stein-Behrens et al, 1994). These results were followed by a 
long period of silence on the subject and only recently, indications of changes in the 
microtubular system following stressors have been strengthened by data showing that 
different components of the microtubular system are modified in the hippocampus of 
rodents submitted to both acute and chronic stress models or treated with glucocorticoids. 
These modifications consist of changes in specific α-tubulin post-translational 
modifications such as Tyr-Tub and Acet-Tub and in different MAPs, like MAP-2, 
MAP-1A and TAU (Table 7).  
     Studies on the effects of antidepressant treatment upon the neuronal microtubular 
system are still in the early stages. However, current data indicate that both acute and 
chronic antidepressant treatments could exert an action on neuronal microtubular 
proteins and microtubule dynamics. It has been reported that citalopram can decrease the 
mRNA expression of α2-tubulin. Protein expression of MAP-2 and of α-tubulin 
post-translational modifications can be affected by acute treatment with antidepressants 
in rat hippocampus. The expression of Tyr-Tub was unchanged by fluoxetine and 
tianeptine treatment while Acet-Tub was significantly increased by both antidepressants. 
Chronic restraint stress of rats for three weeks did not change the MAP2 mRNA 
expression, which suggests that MAP2 are not likely to be directly related to the chronic 
stress-induced dendritic atrophy or the prevention of the atrophy (Kuroda and McEwen, 
1998). Perez et al showed that long-term treatment with desipramine can change the 
endogenous phosphorylation of MAP-2 in the rat cerebrocortical soluble fraction (Perez 
et al, 1989). And the enhancement in MAP-2 phosphorylation paralleled an increase in 
the activity and amount of the R subunit of cAMP-dependent protein kinase (PKA) type 
II (Popoli et al, 2000). The PKA family is involved in the regulation of neuronal gene 
expression and synaptic plasticity. In neurons one third of the cytosolic PKA is 
associated with microtubules and PKA itself was firstly identified in brain microtubule 
preparation co-purified with MAP-2 (Schulman 1991; Obar et al, 1989). Indeed, several  
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Table 7. Effects of etress and glucocorticoids on the 















            
 
 
               
 (+): increase; (=): no change; (-): decrease. 
 
pieces of evidence showed that serotonin transporter (SERT) and norepinephrine 
transporter (NET) inhibitors can increase the activity of the R subunit of PKA type II in 
rat cerebral cortex. MAP-2 is the major substrate for PKA and it has been shown that 
one third of the brain PKA type II is bound to microtubules (Popoli et al, 2000; Sanchez 
et al, 2000). Together, these findings strongly suggest that MAP-2 phosphorylation can 
be affected by chronic antidepressant treatment via PKA modulation. The increase in 
MAP-2 phosphorylation has not been shown following acute antidepressant treatment or 
in vitro addition of the antidepressants suggesting that MAP-2 alterations are part of the 
adaptative changes induced by antidepressants in postreceptor signalling and could 
contribute to their therapeutic effect (Racagni et al, 1992). However, the effect on 
MAP-2 phosphorylation is not a common action to all antidepressants. Indeed, 5 days of 
fluvoxamine treatment can enhance the phosphorylation of MAP-2, but failed to produce 
this effect after 12 or 21 days of treatment (Perez et al, 1995). Interestingly, a recent 
study has shown that MAP-1A mRNA was up-regulated in the rat hypothalamus by 
chronic treatment with imipramine (Wong et al, 2004). More recently, it was showed 
 Effect Method 
Stress 
Combination of stressors(3 
days) 
(-) MAP-2 in CA3 Immunocytochemistry 
Combination of stressors 
(28 days) 
(-)MAP-2 in CA1 and 
CA3 
Immunocytochemistry 
Repeated restraint stress 
(4h for 3 days every day) 
(+) MAP-1A Western Blot 
Chronic restraint stress (6h 
for 21 days every day) 
(=) MAP-2 In situ hybridisation 
Acute restraint stress (6h 
for 1day) 
(+) Acet-Tub Western Blot 
Sub-chronic restraint stress 
(6h for 4 days every day) 
(+) Acet-Tub, (-) 
Tyr-Tub 
Western Blot 
Forced swimming test 
(15min + 5min 24h later) 
(-) Tyr-Tub Western Blot 
Cold water stress (5 min) (+) HP-TAU Western Blot 




(+) TAU Immunocytochemistry 
Dexamethasone (from 0.7 
to 20 mg/kg IP) 
(-) MAP-2 in DG, 
CA1 and CA3 
Immunocytochemistry 
Betamethasone(48h 
infusion at 10µg/h) 
(-) MAP-2 Immunocytochemistry 
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that chronic treatment with venlafaxine accelerated the recovery from the increase in 
MAP-1A expression observed following repeated restraint stress (Xu et al, 2004). 
Finally, a recent proteomic study has shown that chronic treatment with either fluoxetine 
or venlafaxine increased the expression of collapsing response mediator protein -2 
(CRMP-2) in rat hippocampus (Khawaja et al, 2004). Importantly, CRMP-2 is a 
tubulin-binding protein promoting axonal growth and branching in vitro (Fukata et al, 
2002). Taken altogether, these data indicate that chronic treatment with antidepressants 
may increase microtubule dynamics affecting different aspects and components of the 
microtubular system. 
Using SDS-PAGE analysis, we discovered a dramatic decrease of a novel protein in 
ischemic brain tissue following experimental occlusion of the middle cerebral artery in 
rats. Using a polyclonal antibody, we found the protein primarily in the brain and 
pancreas, for that reason, we named the protein brain-pancreas relative protein (BPRP). 
BPRP was analyzed by peptide mass fingerprinting (PMF) and matrix-assisted laser 
desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS), which 
indicates that BPRP is a novel protein (Yao et al, 2003). Based on the protein database, 
BPRP possesses significant matching relation to MAP, which is thought to be involved 
in the neuroplasticity. In one of our studies, we reported a possible role of BPRP in male 
rats exposed to chronic unpredictable mild stress (CUMS) for 3 weeks to mimic 
depression. Compared to unstressed rats, those exposed to CUMS showed a significant 
reduction in pancreatic BPRP, accompanied by an increase in levels of blood glucose. 
But stressed rats showed no apparent alteration in levels of BPRP in the hippocampal 
formation, which nevertheless displayed a thinner dentate granule cell layer perhaps 
related to elevated MAO-B activity (Lin et al, 2005).  
 
 
Involvement of CREB in neuronal plasticity, stress and 
antidepressant effects 
 cAMP-response-element-binding protein (CREB) is expressed in all cells in the 
brain and is a member of a family of leucine zipper transcription factors. This family 
consists not only of transcriptional activators, including CREB and activating 
transcription factor (ATF), but also repressor molecules like cAMP response element 
modulator (CREM) and inducible cAMP early repressor (ICER). Localized within the 
nucleus, transcription factors such as CREB are crucial for stimulus-transcription 
coupling: the transmission of events that occur at cell membranes into alterations in gene 
expression. In turn, altering gene expression, by regulating the expression of virtually all 
types of neuronal proteins, can ultimately affect the function of individual neurons and 
entire neuronal circuits. The key steps involved in CREB-mediated gene transcription 
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include dimerization, binding at response elements in DNA, and phosphorylation 
(Shaywitz and Greenberg, 1999; Mayr and Montminy, 2001). CREB binds as dimers to 
the cAMP-response element (CRE), a specialized stretch of DNA that contains the 
consensus nucleotide sequence 5'TGACGTCA-3'. There are numerous phosphorylation 
sites on the CREB protein that differentially regulate CREB activity. PKA, 
mitogen-activated protein kinase (MAP) kinase signalling pathway (MEK/ERK), the 
calcium-CaMKII/IV cascade, as well as phospholipase C (PLC) signaling each 
phosphorylate CREB at serine 133, which stimulates the recruitment of CREB-binding 
protein (CBP) and thereby leads to activation of gene transcription (Gonzalez and 
Montminy, 1989). By contrast, CaMKII phosphorylates CREB at serine 142, which 
promotes the dissociation of the CREB dimer and thus reduces CREB-mediated gene 
transcription (Matthews, 1994; Wu and McMurray, 2001).  
 CREB is implicated in both stress- and antidepressant-induced transcriptional 
regulation (Hatalski and Baram 1997; Conti et al, 2002; Sairanen et al, 2007). The 
cAMP-CREB signalling cascade is critical to the generation of new neurons in the 
rodent hippocampus, and also facilitates their subsequent morphological maturation 
(Nakagawa et al, 2002; Fujioka et al, 2004; Giachino et al, 2005). Thus, given its 
neuro-protective and survival-enhancing properties, it is an attractive candidate molecule 
that may be targeted by antidepressant therapy. However, emerging evidence suggests 
that CREB activity has very different roles--sometimes beneficial, sometimes 
detrimental-depending on the brain region involved. 
 Research in the past decade provides strong support for an up-regulation of the 
postreceptor cAMP pathway following chronic antidepressant administration (Duman et 
al, 1997). Results include increased coupling of the stimulatory G protein, Gs to 
adenylyl cyclase (Ozawa and Rasenick, 1991), increased PKA activity in the particulate 
fraction of limbic structures, increased PKA levels in the nuclear fractions of cerebral 
cortex (Nestler et al, 1989; Perez et al, 1989) and increased mRNA expression of the 
type1 adenylyl cyclase in the rat hippocampus (Jensen et al, 2000). The downstream 
target of the cAMP-PKA pathway is the transcription factor, CREB. The up regulation 
of CREB expression was observed with administration of different classes of 
antidepressants, including a selective serotonin reuptake inhibitor (fluoxetine and 
sertraline), a selective norepinephrine (NE) reuptake inhibitor (desipramine), a dual 
aminergic reuptake inhibitor (imipramine) and chronic electroconvulsive seizures (ECS) 
(Tardito et al, 2006). The nonantidepressant psychotropic drugs, cocaine and haloperidol, 
did not influence CREB mRNA expression indicating the specificity of CREB induction 
to antidepressants. Moreover, there was a strong correlation between the clinical efficacy 
of these drugs and their influence on CREB expression because this increase was 
observed with chronic, not acute, treatment (Blendy, 2006), suggesting that CREB 
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induction is secondary to some other adaptations in gene expression occurring in the 
brain. A goal of current studies in depression has been to identify these adaptations. In 
transgenic mice with a CRE-Lac Z reporter construct activation of the CRE site led to 
increased expression of the LacZ gene product, -galactosidase suggest that chronic 
antidepressant treatment activates CREB and CRE-mediated gene transcription in vivo 
(Thome et al, 2000; Impey et al, 1998).  
 The mechanism underlying the up-regulation of CREB by antidepressants and by 
activation of monoaminergic systems has been characterized in vitro and more recently, 
in vivo. Studies in vitro indicate that CREB can be activated directly by the cAMP-PKA 
pathway via stimulation of the NE (β-adrenergic and α1-adrenergic) (Roseboom et al, 
1997; Lin et al, 1998) and 5-HT (5-HT4,7) receptors (Duman, 1998; Markstein et al, 1999; 
Lambert et al, 2001). CREB activity can also be directly induced by Ca2+-dependent 
protein kinases and PKC which were activated by stimulation of the α1 adrenergic 
receptor and 5-HT2 receptors (Duman, 1998; Shaywitz et al, 1999). Finally, CREB can 
also be directly phosphorylated by activating the Ras-MAPK signaling pathway (Ghosh 
et al, 1994). Studies in primary neuronal cultures have demonstrated that NE via the α2 
adrenergic receptors and 5-HT via the 5-HT1A and/or 5HT7 receptor activates the 
Ras-MAPK cascade (Luttrell et al, 1999; Mendez et al, 1999; Errico et al, 2001). This 
could explain, in part, how antidepressants that act by inhibiting NE and 5-HT reuptake, 
could mediate their effects on CREB.  
     There is evidence that the expression of the high affinity type 4 
phosphodiesterases (PDE4), which metabolize intracellular cAMP, was also induced by 
activation of the cAMP system (Rossby et al, 1999). Long-term administration of the 
different classes of antidepressants increased mRNA and protein levels of the 
cAMP-specific PDE4 isozymes, PDE4A and PDE4B in rat frontal cortex and 
hippocampus (Conti and Jin, 1999; Ye et al, 1997; Zhang et al, 2006; Dlaboga et al, 
2006; Fujita et al, 2007). The up regulation of PDE4 gene expression in response to 
sustained activation of the cAMP-CREB cascade was a compensatory adaptation that 
would reduce cAMP levels back to baseline (Rossby et al, 1999). The increased 
expression of the PDE4 isozymes by chronic antidepressant treatment therefore could 
blunt the efficacy of antidepressants and contribute to their delayed action and overall 
efficacy. An induction of PDE4s also suggests that inhibition of these enzymes may 
represent a novel strategy for developing new therapeutics (Conti and Jin, 1999; Ye et al, 
1997; Zhang et al, 2006; Dlaboga et al, 2006; Fujita et al, 2007) and further supports the 
role of the cAMP-CREB cascade in depression. 
     Several rodent models have been developed to study the specific role of CREB in 
these behavioral paradigms through the generation of knockout mice or viral 
overexpression of CREB or mutant forms of CREB. Two criteria that have been 
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proposed for evaluating animal models of depression are that these paradigms have 
strong predictive validity and that the behavioral response is reliable and robust within 
and across laboratories (Geyer and Markou, 1995). Three behavioral tests meeting these 
criteria are the forced swim test (FST), the tail suspension test (TST), and learned 
helplessness. In these studies, like antidepressant drugs, acute viral vector-mediated 
overexpression of CREB in the dentate gyrus of the rat hippocampus significantly 
reduced immobility times in the FST and decreased the number of escape failures in the 
learned helplessness paradigm (Chen et al, 2001a). In contrast, overexpression of CREB 
in either the CA1 pyramidal cell layer of hippocampus or the prefrontal cortex did not 
produce an antidepressant response in these same tests (Chen et al, 2001a). In frontal 
cortex, activation of the cAMP pathway, which would be expected to increase CREB 
activity, can either promote or impair cognitive performance depending on the age of the 
animal (Ramos et al, 2003). 
     Increasing evidence indicates that CREB function in nucleus accumbens (NAc) 
regulates anxiety-like behavior in rodents. Disruption of CREB function within the NAc, 
achieved by viral overexpression of mCREB (A mutation in the Creb gene that changes 
the amino acid serine at postition 133 to an alanine effectively blocks phosphorylation of 
the protein, this mutation is referred to as M1 or mCREB (Karin and Hunter, 1995)), 
produces anxiety-like effects, whereas increased CREB function causes opposite 
changes (Barrot et al, 2002; Barrot et al, 2005). On the other hand, global knockdown of 
CREB reduced anxiety-like behavior (Valverde et al, 2004), perhaps owing to CREB 
actions outside the NAc. The notion that elevated CREB function in NAc causes certain 
depression-like symptoms, while reduced CREB function in this region causes 
anxiety-like behavior, may seem paradoxical, but can be understood within the role 
CREB may play in this reward circuit under normal conditions. One hypothesis is that 
CREB is a key regulator of the reactivity of brain reward circuits and thereby regulates 
individual sensitivity to emotional stimuli (Carlezon et al, 2005). Short-term increases in 
CREB activity in NAc, induced by normal rewarding or aversive stimuli, would serve to 
dampen responses to subsequent stimuli and facilitate the ability to actively deal with the 
situation at hand (e.g., consumption of reward, escape from danger). Under more 
pathological conditions, however, larger and more sustained increases in CREB activity, 
induced by drugs of abuse or excessive stress, would lead to an excessive dampening of 
emotional reactivity and to the behavioral phenotype outlined above. Conversely, 
sustained reductions in CREB activity, which are seen under conditions of social 
isolation (Barrot et al, 2005), would heighten emotional reactivity and in the extreme be 
associated with a state of anxiety. This work highlights the notion that extreme increases 
or decreases in CREB function in NAc may be detrimental and contribute to the 
symptomology of different subtypes of depression (Carlezon et al, 2005). 
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     Reductions in CREB activity in the rat NAc, through viral vector-mediated 
expression of the dominant negative mutant mCREB, increased the rewarding effects of 
cocaine, morphine, and sucrose (Carlezon et al, 1998; Barrot et al, 2002; DiNieri et al, 
2005) and produced antidepressant-like effects in the forced swim test (Pliakas et al, 
2001) and learned helplessness paradigm (Newton et al, 2002). Likewise, expression of 
mCREB in the NAc of inducible transgenic mice produced antidepressant-like effects 
(Newton et al, 2002). Targeted deletion of predominant CREB isoforms in mutant mice 
also produced antidepressant-like effects (Conti et al, 2002).  
     All in all, regions such as the hippocampus, frontal cortex, amygdala, and nucleus 
accumbens subserve a diverse set of behaviors, from learning and fear conditioned 
responses to hedonia. Given the clinical heterogeneity of depression, it is reasonable to 
consider that CREB might initiate a different series of downstream effects, which 
eventually impinge upon behavior, such that these behaviors will vary depending on the 
brain region in which CREB is active.  
 
 
Involvement of BDNF in neuronal plasticity, stress and 
antidepressant effects 
     Trophic factors are essential for the survival and differentiation of neurons during 
development and the survival and function of neurons in the adult (Soule et al, 2006). 
One such factor is brain-derived neurotrophic factor (BDNF), which belongs to the 
family of neurotrophins that includes nerve growth factor, neurotrophin-3 and 
neurotrophin 4/5. Neurotrophins exert their effects by binding to tyrosine kinase (Trk) 
receptors and activating intracellular pathways such as the mitogen activated protein 
kinase (MAPK) cascade (Thoenen, 1995). The neurotrophins are primarily synthesized 
as 30-35 kDa precursor proteins or pro-neurotrophins, which are cleaved by 
pro-convertases at a highly conserved dibasic amino acid cleavage site, thus generating 
the mature proteins. These later proteins have a number of shared features, including a 
similar number of amino acids (118-120), close molecular weights ( 12 kDa), 
isoelectric points in the 9-10 range, and 50% identity in the primary structure 
(Tapia-Arancibia et al, 2004). 
  More and more evidence demonstrates that stressors decrease the expression of 
critical trophic factors in the brain. Prolonged exposure to several stressors resulted in a 
down-regulation of BDNF expression in the hippocampus (Smith et al, 1995; 
Rasmusson et al, 2002; Gronli et al, 2006; Alfonso et al, 2006). Animal models like 
learned helplessness also resulted in a decline in hippocampal BDNF expression (Song 
et al, 2006). In addition to the decrease in BDNF mRNA expression, chronic stress also 
increased mRNA levels of its receptor, catalytic TrkB in the hippocampus (Smith et al, 
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1995). This occurred as an adaptive compensatory response to the downregulation of 
BDNF (Nibuya et al, 1999). It has been proposed that repression of transcription at the 
BDNF gene promoter by the activated corticosteroid receptor played a role (Schaaf et al, 
2000), which is confirmed by a recent study that BDNF regulation by social stress was 
mediated through epigenetic mechanisms of methylation, and hence transcriptional 
repression, of the BDNF III and IV promoters (Tsankova et al, 2006). Related 
compatible evidence suggests that a dysfunction of the cAMP-CREB signaling cascade 
might underlie the stress-induced BDNF down regulation (Duman et al, 1997; Nair and 
Vaidya, 2006). These cellular studies demonstrate that decreased BDNF level is a crucial 
phenomenon associated with stress and particularly relevant to our understanding of 
stress-related depressive disorders.  
      Studies also have clearly indicated that BDNF serves as a target for 
antidepressant treatments. Antidepressant therapies, including pharmacological 
antidepressants, electroconvulsive seizures and physical activity - a natural 
antidepressant, robustly increased the expression of this neurotrophin in the 
hippocampus and cortex, this up-regulation followed the time course for the therapeutic 
action of antidepressant treatments (Nibuya et al, 1995; Dias et al, 2003; Farmer et al, 
2004; Alfonso et al, 2006). Distinct classes of antidepressants appeared to regulate the 
BDNF gene through differential recruitment of individual BDNF promoters (Dias et al, 
2003). Additionally, the stress-mediated reduction in BDNF expression can be prevented 
with pre-administration of antidepressant therapy (Nibuya et al, 1995), which appeared 
to be capable of reversing the epigenetic shut down of the BDNF III and IV promoters 
caused by stress. Indeed, overexpression of histone deacetylases, which would 
de-repress the epigenetic control of the BDNF promoters, was shown to upregulate 
hippocampal BDNF expression and exerts antidepressant-like effects in animal models 
(Tsankova et al, 2006). Furthermore, truncated trkB over-expressing mice which show 
reduced BDNF signaling, were resistant to the effects of antidepressants in the forced 
swim model of depression (Saarelainen et al, 2003). There is also evidence that some of 
the structural changes in the hippocampus that ensue from sustained antidepressant 
treatment are mediated, at least in part, by BDNF. The mossy fiber sprouting seen in the 
hippocampus following chronic ECS was partially lost in BDNF heterozygote mice 
(Vaidya et al, 1999). Finally, the effects of the antidepressant desipramine in the forced 
swim test were lost in adult-onset forebrain knockouts of BDNF, thus indicating that 
BDNF plays a role in the behavioral actions of antidepressants (Monteggia et al, 2004; 
Monteggia et al, 2007).  
 BDNF, itself, can act as an antidepressant. Infusion of exogenous BDNF into the 
ventricles, midbrain or the hippocampus of rodents had an antidepressant-like effect in 
several models of depression (Siuciak et al, 1997; Shirayama et al, 2002; Eisch et al, 
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2003). In addition, BDNF receptor ‘trkB’ overexpression mice exhibited antidepressant- 
like responses in the forced swim test (Koponen et al, 2005). However, in a manner 
reminiscent of CREB, the spatial expression of BDNF is critical in its antidepressant- 
like activity. Whereas increased BDNF expression in the hippocampus appeared to be 
antidepressant in nature, increased BDNF activity in the ventral tegmental area (VTA) or 
nucleus accumbens (NAc) resulted in a pro-depressive state (Eisch et al, 2003). Other 
factors such as GDNF (glial cell-line derived neurotrophic factor) were also involved in 
the survival and neuroprotection of neurons (Lin et al, 1993) besides BDNF. In vitro 
studies using the astrocytic-derived C6 glioma culture cells showed that different classes 
of antidepressants increased GDNF mRNA expression and enhanced its release into the 
media (Hisaoka et al, 2001). In contrast, in vivo studies using long-term administration 
of several different classes of antidepressants did not show regulation of either GDNF, 
or its receptors (GFR-1, GFR-2 and c-Ret) (Chen et al, 2001b). That the results differ 
between in vitro and in vivo studies indicates that caution must be used when comparing 
different models systems. 
  Regions exhibiting an up-regulation of BDNF in response to antidepressant 
administration overlap closely with the regions that show an up-regulation of CREB. 
This spatial correlation suggests that CREB may contribute to the antidepressant induced 
increase in hippocampal BDNF expression. A role for the cAMP system in mediating 
the antidepressant-induced increase in BDNF expression was supported by studies with 
the PDE inhibitors papaverine and rolipram (Nibuya et al, 1996). PDE inhibitors have 
been shown to enhance BDNF expression and to accelerate the induction of BDNF when 
co-administered with an antidepressant. In addition, culture studies indicate that 
activation of the cAMP or Ca2+ signalling systems up-regulates BDNF expression (Tao 
et al, 1998; Shieh et al, 1998). Studies indicate that there is a CRE-like element within 
the promoter region of exon III of BDNF. Further studies are required to dissect the role 
of CREB in mediating the up-regulation of BDNF expression following chronic 
antidepressant treatment. In addition to regulation of BDNF expression through the 
cAMP/Ca2+ signalling and CREB system, an alternate pathway may involve βAR or 
5-HT2 receptor internalization. Receptor internalization recruits Ras and the MAP 
kinase intracellular cascade and may thus influence BDNF expression independent of 
the cAMP signalling cascade.     
     Similar to the action of CREB, a caveat also relates to the actions of BDNF in 
different brain regions. Although administration of BDNF into the midbrain, 
hippocampus, or lateral ventricles produces an antidepressant effect in models of 
depression, overexpression of BDNF in other regions has a different effect. This has 
been studied most extensively in the mesolimbic dopamine system or the reward circuit. 
Antidepressant treatment has been shown to increase BDNF levels in the ventral 
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tegmental area (VTA) and the substantia nigra (SN) (Van Hoomissen et al, 2003). 
However, overexpression of BDNF in the VTA produced an increase in depressive-like 
behaviors, and overexpression of a dominant-negative form of TrkB in the nucleus 
accumbens produced an antidepressant response (Eisch et al, 2003). It is interesting that 
BDNF infusion into the mesolimbic dopamine (DA) system produces a prodepressive 
effect since this brain region may be involved in mediating some of the anhedonic 
responses observed in depressed patients. In any event, these data suggest that BDNF 
and the TrkB receptors, may produce different effects on depression-like behavior 
depending on the brain regions and could ultimately account for different aspects of the 
disease phenotype. 
 Taken together, these studies indicate that antidepressants up-regulate BDNF 
expression and BDNF itself exerts an antidepressant effect. First, chronic, but not acute, 
antidepressant treatment increases hippocampal BDNF mRNA with the induction 
following the time-course observed for the therapeutic effects of antidepressant 
treatments. In addition, pre-administration of antidepressants prevents stress-induced 
decreases in hippocampal BDNF mRNA. Second, direct infusion of BDNF protein into 
the midbrain exerted antidepressant effects in two models of depression, i.e. the forced 
swim and learned helplessness models (Siuciak et al, 1996). Third, BDNF exerted a 
strong trophic effect on serotonergic and noradrenergic neurons regulating morphology, 
neurotransmitter metabolism and firing patterns of these neuronal populations 
(Sklair-Tavron and Nestler, 1995; Mamounas et al, 1995). Fourth, chronic stress is 
known to result in neuronal damage and death. Decreased BDNF expression as a 
consequence of stress may play a role in stress-induced neuronal damage. Fifth, effects 
of BDNF have brain region difference. 
 
 
Roles of CREB and BDNF in neuronal survival and neurogenesis 
 The evidence presented above strongly supports the hypothesis that CREB and 
BDNF contributes to the therapeutic actions of antidepressants. So how can regulation of 
these molecules contribute to neuronal plasticity and survival in the brain? As mentioned 
above, stress and depression are associated with volume decreases and cellular 
remodeling, processes that underlie neural plasticity. Exciting recent work has placed 
CREB and BDNF center stage as critical mediators of neural plasticity and survival. The 
pathways governing neural plasticity and cell survival were intimately linked (Shaywitz 
and Greenberg, 1999; Greisen et al, 2005). Neuronal survival is critically dependent on 
neuronal activity, synaptic contact of a neuron with its surrounding cells and importantly, 
neurotrophic support (Ghosh et al, 1994; Sairanen et al, 2005). Withdrawal of 
neurotrophic support from neurons triggers apoptosis. Neurotrophins regulate neuronal 
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apoptosis mainly through the phosphoinositide 3-kinase/Akt and the Ras/MAPK 
pathways (Yuan and Yankner, 2000). 
 Recent seminal studies have elucidated the mechanism by which BDNF and 
CREB inhibits apoptosis in neurons. Activation of CREB via the Ras/MAPK cascade is 
mediated by the CREB kinases or ribosomal S6 kinases called Rsks. It has been 
demonstrated that BDNF-induced survival of cerebellar granule cells is dependent on the 
activation of Rsk. Activated Rsk inactivates the pro-apoptotic protein BAD by 
increasing its phosphorylation state (Bonni et al, 1999). Rsk also increases the 
phosphorylation of CREB at Ser133 and provides neuroprotection by increasing the 
expression of the antiapoptotic protein, BCL-2. On the other hand, an inhibition of 
CREB phosphorylation triggered apoptosis (Bonni et al, 1999). In a parallel study, a 
requirement for CREB and up-regulation of BCL-2 in neurotrophin-mediated survival 
was also documented in cerebral cortical neurons and sympathetic neurons (Riccio et al, 
1999). These researchers also demonstrate that the CRE in the BCL-2 gene promoter 
mediates responsiveness to CREB. Up-regulation of CREB and BDNF by 
antidepressants therefore, suggests that these drugs could act through triggering survival 
signals to counteract cellular death cascades. Although the regulation of Rsks and the 
BCL-2 family of antiapoptotic proteins by antidepressant treatment have not been 
studied, it is tempting to hypothesize that antidepressants could mediate their survival 
effects by regulating these proteins within the brain. Within this context, it is interesting 
to note that the mood stabilizers, lithium and valproate used in the treatment of bipolar 
disorders, increase BCL-2 protein levels in the frontal cortex and hippocampus (Manji et 
al, 2000). 
 Another explanation of the cellular mechanism of the long-term action of 
antidepressants involves the effect of these drugs on the rate of new neuron formation in 
the adult brain (Duman et al, 2001). Recent evidence demonstrates that chronic 
administration of different classes of antidepressants increased the proliferation as well 
as number of newly formed neurons in the hippocampus (Hajszan et al, 2005). This 
increase is not seen in response to chronic treatment with non-antidepressant 
psychotropic drugs indicating a high degree of specificity of this effect to 
antidepressants. These data suggest that neurogenesis may be a mechanism by which 
antidepressant treatment reverses the stress-induced decrease in hippocampal granule 
cell proliferation (Warner-Schmidt and Duman, 2006).  
     It was reported that the behavioral effects of antidepressants require the 
hippocampal neurogenesis. Using genetic and radiological methods, they showed that 
disrupting antidepressant-induced neurogenesis blocks behavioral responses to 
antidepressants. Serotonin 1A receptor null mice were insensitive to the neurogenic and 
behavioral effects of fluoxetine. X-irradiation of a restricted region of mouse brain 
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containing the hippocampus prevented the neurogenic and behavioral effects of two 
classes of antidepressants. These findings suggest that the behavioral effects of chronic 
antidepressants may be mediated by the stimulation of neurogenesis in the hippocampus 
(Santarelli et al, 2003). 
 
 
Clinical studies of CREB and BDNF in depression and 
antidepressant action 
     While a robust body of literature exists suggesting a role for CREB and BDNF in 
depression as well as in antidepressant action, a majority of the work is restricted to 
animal models. However, building evidence from clinical studies also supports the idea 
that CREB and BDNF is involved in the pathogenesis of depression and in the 
mechanisms of antidepressant action. 
     Postmortem studies showed a decrease in CREB expression in the cerebral cortex 
of patients not undergoing antidepressant therapy, while CREB immunoreactivity 
increased in response to antidepressant treatment (Dowlatshahi et al, 1998). Similarly, 
BDNF immunoreactivity was considerably decreased in the brains of treatment-naive 
patients, while antidepressant therapy increased BDNF expression to levels resembling 
that of healthy control individuals (Chen et al, 2001b). Serum BDNF, which is believed 
to be reflective of BDNF levels in the brain, also showed a similar trend, with decreased 
levels of serum BDNF seen in patients suffering from depression. This decline in serum 
BDNF levels was negatively correlated with the MADRS (Montgomery-Ashberg 
Depression Rating Scale), i.e. with the severity of the depressive symptoms (Karege et al, 
2002). 
     Insights from genetic linkage studies provide further support for a role of CREB 
and BDNF in depressive disorders. The CREB1 locus was thought to have an epistatic 
influence in defining susceptibility to recurrent, early-onset, major depression (Zubenko 
et al, 2003). The BDNF locus has been implicated in altered vulnerability for bipolar 
disorder (Neves-Pereira et al, 2002) and childhood depression (Kaufman et al, 2006). In 
addition, a single nucleotide polymorphism, val66met, in the BDNF coding region had a 
strong association with childhood-onset mood disorder (Strauss et al, 2005) and geriatric 
depression (Hwang et al, 2006). The val66met polymorphism was correlated with a 
decreased hippocampal volume and abnormal hippocampal activation, which may 
underlie an enhanced vulnerability to the development of depression (Bueller et al, 
2005). Furthermore, cell biological studies have revealed that the met-BDNF variant 
showed disruption of activity-dependent release (Egan et al, 2003), raising the 
possibility that the met allele may result in deficits in the ability to mount 
BDNF-induced remodeling of neuronal circuits. In support of such a hypothesis, a recent 
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study indicated that healthy individuals with the met allele exhibited reduced 




     The studies discussed here support the hypothesis that a failure of neural plasticity 
occurs in depression. Data supporting this idea include the stress-induced cellular and 
morphological changes observed in animal models of depression as well as the cellular 
and volumetric impairments observed in patients with depression. This could be the 
result of disruption of neuroplasticity as well as signal transduction cascades at several 
levels, particularly the CREB and BDNF cascades. Antidepressants may exert their 
therapeutic effects by modulating intracellular signaling pathways, counteracting cellular 
death cascades, increasing neuroplasticity and mediating the long-term persistent 
















   
 
    
    Figure 2. Schematic showing the influence of antidepressant treatment on the 
cyclic adenosine monophosphate (cAMP)-cAMP response element-binding protein 
(CREB) cascade and the corresponding role of this cascade and the neurotrophin- 
mitogen activated protein kinase (MAPK) pathway in neural plasticity and cell survival 
(D’Sa and Duman, 2002). 
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Scope of this thesis 
      BPRP, a novel protein found in our lab, is mainly expressed in brain and 
pancreas. How stress effects the expression of BPRP and whether BPRP is involved in 
the pathophysiologic process of depression has not been investigated. Furthermore, 
many experimental studies focusing on the pathophysiology of depression have 
examined the effects of stress in male subjects, and the biological basis of gender 
difference in stress response and recovery after long-term stress still remains poorly 
understood. Therefore, it is an important argument for performing stress research not 
only in male animals but also in females. Thus, the aims of the studies presented in this 
thesis were to explore the possible role of BPRP in the pathophysiologic process of 
depression, and to explore the gender difference in response to stress and recovery at 
the molecular level of the expression of several proteins such as CREB, pCREB etc. 
 
 
Outline of this thesis 
      Chapter 2 describes the effects of 3-week chronic mild unpredictable stress on 
the expression of BPRP in brain and pancreas in male rats. Fluid consumption test is 
applied to evaluate the model of depression, levels of glucose are also measured during 
the whole period. 
      Chapter 3 describes the effects of glucose and insulin, also the supernatant from 
pancreatic β-cells on the expression of BPRP in hippocampal neurons. In chapter 2 it 
was found that stress decreased the expression of BPRP in pancreas while not in brain. 
We suppose there is a relationship between glucose and the expression of BPRP. 
      Chapter 4 describes the effects of acute stress (1 day), chronic stress (42 days) 
and recovery (stressed for 21 days, then recovered for another 21 days) on male and 
female rats using behavioral (open field test), endocrine (corticosterone) and 
neurochemical parameters (CREB and pCREB expression in PFC and DG).  
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Abstract Brain-Pancreas Relative Protein (BPRP) is a novel protein whose 
biological functions remain unknown. Here we reported a possible role of BPRP in male 
rats exposed to chronic unpredictable mild stress (CUMS) to mimic depression for 3 
weeks. Compared to unstressed rats, those exposed to CUMS showed  significantly less 
weight gain with age, decreased consumption of (and preference for) sucrose without a 
change in total fluid consumption. Exposure to CUMS significantly reduced open-field 
exploration, rearing, and grooming indicative of lethargy, apathy, and bodily neglect, 
respectively. Brain MAO-A and MAO-B activities were both significantly increased in 
the stressed rats. These results verified induction of depressive symptoms by CUMS. 
The stressed animals showed a significant reduction in pancreatic BPRP, which was 
accompanied by an increase in levels of blood sugar and a decrease in insulin. But they 
showed no apparent alteration in levels or distribution of BPRP in the hippocampal 
formation, which nevertheless displayed a thinner dentate granule cell layer perhaps 
related to elevated MAO-B activity. These findings suggest that stress-induced reduction 
of pancreatic BPRP may cause diabetic symptoms. Nevertheless, whether those 
symptoms in turn contribute to the onset of depression requires further study. 
 
 



















                                            Effects of stress on BPRP / 59    
Introduction 
 Using SDS–PAGE analysis, we discovered a dramatic decrease of a novel 260 kDa 
protein in ischemic brain tissue following experimental occlusion of the middle cerebral 
artery in rats (Yao et al, 2003). Using a polyclonal antibody, we found the protein 
primarily in hippocampal neurons of the brain and islets cells of the pancreas, with lesser 
amounts found in podocytes of the renal glomeruli and endothelial cells of venous 
sinuses in the spleen. For that reason, we named the 260kDa protein Brain-Pancreas 
Relative Protein (BPRP). While the localization of BPRP in vivo strongly implies its 
functions in these tissues, its physiological and pathophysiologic significances need to 
be clarified. 
 Given its location in both pancreatic islets and the hippocampus, we considered 
whether BPRP plays a role in depression, which is a common mental disorder with 
considerable morbidity and mortality (Schulz et al, 2002). Nevertheless, the factors 
associated with the development of depression have not been clearly identified. A high 
prevalence of depression has been found in diabetic patients. Recent studies 
demonstrated that depression and its associated symptoms constituted a major risk factor 
in the development of diabetes and may accelerate the onset of diabetes complications 
(Musselman et al, 2003). Onset of depression may result in decreased self-care measures 
such as exercise. Also, people with depression are more likely to abuse alcohol and 
smoke cigarettes compared with individuals without depression (Brown et al, 2005). 
These behaviors can potentially increase the risk of developing type-2 diabetes. Several 
prospective observational studies (Arroyo et al, 2004; Everson-Rose et al, 2004; Kumari 
et al, 2004; Palinkas et al, 2004; van der Akker et al, 2004) suggest that depression and 
depressive symptoms may be a risk factor for the development of type 2 diabetes, with 
relative risk estimates ranging from 1.3 to 3.0. Other studies indicate an effect of 
depression on the hippocampal structure and function (Shelinea et al, 2002). The 
hippocampus is vulnerable to damage by stroke, head trauma, and repeated stress 
(Sapolsky, 1992). It is not surprising, then, that hippocampal atrophy has been reported 
in a number of psychiatric disorders, including depression (Shelinea et al, 2002; 
McEwen, 2000). 
  Several behavioral paradigms have been used to create animal models of 
depression, among the more common of which is the chronic stress model (Katz, 1982). 
Willner and his colleagues introduced chronic unpredictable mild stress (CUMS) as a 
more realistic paradigm for inducing depression in animals. In that paradigm, animals 
were subject to chronic, low-grade stressors analogous to those associated with 
depression in humans (Willner et al, 1987). CUMS caused reduced sensitivity to reward, 
termed anhedonia, which is a major symptom of most human depressive states and a 
core feature of the DSM-IV subtype known as melancholia (APA, 1994). Anhedonia is a 
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“sharp, pervasive impairment of the capacity to experience pleasure or to respond 
affectively to the anticipation of pleasure” (Klein, 1974). 
 To determine whether or not BPRP is related to the onset and development of 
depression, we used CUMS to induce features of depression in rats. At weekly intervals, 
we compared control and stressed animals for indices of depression (weight loss, loss of 
preference for sucrose, agitated open-field behaviors, and brain levels of monoamine 
oxidases). These measures of depression were then correlated with brain and pancreatic 
BPRP levels observed at the same weekly intervals. We found that CUMS can induce 
features of diabetic symptoms and that those symptoms may be associated with a 
decrease in pancreatic BPRP. 
 
 
Materials and Methods 
Animals 
  Adult, male Sprague-Dawley (SD) rats, weighing between 200-220 g at the start 
of the experiment, were obtained from the Animal Center of Peking University Health 
Science Center. The rats were assigned randomly to 3 groups (including two stressed 
group, one group for open-field test and fluid consumption test, the other group for 
biochemical analysis) matched for weight, fluid consumption, and locomotor behavior in 
an open-field test before onset of CUMS. The stressed and control rats were kept in 
different rooms to allow independent manipulation of their environments. Control rats 
were housed together, while the stressed rats were housed singly. All rats were housed in 
Perspex cages at a room temperature of 22±2℃, and maintained on a 12-h light/dark 
cycle, with food and water freely available. 
 
 
Fluid consumption tests 
  Rats had access to both tap water and a 1% sucrose solution in their home cages 
for a 48h prior to the start of the experiment. Over the next 23 h, the animals were food- 
and water-deprived. Fluid consumption was recorded by reweighing preweighed bottles 
of test solution. Bottles were counterbalanced across left and right sides of the cages 
throughout the experiment. Tests for fluid consumption were carried out weekly between 
1400 and 1500 hours on the same day each week (Friday) throughout the experiment 
(Willner et al, 1987). A percent preference (PP) for sucrose was calculated by 
determining the percentage of total fluid consumption accounted for by ingestion of the 
1% sucrose solution. 
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Open-field tests 
   Open-field test was conducted between 700 and 1100 hours on the same day each 
week (Thursday) in a quiet room. The open-field apparatus consisted of a square arena 
100×100 cm, with a white, opaque wall 40 cm high. The floor was marked with a grid 
dividing it into 25 equal-size squares. The apparatus was illuminated with a low intensity 
diffuse light (45 W) situated 45 cm above the base. Each animal was tested in the 
apparatus once. It was placed in the central square and observed for 5 min. A record was 
kept of the time each rat stayed in the central square, the amount of time it spent 
grooming and rearing (defined as standing upright on its hind legs), and the number of 
grid lines it crossed with at least three paws. Between animal tests the apparatus was 




    The stressed rats were subjected to the following conditions used by Willner et al 
(Willner et al, 1987) and Reid et al (Forbes et al, 1996; Matthews et al, 1995) with minor 
modification: 3 h and 5 h periods of white noise (85 dB), one 17 h period of group 
housing (5 rats to a cage), one 17 h period of exposure to a novel odor (household air 
freshener), one 17 h period of soiled bedding (150 ml water in a cage), one 7 h period of 
exposure to a foreign object (for example, a piece of plastic), 19, 22 and 24 h periods of 
food deprivation, 17,19, 20 and 21 h periods of water deprivation, twice the normal 
period of overnight illumination (lights on for a total of 36 h), 7h and 17h periods of 
cage tilt (45℃), and two 10 minutes periods of a 160 Hz rocking bed (Table 1). At the 
beginning of first week and at the end of first, second, third week of CUMS, rats in one 
stressed group were sacrificed for determinations of BPRP and MAO-A/B in brain 




   Rats were anesthetized by i.p. injection of 3.5% chloral hydrate in normal saline (1 
ml/100 g body wt.), and the brains and pancreas were removed. Tissue blocks 3 mm 
thick were cut and fixed with 4% formaldehyde in 0.1 M phosphate buffer (pH 7.3) for 
24 h. Fixed blocks from the pancreas and the brain posterior to the infundibular stalk 
were embedded in paraffin. Coronal tissue sections 6 µm thick were cut on a rotary 
microtome and mounted onto APES-coated slides. Paraffin sections were dewaxed with 
xylenes and rehydrated in a graded series of ethanol. Slides were submerged in 3% 
hydrogen peroxide to quench any endogenous peroxidase activity, washed with distilled 
water and heated at 95-98°C in 1 mM EDTA (pH 8.0) for 15 min, then cooled at room 
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temperature for 40 min and washed with PBS. An aliquot of 10% non-immune goat 
serum was applied to eliminate nonspecific staining. Sections were incubated overnight 
at 4°C with 1:1000 diluted rabbit anti-rat 260 kDa protein antibody. The sections were 
washed with PBS and incubated with biotinylated goat anti-rabbit IgG antibodies for 40 
min, rewashed with PBS, and incubated with peroxidase-conjugated streptavidin for 40 
min. The peroxidase activity was visualized by incubating the sections with a peroxidase 
substrate solution, after sufficient washing. The sections were counterstained with 
hematoxylin and mounted. A 1:1000 diluted solution of non-immune rabbit serum was 
used as controls in the immunohistochemical localization of the BPRP protein. 
 
 




















  Rats were anesthetized by i.p. injection of 3.5% chloral hydrate in normal saline 
(1 ml/100 g body wt.), and the hippocampus and pancreas were removed and stored at 
-80℃. The tissues were suspended in a solution containing 0.32M sucrose, 0.3 mM 
phenylmethylsulfonyl fluoride, and 20 mM Tris-HCl (pH 7.4), and homogenized in a 
Teflon-glass homogenizer. The homogenates were centrifuged at 4°C for 25 min at 800g. 
The supernatant was collected and centrifuged again at 4°C for 1.5 h at 16,000g. Protein 
concentrations of each sample were measured by the Bradford method. Aliquots were 
Friday    10:00   clean cages, dry cages 
          13:00   make up test solution; weigh all rats and solutions 
          14:00   testing period 
          15.00   weigh bottles; restore food; switch on white noise 
                  for 3 h; switch lights to on overnight 
          18:00   switch off white noise 
Saturday  10:00   commence 10 min rocking bed, room lights off 
          11:00   restore water 
          17:00   remove water 
Sunday   10:00   restore water; remove food; tilt cages for 7 h 
          17.00   untilt cages; group housing overnight 
Monday   10:00   rehouse singly;  
          l2:00   restore food; switch on white noise for 5 h 
          17:00   switch off white noise; exposure to novel odour  
Tuesday  10:00   remove novel odour; Place a foreign object in a cage 
          17:00   remove food and water; remove foreign object; 
                  switch lights to on overnight 
Wednesday12:00   weigh all animals; restore food and water; tilt cages 
Thursday  07:00   open-field test 
          10:00   commence 10 min rocking bed, room lights off, untilt     
                  cages 
          17:00   commence food and water deprivation, soil bedding 
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stored at –80 °C prior to use. Separating (7.5%) and stacking (4%) polyacrylamide gels 
containing 0.1% SDS were used. Tissue proteins were suspended in a sample buffer 
containing 2% SDS, 0.1 M Tris-HCl buffer (pH 6.8), 10% glycerol (v/v), and 0.1 M 
dithiothreitol (DTT), and heated at 100°C for 5 min in a water bath. 50µg protein was 
loaded in each lane of the polyacrylamide gels, which were electrophoresed at 150 volts 
constant power for 1h. Proteins were transferred electrophoretically at 50 mA to a 
polyvinylidene difluoride (PVDF) immobilion - P membrane (0.45-µm pore size: 
Millipore Corp, Bedford, MA) in a transfer buffer (pH 8.3) composed of 25 mM 
Tris-HCl, 192 mM glycine, and 20% methanol at 4°C overnight. The membranes were 
incubated in Tris-buffered saline (TBS, 100 mM Tris-HCl and 0.9% NaCl, pH 7.5) 
containing 5% skim milk for 1 h at 20-22°C and subsequently incubated with the 
primary antibody at 1:2000 dilution and shaken on a rotator at 20-22°C for 1.5 h. The 
membranes were washed three times with TBS containing 0.1% Tween-20 (TBS-T) and 
incubated with the 1:3000 streptavidin AP-conjugated antibody (Santa Cruz) as the 
second antibody in TBS containing 2.5% skim milk for 1 h at 20-22°C. The membranes 
were washed three times with TBS-T. The blots were developed using BCIP/NBT (nitro 
blue trazolium/5-Bromo-4-chlor-3indolyl phosphate salt) system. Densitometric analysis 
was used by Gel Doc 2000 (Bio-Rad). 
 
 
Analysis of MAO-A and MAO-B activity in rat brain 
 For monoamine oxidase (MAO) enzyme preparation, a crude mitochondrial 
fraction was isolated from whole rat brains by the method of Thull and Testa (Thull and 
Testa, 1994) and was stored at -80ºC until use. Protein concentration was determined 
using bovine serum albumin as a standard, and MAO activity with kynuramine (Sigma) 
as a substrate (Kraml, 1965). The 380 nm fluorescence intensity of 4-hydroxyquinoline 
formed from kynuramine by MAO was measured in a fluorophotometer (PELS-50B) 
using a 315 nm excitatory wavelength. The activities of MAO-A and MAO-B in rat 
brain were measured after a 15 min preincubation in 1 M l- deprenyl (type B inhibitor) 
or clorgyline (type A inhibitor). The test solutions were dissolved in dimethylsulfoxide, 
which was confirmed to have no effect on MAO activity below 2.8% concentration. 
  
 
Blood assay for glucose and insulin levels 
  Rats were anesthetized by i.p. injection of 3.5% chloral hydrate in normal saline (1 
ml/100 g body wt.), and blood was collected. Blood was stored at room temperature for 
30 min, then centrifuged for 10 min at 1000 rpm, after which aliquots were collected. 
Serum blood sugar levels were determined using a diagnostic kit (Nanjing Jiancheng 
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Bioengineering Institute), plasma insulin was assayed with a radioimmunoassay kit 




 All data were presented as means ± SD. Two-way analysis of variance followed 





CUMS decreased body weight  
 The mean body weight of rats in the two experimental groups did not differ 
significantly initially. Over the three weeks of the experiment (Fig. 1), the mean body 
weight increased in both groups, but the weight gain was significantly less in the group 
exposed to CUMS by the end of the first week (P<0.05) and continued to be 
significantly reduced by the end of the second and third week (P<0.01). At the end of 














Figure 1. Time course of weight gain in control (●) and stressed (○) rats. Data are 
represented as the means ± SD. *P < 0.05, **P < 0.01, n = 15 animals in each group. 
 
 
CUMS reduced consumption of and preference for sucrose solution  
 No difference was found between control and stressed animals in total fluid 
consumption (tap water plus 1% sucrose solution) over the three weeks of the study (Fig. 
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2A). In contrast, the stressed animals consumed significantly less sucrose solution by the 
end of the first week and continued to do so at the end of the second and third weeks 
(P<0.01, Fig. 2B). As that suggests that ingestion of the sucrose solution accounted for a 
smaller percentage of total fluid consumption in the stressed than in the control animals 
(P<0.01, Fig. 2C). The percentage preference for sucrose was thus significantly reduced 


























     Figure 2. Time course of total (A), sucrose (B) fluid consumption, and sucrose 
percentage (C) in control (●) and stressed (○) rats. Prior to each test, rats were food- and 
water-deprived for 23 h. They were then exposed to both a 1% sucrose solution and tap 
water. Sucrose preference = amount of sucrose solution consumption / total fluid 
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Effect of CUMS on exploratory behavior, rearing, and grooming  
 Open-field testing is used to assess locomotion, exploration, and anxiogenic- like 
behavior of rats or mice (Keeney and Hogg, 1999). Compared to the controls, stressed 
animals spent less time in the center of the field (where they initially placed) by the end 
of the second (P<0.01) and third weeks (P<0.001) of the experiment (Fig. 3A). As that 
implies, the control animals were more active in the open field: from the end of the first 
week onward they crossed more grid lines (P<0.01, Fig. 3B), reared more frequently 
(P<0.01, Fig. 3C), and groomed more frequently (P<0.05 [week 1]; P<0.01 [week 3], 























 Figure 3. Time course of exploratory behavior (A, B), rearing frequency (C), and 
grooming frequency (D) in control (●) and stressed (○) rats. Rats were placed in the 
central square of the open field and observed for 5 min. The amount of time they stayed 
in that square was recorded (A), as was the number of lines crossed on the floor grid (B), 
the frequency of rearing (C), and the frequency of grooming (D). Data are represented as 
the means ± SD. *P<0.05, **P<0.01, ***P<0.001, n = 15 animals in each group.  
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CUMS increased activity of both MAO-A and MAO-B 
   The MAO isoenzymes MAO-A and MAO-B are involved in catabolism of the 
neurotransmitters dopamine, norepinephrine, and serotonin. Elevated MAO activity thus 
affects brain levels of those transmitters, among which norepinephrine and serotonin are 
often elevated in depression (Elhwuegi, 2004). Compared to control animals, brain 
MAO-A and MAO-B activity was significantly elevated in the stressed animals after 3 
weeks of CUMS (P<0.05, Fig. 4). Consistent with the behavioral findings detailed above, 















 Figure 4. Effect of chronic unpredictable mild stress (CUMS) on brain MAO-A 
and MAO-B activity in control rats and those subjected to CUMS for three weeks. Data 




Effect of CUMS on BPRP levels in hippocampus and pancreas 
 Western blotting demonstrated that the hippocampus had higher levels of BPRP 
than the pancreas (P<0.01, Fig. 5). Western blotting also showed that 3 weeks of CUMS 
led to a significant reduction of BPRP in the pancreas (P< 0.001), but not in the 
























 Figure 5. Western blotting analysis of BPRP in the hippocampus and pancreas of 
control rats and rats subjected to chronic unpredictable mild stress for three weeks. 
Intensity of Western bands was quantified with a densiometric scanner. Data in the bar 
graph are represented as the means ± SD from four independent experiments. **P< 0.01, 





CUMS reduced BPRP immunoreactivity in the pancreas, but not the 
hippocampus   
 While CUMS had no clear effect on BPRP immunoreactivity in the hippocampus, 
it led to an apparent absence of such immunoreactivity in pancreatic islets three weeks 
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Figure 6. Immunohistochemical localization of BPRP (brown line in A and B, 
brunneus circle in C) in hippocampal field CA1 (A, B) and pancreas (C, D) in control 
rats (A, C) and rats subjected to three weeks of chronic unpredictable mild stress (C, D). 
Tissue was counterstained with hematoxylin and is shown at ×100. Note that stress 
appeared to have no effect on BPRP immunoreactivity in the hippocampus, but appeared 




Effect of CUMS on dentate gyrus 
 Examination of coronal sections stained with hematoxylin and eosin revealed an 
obvious reduction in the thickness of the granule cell layer of the dentate gyrus in the 
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  Figure 7. The dentate gyrus of control rats (A) and rats subjected to three weeks of 
chronic unpredictable mild stress (B) as seen at ×100 in coronal sections stained with 
hematoxylin and eosin. Note the reduced thickness of the granule cell layer.  
 
 
Effect of CUMS on blood glucose and insulin levels 
   Three weeks of CUMS had opposite effects on blood glucose and insulin levels 
(Fig. 8): the former was increased significantly (P<0.05), while the latter was decreased 











   
 
  
Figure 8. Blood glucose and insulin levels in control rats and those subjected to 
chronic unpredictable mild stress for three weeks. Data are represented as the means ± 
SD. *P< 0.05, n = 8 animals in each group.  
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Discussion 
  Since it is believed that long-term exposure to multiple, inescapable stressors can 
promote clinical depression in humans, chronic unpredictable mild stress is considered a 
realistic means of producing an animal model of depression (Willner, 1986). No single 
stressor in the CUMS regimen appears necessary or sufficient to induce depressive 
behaviors in rats. Such behaviors arise instead from the variety and frequent presentation 
of stressors in the regimen (Muscat and Willner, 1992). Animals subjected to the CUMS 
regimen display several features of clinically depressed humans (Marta et al, 1998; 
Willner, 1984). Among the most notable is anhedonia, an inability to experience 
pleasure from normally pleasurable sources. Anhedonia in rats exposed to CUMS is 
evident in decreased self-stimulation of reward pathways in the brain (Harro et al, 1999) 
and in decreased preference for a dilute sucrose solution (Forbes et al, 1996; Matthews 
et al, 1995; Willner et al, 1987) as confirmed in the present study. The reduced 
preference for sucrose we observed was not attributable to decreased thirst in general, 
because total fluid consumption was not decreased in the stressed rats. Nor was it 
secondary to the slower weight gain in the stressed animals, as demonstrated in previous 
research (Willner et al, 1996). A change in PP is clearly a valuable measure. Willner et 
al (Willner et al, 1987) reported a statistically significant decrement in preference for a 
1% sucrose solution, from a baseline value of around 80% to a value of 65% in stressed 
animals. Despite the PP in our study was about 60% which seemed no preference, there 
was a significant reduction in PP to around 30%. Reid et al (Forbes et al, 1996; 
Matthews et al, 1995) speculated that reduction in total sucrose consumption may be 
contributed to the weight loss, therefore, they analyzed the mean sucrose consumption 
per gram of body weight. If so, why the total fluid didn’t decrease followed the weight 
loss? So we think it may be reasonable to analyze the PP to evaluate the effect of CUMS. 
Anhedonia may thus be reflected as well in the depressed appetite of the stressed rats. 
Other symptoms of clinical depression in humans are also likely in animals subjected to 
CUMS (Willner, 1997; Willner and Mitchell, 1992). In our open field tests, for example, 
lethargy, apathy, and bodily neglect may be inferred from reduced exploration, rearing, 
and grooming behavior, respectively. High score of grooming is considered to reflect a 
higher level of emotionality (Pardon et al, 2000). So anhedonia resulting from CUMS 
was further confirmed by the reduced grooming behavior.  
 Further evidence that animals subjected to CUMS develop depressive states is the 
repeated observation that loss of preference for sucrose can be reversed by treatment 
with antidepressives (Papp et al, 1996; Willner, 1997). One such antidepressive is 
Moclobemide (Moreau et al, 1993), which is a reversible inhibitor of MAO-A (Yamada 
and Yasuhara, 2004). Our study provided a likely explanation for that observation, 
because we found that CUMS significantly increased the activity of MAO-A in the brain. 
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An increase in brain MAO-B activity was also observed in the stressed animals. Since 
inhibition of MAO-B is neuroprotective (Yamada and Yasuhara, 2004), increased 
activity of that enzyme in the brain may play a role in the atrophy and/or cell death of 
dentate gyrus granule cells we observed in brains of rats subjected to CUMS (Luca et al, 
2003). Such cells are normally replaced by neurons deriving from stem cells located in 
the subgranular zone of the dentate gyrus (Seri et al, 2004). Given that environmental 
stress reduces proliferation of subgranular stem cells (Fuchs et al, 2004; Malberg, 2004). 
CUMS may impair replacement of dentate granule cells and thereby lead to the 
noticeably thinner dentate granule cell layer we observed. This may be directly related to 
the depressive state of the animals given increasing evidence that antidepressants 
promote proliferation of subgranular stem cells with a lag time similar to that of the their 
clinical effectiveness (Malberg, 2004; Malberg and Schechter, 2005).  
 Within three weeks of CUMS onset, BPRP was unaffected in the hippocampal 
formation but was virtually undetectable in the pancreas by Western blotting or 
immunohistochemistry. The loss of pancreatic BPRP, which was normally found in 
islets (Yao et al, 2003), was accompanied by decreased blood levels of insulin and 
increased blood levels of glucose, consistent with a report of glucose intolerance in rats 
subjected to CUMS (Bhattacharya et al, 2000). Here hyperglycemia did not induce a 
decline or increase in hippocampal BPRP after CUMS, the reason why there was no 
effect on the hippocampal BPRP may be that the glucose level was not enough high to 
affect the hippocampal BPRP expression. In fact a researcher in our lab have found that 
hippocampal BPRP expression was decreased significantly in alloxan-induced diabetic 
rats in which glucose levels reached to 40mmol/L, while pancreatic BPRP was affected 
in the same way. Different response to the hyperglycemia and hypoinsulinemia suggests 
that the BPRP in pancreas is more sensitive to the changes in levels of glucose and 
insulin than the BPRP in hippocampus. With a full time course on BPRP levels and on 
measures of glucose tolerance and insulin sensitivity, it can be argued that the pancreas 
was affected after hyperglycemia developed, and we can determine that depressive 
symptoms in stressed animals are likely to be responsible for decreased pancreatic BPRP 
and that change is likely to play a role in onset of diabetic condition. A depressive state 
induced by CUMS can thus lead to relatively advanced diabetic conditions 
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Effects of glucose, insulin and supernatant    
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78 / Effects of Glucose on BPRP 
Abstract Brain-Pancreas Relative Protein (BPRP) is a novel protein that is mainly 
expressed in brain and pancreas. In our previous study, we found that various stressors 
significantly decreased the expression of BPRP in pancreas in vivo, accompanied by changes 
in insulin and glucose levels, and that expression of BPRP in pancreas was also decreased 
significantly in diabetic rats induced by Streptozocin (STZ). All these findings suggest that 
BPRP may be a glucose or insulin-sensitive protein. However, how the changes in insulin 
and glucose levels influence the expression of BPRP in hippocampus requires further study. 
Here, we investigated the effects of insulin and glucose on the expression of BPRP in 
primary cultured hippocampal neurons. We supplied hippocampal neurons with glucose, 
insulin, or supernatant from pancreatic β-cells, which secrete insulin into the supernatant. 
Our data showed that insulin had beneficial effect on the viability while no significant effect 
on the expression of BPRP in hippocampal neurons. On the contrary, 40mM glucose or free 
glucose culture significantly decreased the expression of BPRP, while had no significant 
effect on the viability and apoptosis of hippocampal neurons. Further study showed that 
levels of insulin in the supernatant collected from pancreatic β-cells medium changed over 
days, and that supernatant increased the viability of hippocampal neurons, while it had no 
obvious effect on the expression of BPRP in hippocampal neurons. These results suggest that 
BPRP may be a glucose-sensitive protein.   
 
 
Keywords Brain-Pancreas Relative Protein, pancreatic β-cells, hippocampal 
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Introduction 
  Using SDS–PAGE analysis, we discovered a dramatic decrease of a novel 260 
kDa protein in ischemic brain tissue following experimental occlusion of the middle 
cerebral artery in rats (Yao et al, 2003). Using a polyclonal antibody, we found that 
expression of this protein primarily occurred in hippocampal neurons and pancreatic 
β-cells, with lesser amounts found in podocytes of the renal glomeruli and endothelial 
cells of venous sinuses in the spleen. For that reason, we named the protein 
Brain-Pancreas Relative Protein (BPRP) (Yao et al, 2003). In our previous study, we 
found that chronic mild stressors decreased the expression of BPRP in pancreas 
accompanied by changes in insulin and glucose levels (Lin et al, 2005), and that 
expression of BPRP in pancreas was also decreased significantly in diabetic rats induced 
by Streptozocin (STZ) (data not published). These findings suggest that BPRP in 
pancreas is regulated by insulin and/or glucose, and that BPRP may be a diabetes-related 
protein. At the same time, in view of that diabetes causes a variety of functional and 
structural disorders in the central and peripheral nervous systems (Biessels et al, 1994), 
it is interesting and necessary to further study how the changes in insulin or glucose 
levels influence the expression of BPRP in hippocampal neurons.  
  It has been known for more than 30 years that insulin is present in the central 
nervous system (CNS) (Margolis and Altszuler, 1967; Woods and Porte, 1977; Szabo 
and Szabo, 1972; Storlien et al, 1975). By use of fluorescent staining, Dorn et al 
demonstrated the presence of insulin in neurons of the hypothalamus, thalamus, 
amygdala and hippocampus of the murine brain (Dorn et al, 1981). The presence of 
insulin and insulin receptors in the brain suggests that the brain is a target organ for 
insulin (Zhao et al, 2004). Nevertheless, how insulin affects the hippocampal neurons 
and the expression of BPRP in vitro remains unknown.  
  Glucose supplies energy for the maintenance and activities of the central nervous 
system. Deterioration in glucose homeostasis including hypoglycemia and 
hyperglycemia can trigger neuronal injuries (Singh et al, 2004). Hypoglycemia is 
considered to kill neurons by depriving them of glucose (Auer, 2004). A conspicuous 
feature of hypoglycemic brain damage in the rat is neuronal necrosis in the dentate gyrus 
of the hippocampus (Auer et al, 1985). In diabetic rodents, structural abnormalities 
including synaptic and neuronal degeneration, neuron loss, glycogen accumulation, 
dilated and fragmented endoplasmic reticulum, increased microtubuli, and irregular 
nuclei have been demonstrated (Bestetti and Rossi, 1980; Bestetti and Rossi, 1982; 
Garris et al, 1982; Luse, 1970; Mukai et al, 1980). However, how glucose affects the 
expression of BPRP in hippocampal neurons deserves further study. 
  The aim of the study was to investigate the changes in the expression of BPRP in 
hippocampal neurons exposed to different levels of insulin or glucose in vitro. We also 
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examined the effects of the supernatant of pancreatic β-cells during different days on the 
expression of BPRP in hippocampal neurons. Changes in the expression of BPRP 
induced by glucose, supernatant, or insulin were measured with flow cytometer (FCM). 
 
 
Experimental Procedure  
Pancreatic β-cells culture  
 Male Sprague-Dawley (SD) rats (weighing 180-200 g) were obtained from the 
Animal Center of Peking University Health Science Center. The local animal committee 
at Peking University approved all experiments. Pancreatic β-cells were isolated by 
collagenase digestion. In brief, rats were anesthetized by i.p. injection of 3.5% chloral 
hydrate in normal saline (1ml/100 g body wt.), the abdominal cavity was opened and the 
entire pancreas was carefully dissected and collected in a petri dish with cold Hanks’ 
balanced salt solution (HBSS). Fat and connective tissues were removed and the pooled 
pancreases were minced into pieces of approximately 2 mm each and washed several 
times with cold HBSS to remove cell debris, blood, and remaining fat tissue. The 
pancreas was digested for 10-12 min under continuous shaking (150 strokes/min) at 
37°C in 2.5-3.0 ml HBSS containing 6-8 mg collagenaseⅤ (Sigma). After digestion, 
15-20 ml cold HBSS was added into the incubation medium. Undigested tissue was 
removed using a 500µm screen, and the recovered tissue was washed twice with cold 
HBSS followed by centrifugation at 250 g for 4 min. The sediment was washed several 
times with cold HBSS. Pancreatic β-cells were cultured in RPMI medium 1640 (GIBCO) 
supplemented with 10% heat- inactivated FBS (Fig. 1). The supernatant of pancreatic 
β-cells was collected every 2 days and stored at -80°C. The supernatant was used to 












     Figure 1. Pancreatic β cell cultured in vitro. A, normal pancreatic β cell; B, 
Pancreatic β cell stained with dithizone.  
       A (×100)               B (×400)
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Insulin measurement 
 Insulin in supernatant was measured by radioimmunoassay (RIA) using a 
commercially-available kit (China Atomic Energy Research Institute) within a period 
not exceeding 7 days (Herbert et al, 1965). 
 
 
Hippocampal neurons culture 
  Primary hippocampal neurons culture was prepared from 1-day-old SD rats. 
Briefly, brains were removed, and the hippocampus was dissected and placed in cold 
HBSS containing 15 mM Hepes. The tissue was incubated with 0.25% trypsin for 10 
min at 37 °C and then rinsed several times in Dulbecco's modified Eagle's medium 
(DMEM, 1g glucose/L) (GIBCO) containing 20% heat-inactivated fetal bovine serum 
and 100U/ml penicillin, 100µg/ml streptomycin. Neurons were seeded into 16 mm2 
culture wells containing poly-L-lysine-coated glass coverslips, and routinely cultured at 
37°C in a humidified 95% air–5% CO2 chamber. After 24 h, the medium was changed to 
DMEM medium containing 10% fetal bovine serum. On the third day 10µM Cytosine 
(Sigma) was added into the medium. The neurons were used for immunofluorescence 
assay, viability assay and BPRP expression study 7 days after plating. For different 
purposes, we supplied the neurons with different concentrations of insulin or glucose or 
we replaced the medium with supernatant deriving from pancreatic β-cells for 2 days.  
 
 
Identification of BPRP with confocal laser scanning microscopy assay  
  Cells were seeded on the glass coverslips. Before detecting protein levels by 
immunofluorescence, cells were permeabilized in phosphate buffered saline (PBS)/ 
0.1% Triton X-100 for 5 min, then preincubated with 10% goat serum for 5 min. BPRP 
antibody (Yao et al, 2003) was diluted at 1:1000 in PBS/1.5% BSA and incubated for 2h, 
FITC- conjugated goat anti-rabbit IgG (Santa Cruz) was diluted at 1:2000 in PBS/1.5% 
BSA and incubated for 1.5 h at room temperature. To distinguish the nucleus and cytosol, 
propidium iodide (PI) (Sigma) which can specifically stain nucleus to be red was 
incubated (0.625µg/ml, dissolved in PBS) for 20 min. After being washed three times, 
the coverslips were sealed and cells were analyzed with the confocal laser scanning 
microscopy (CLSM) (LEICA, TCS SP2). Negative controls were set without the 
presence of the primary antibody. 
 
 
BPRP analysis with flow cytometer  
82 / Effects of Glucose on BPRP 
 Quantification of the expression of BPRP was performed by flow cytometer (FCM) 
(Becton Dickson). In brief, pancreatic β- cells and hippocampal neurons were collected 
after being treated with glucose or supernatant, then washed with cold 0.1 M PBS 
(3×10 min, pH 7.4) and centrifuged at 800 rpm for 5 min at 4°C. After that, cells were 
fixed with 70% ethanol for at least 18 h at 4°C. The cells were washed with cold 0.1 M 
PBS (3×10 min, pH 7.4) and centrifuged at 800 rpm for 5 min at 4°C, then incubated 
with BPRP antibody which was diluted at 1:1000 in PBS /1.5% BSA for 2h. After being 
washed and centrifuged as above, the cells were incubated with FITC-conjugated goat 
anti-rabbit IgG (Santa Cruz) which was diluted at 1:2000 in PBS/1.5% BSA for 1.5 h at 
room temperature. The cells then were analyzed with FCM after being washed with cold 
0.1 M PBS (3×10 min, pH 7.4) and centrifuged at 800 rpm for 5 min at 4°C. Negative 
controls were set without the presence of the primary antibody. The data were expressed 
as BPRP expression which was analyzed and compared to the internal standard by the 




  Quantification of the apoptotic rate was examined by flow cytometer (FCM) 
(Becton Dickson). In brief, cells (>106 cells/ml) were fixed with 70% ethanol for at least 
18 h at 4°C. After washing, cells were incubated with 0.625µg/ml PI for 20min, then 
apoptotic rate was quantified by means of FCM. 
 
 
Determination of cell viability 
 Cells were planted into the 96-well plates and treated with supernatant, insulin or 
glucose for certain time. After that cells were incubated with 0.5 mg/ml 3-(4, 5- 
dimethylthiazol- 2-yl)-2,5- diphenyltetrazolium bromide (MTT) (Sigma) for 4 h at 37℃, 
subsequently the medium was carefully removed and the formed formazan was 
dissolved in 100 µl DMSO per well. The amount of MTT formazan product was 
determined by measuring optical density with a microplate reader (Thermo Miltiskan 
MK3) at a test wavelength of 570 nm and a reference wavelength of 655 nm.  
 
 
Statistical analysis  
 Data were evaluated for statistical significance with one way ANOVA (Bonferroni 
post-Hoc) with the SPSS software. The number of experimental samples used in each 
group was presented in the figure legends. All data are represented as the means ± SEM. 
P<0.05 was considered statistically significant. 
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Results 
BPRP expressed in hippocampal neurons 
  Previously we found that BPRP was expressed in certain brain regions such as 
hippocampus (Yao et al, 2003), which was further confirmed in our study. As shown in 
Fig. 2, the green fluorescence represented the expression of BPRP, while the red 
fluorescence represented the nucleus of a cell. We found that BPPR was expressed in the 




   
 
                






    
   
  Figure 2. Confocal image of BPRP expression in hippocampal neurons. Picture A 
(λex=488nm, λem=515nm) represents the expression of BPRP (green) and B (λex=488nm, 




Effect of insulin on viability and expression of BPRP in hippocampal 
neurons 
 We added different levels of insulin into normal RPMI medium for 2 days and 
then observed the effect of insulin on viability and expression of BPRP in hippocampal 
neurons. As shown in Fig. 3 that although insulin had no significant effect on the 
viability of hippocampal neurons compared to normal RPMI medium, it induced an 
increasing trend in the viability. Also no significant effect of insulin on the BPRP 
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 Figure 3. Effect of insulin on viability and expression of BPRP in hippocampal 
neurons. Hippocampal neurons were incubated with different concentrations of insulin 
for 2 days. A, effect of insulin on the viability of hippocampal neurons; B, effect of 
insulin on the expression of BPRP in hippocampal neurons. All data are represented as 




Insulin secretion in pancreatic β- cells 
   As shown in Fig. 4 that pancreatic β-cells constantly secreted insulin during 10 
days, the maximum level of insulin may reach on the second day, up to 5.68 µU/ml, it 
decreased stably to 3.52 µU/ml on the fourth day, to 2.74 µU/ml on the sixth day, and 











  Figure 4. Time course of insulin secretion during 10 days. All data are represented 
as the means ± SEM and the values are obtained from three separate cultures. 
Concentratoin of insulin (uU/ml )
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Effect of supernatant on viability and expression of BPRP in 
hippocampal neurons 
The medium of hippocampal neurons was removed on the 7th day and cells were 
incubated with the supernatant of pancreatic β- cells respectively for 1, 2 or 4 days, 
while the normal group’s medium was replaced with completed RPMI 1640 medium. As 
shown in Fig. 5A, hippocampal neurons cultured with normal completed RPMI 1640 
medium or supernatant from the 8th day grew slowly and there was no significance 
compared to the “0” day neurons or the corresponding day neurons in normal RPMI 
1640- cultured group. Supernatant from the 4th and 6th day increased the viability of 
hippocampal neurons more quickly, whereas there was still no significance compared to 
the normal RPMI 1640-cultured group. However, supernatant from the 2nd day 
obviously increased the viability of hippocampal neurons after 2 or 4 days incubation 
(P<0.05). As shown in Fig. 5B, supernatant, irrespective of the age of the islet cells, 
including the 2nd day’ s supernatant had no obvious effect on the expression of BPRP 













     
 
    Figure 5. Effect of supernatant from pancreatic β- cells on the viability and 
expression of BPRP in hippocampal neurons. The medium of hippocampal neurons was 
replaced with supernatant of pancreatic β- cells on the 7th day, while the normal group’s 
medium was replaced with complete RPMI 1640 medium. A, effect of supernatant on 
the viability of hippocampal neurons; B, effect of supernatant on the expression of BPRP 
in hippocampal neurons. All data are represented as the means ± SEM and the values 
were obtained from six (MTT) or three (FCM) separate cultures, *P<0.05, # P<0.05 vs 
normal group. 
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Effect of glucose on the viability, expression of BPRP and apoptosis 
in hippocampal neurons 
 Hippocampal neurons were treated with different concentrations of glucose for 1 
day. As shown in Fig. 6A, different concentrations of glucose had no obvious effect on 
the viability of hippocampal neurons. However, free glucose and 40mM glucose 
obviously decreased the expression of BPRP in hippocampal neurons compared to 5mM 
glucose group (P<0.05) (Fig. 6B). In order to exclude the possibility that the reduction in 
the expression of BPRP induced by free glucose or high concentrations of glucose was 
due to apoptosis, we tested the effect of glucose on the apoptosis and found that although 
it led to a decreasing trend in apoptosis, free glucose, 20mM and 40mM glucose had no 






















  Figure 6. Effect of glucose on viability, apoptosis and expression of BPRP in 
hippocampal neurons. Hippocampal neurons were incubated with different 
concentrations of glucose for 1 day. A, effect of glucose on the viability of hippocampal 
neurons; B, effect of glucose on the expression of BPRP in hippocampal neurons. C, 
effect of glucose on the apoptosis of hippocampal neurons. All data are represented as 
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the means ± SEM and the values were obtained from six (MTT) or three (FCM) separate 




  There is increasing evidence that insulin has metabolic, neurotrophic, 
neuromodulatory, and neuroendocrine effects in the brain (Gasparini et al, 2002; Snyder 
and Kim, 1980), and that hippocampus contains substantial amounts of immunoreactive 
insulin, insulin receptors (Baskin et al, 1983; Schulingkamp et al, 2000; Unger et al, 
1991; Schechter et al, 1990; Zhao et al, 1999), insulin-like growth factor and its receptor 
(Moxham et al, 1989). All these are necessary for neuronal growth, differentiation, and 
function (Jonas et al, 1997; Recio-Pinto et al, 1984; Wan et al, 1997; Zheng et al, 2002). 
In our study, although there was no significance compared to normal group, our data 
showed that insulin induced an increasing trend in the viability. However, no significant 
effect of insulin on the expression of BPRP in hippocampal neurons was examined. 
These findings confirm that insulin is necessary for neuronal growth, differentiation and 
function.  
 In view of the complex effect of insulin and other components in vivo, we further 
cultured pancreatic β-cells and collected the supernatant which contained different levels 
of insulin. It showed that supernatant from pancreatic β-cells significantly increased the 
viability of hippocampal neurons. Our data were in concordance with the data from 
Hooghe-Peters et al who found that if nerve cells dissociated from the cerebral cortex of 
mice were co-cultured with isolated pancreatic islets of Langerhans, the attachment 
and/or survival and differentiation of these nerve cells were markedly promoted 
(Hooghe-Peters et al, 1981). Furthermore, the hippocampus of rats with uncontrolled 
insulin- dependent diabetes undergoes retraction and simplification of apical dendrities 
of the CA3 pyramidal neurons, and peritoneal implantation of macroencapsulated 
pancreatic islets prevents the dendritic retraction (Magarino et al, 2001). All these 
findings suggest that the supernatant contains some neurotropic factors, including insulin, 
which can stimulate the growth of hippocampal neurons. Although supernatant 
stimulated the growth of hippocampal neurons, it had no obvious effect on the 
expression of BPRP in hippocampal neurons. Obviously, insulin was responsible for 
partial effects on viability of hippocampal neurons according to the former data. Thus, 
which factors else were also responsible for the effects on viability maybe an interesting 
topic and requires further study due to the fact that we used a supernatant from cell 
culture and the composition of that solution was unknown,   
  Disturbances in glucose homeostasis that results from hypoglycemia or 
hyperglycemia can trigger neuronal injuries (Singh et al, 2004). In our study, free 
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glucose or high concentrations of glucose decreased the expression of BPRP. However, 
it is essential to check the survival of the neurons in presence of such different 
concentrations of glucose in order to study the possibility that the decrease in expression 
of BPRP may be due to the presence of fewer surviving cells. Our data showed that free 
glucose and 40 mM glucose, although it induced a decreasing trend, had no significant 
effect on the viability of hippocampal neurons. Furthermore, free glucose and 40 mM 
glucose did not induce significant apoptosis. According to these findings, the reduction 
of the expression of BPRP was not attributed to less number of hippocampal neurons. In 
our other study, we also found that glucose- and oxygen- deprivation significantly 
decreased the expression of BPRP mediated by reactive oxygen species (ROS) (Lin et al, 
2007), which further indicated that not only hypoglycemia but also hyperglycemia 
decreased the expression of BPRP in hippocampal neurons. All these findings suggest 
that a relation exists between expression of BPRP and changes in glucose levels.  
 We previously found that glucose levels did not influence the expression of 
BPRP in hippocampal neurons in vivo (Lin et al, 2005). An explanation for this 
discrepancy could be that although the glucose level in vivo changed, levels were still 
within the range suitable for hippocampal neurons to survive and subsequently no effect 
on the expression of BPRP was found. In the present study we found that 10mM glucose 
had no effect on the BPRP expression in hippocampal neurons, which was consistent 
with the results found in vivo. However, once glucose levels increase to a certain extent, 
it will damage the brain (Singh et al, 2004) and affect the expression of hippocampal 
BPRP expression, as was shown in this report. Furthermore, glucose seems to be 
compartmentalized within the brain, and there is dissociation in glucose concentrations 
between different brain areas and between the brain and the blood, and brain glucose 
levels do not readily follow levels in blood (McNay et al, 2000; McNay et al, 2001). At 
the same time insulin present in the central nervous system is a hormonal regulator of 
central glucose metabolism (Wozniak et al, 1993; Henneberg and Hoyer, 1995; Hoyer et 
al, 1993; Wree, 1991). These are also the reasons for us to choose the in vitro model to 
study the effects of insulin and glucose on BPRP in hippocampus. Nevertheless, the in 
vivo relevance of expression of BPRP in different model of hyperglycemia and 
hypoglycemia also requires further study. 
     Based on these results, we concluded that glucose deprivation and high levels of 
glucose both decreased the expression of BPRP in hippocampal neurons, and that the 
reduction in BPRP expression was not due to the less number of hippocampal neurons. 
Although insulin had a positive effect on neuronal growth, it did not affect BPRP 
expression in cultured hippocampal neurons. Combining the former data and the data in 
this report, we can draw a conclusion that BPRP is a glucose-sensitive protein both in 
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pancreas and in brain. However, whether the reduction in the expression of BPRP is a 
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4 
Effects of long-term stress and recovery        
on the prefrontal cortex and dentate         














94 / Gender differences in stress response and recovery 
Abstract Women show a higher prevalence for depression than men, and stress 
plays an important role in the development of depression. However, the biological basis 
of the gender differences and the effects of recovery after long-term stress still remain 
poorly understood. Therefore, the aim of the present study was to assess the gender 
difference in response to acute stress (1 day), chronic stress (42 days) and recovery 
(stressed for 21 days, then recovered for another 21 days) using behavioral, endocrine 
and neurochemical parameters. Our results showed that stress decreased the male body 
weight while had no effect on female rats. Open field test demonstrated that chronic 
stress increased the grooming frequency both in male rats and female rats. Chronic and 
acute stress also increased the activity of HPA axis reflected by adrenal hypertrophy and 
increase of corticosterone levels except in the socially-housed female rats. Gender and 
brain region differences in response to stress and recovery were found in the expression 
of cAMP response element-binding protein (CREB) and phosphorylated CREB 
(pCREB). On the whole, expression of CREB and pCREB in male dentate gyrus (DG) 
and prefrontal cortex (PFC) was sensitive while in female DG and PFC it was resistant 
to acute and chronic stress. Interestingly, recovery restored the measured parameters to 
the normal level in male rats. However, in female rats we did not find such recovery 
after 3-week’s. In conclusion, these results suggest that male and female rats responded 
to stress and recovery in a different way. 
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Introduction 
     Depression, a common public health problem, occurs twice as frequently in 
women as in men (Kessler et al, 1993; Kessler, 2003; Sun and Alkon 2006). Such a 
gender difference in depression may occur for a number of reasons, including the 
influence of particular sex hormones (Matheson and Anisman, 2003). In rodents, 
females typically respond to a stress with a greater release of both adrenal corticotropic 
hormone (ACTH) and corticosterone compared to males (Rivier et al, 1999; Tinnikov et 
al, 1999). Dysregulation of the hypothalamic-pituitary- adrenocortical (HPA) axis is 
associated with vulnerability to a number of psychiatric diseases including major 
depression (Howell and Muglia, 2006). There are also anatomical differences and fMRI 
studies show different patterns of brain activity in males and females. Therefore, the 
gender differences in stress reactions and depression derived from both clinical and 
preclinical studies are an important argument for performing stress and pharmacological 
studies not only in male animals but also in female animals (Renard et al, 2005). The 
cellular, molecular and the psychosocial mechanisms underlying stress responses and 
depression may differ between males and females (Sjoberg et al, 2006). However, many 
experimental studies focusing on the pathophysiology of depression have examined the 
effects of stress and/or antidepressants in male subjects (Palanza, 2001), and the gender 
differences in the pathophysiology of depression remain poorly understood.  
The onset of major depression is often preceded by chronic stress or stressful life 
events, indicating the importance of stress in the development of depression (Bale, 2006). 
However, the cellular and molecular mechanisms underlying depression have been 
difficult to grasp due to the complex pathophysiology of depression. In recent years, the 
focus of research has been at a level beyond the serotonin and norepinephrine 
transporters to the intracellular signal transduction cascades that underlie the regulation 
of neuronal functioning (Tardito et al, 2006). Novel theories suggest that dysregulation 
of intracellular pathways is linked to neuroplasticity as key events in depression 
development (Duman et al, 1997; Manji et al, 2001). One of the action mechanisms of 
stress may involve the dysregulation of the cyclic adenosine monophosphate (cAMP) 
cascade (Duman et al, 1997). This upregulation extends to several components of the 
cascade: coupling of stimulatory G-protein and adenylate cyclase (Ozawa and Rasenick, 
1991), cAMP-dependent protein kinase (Nestler et al, 1989), transcription factor cAMP 
response element binding protein (CREB) (Nibuya et al, 1996) and brain derived 
neurotrophic factor (BDNF) (Nibuya et al, 1995). Among them CREB is a critical 
mediator of neural plasticity and has been implicated in learning, memory and the 
long-term actions of opiates, psychostimulants, as well as antidepressants (Newton et al, 
2002). Phosphorylation of CREB (pCREB) at serine 133 has been reported to lead to 
activation of gene transcription, such as BDNF (Carlezon et al, 2005), therefore, nuclear 
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staining of pCREB reports activation of a particular brain area in response to external or 
internal stimuli, as does nuclear staining immediate early genes (IEG), like fos. Despite 
the importance of CREB and pCREB involved in neuroplasticity, few studies were 
designed to elucidate the gender differences in CREB and pCREB expression induced 
by stress and recovery after long-term stress. 
     Chronic footshock exposure has been proposed as a valid animal model for 
affective disorders (Westenbroek et al, 2003b). Chronic stress impairs the ability to 
anticipate reward which resembles anhedonia and can be reversed by antidepressants 
(Willner, 1997). At the same time, evidence show that some patients who respond to 
antidepressants also respond to placebo and there is natural recovery after depression, 
(Vallance, 2007). However, gender differences in recovery after long-term footshock 
exposure remain unknown.   
     To address these issues above, we attempted to determine the neurobiological 
adaptations underlying acute stress, long-term stress and recovery effects on 
individually- housed male and female rats. At the same time, behaviorally, females seem 
to have adopted a “tend- befriend” strategy, actively seeking social contact in times of 
stress (Taylor et al, 2000), so we also used socially-housed female rats to control for 
isolation stress in female rats. Particular focuses were on the prefrontal cortex (PFC) and 
dentate gyrus (DG), giving that studies in humans and animals have demonstrated that 
depression and stress-induced pathologies are implicated in DG and PFC, the key 
regions for HPA axis glucocorticoid feedback (Popoli et al, 2002; Sheline 2003; Radley 
et al, 2004; Sairanen et al, 2007). These relationships were studied by using markers of 
HPA axis function, behavioral test, and expression of CREB and pCREB. The present 
results may thus provide novel insights into cellular and molecular mechanisms 
underlying effects of stress, recovery on neuronal functions in the male and female rats.   
 
 
Materials and Methods 
Animals 
     Male (n=32) and female (n=48) Wistar rats were used in the present experiment. 
At the start of the experiment, rats were of the same age with male rats weighing 
204±1.5 g and female rats weighing 186±1 g. All male rats and 32 female rats were 
individually housed, 16 female rats were socially housed (4 rats/cage), with ad libitum 
access to food and water. A plastic tube (diameter 8×17 cm.) was placed in each cage as 
a shelter. The light-dark cycle was reversed (lights on 19:00 - 7:00 h). All experimental 
procedures, designed to minimize the number of animals and suffering, were approved 
by the Animals Ethics Committee of the University of Groningen (FDC: D4445). The 
estrus cycle of the female rats was monitored by stroking them gently on the back, 
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producing lordosis during estrus and weight loss was observed on the day of estrus. In 
the current study effects of the estrous cycle on the stress response were not specifically 
investigated. It was hypothesized that since female rats were exposed to the stressor 
during all stages of the cycle this would overrule sex hormone related stress sensitivity 
differences (Westenbroek et al, 2003b). 
 Individually-housed male and female rats were randomly assigned to four 
experimental groups: 1; Control group: subjected to no footshock throughout the 
experiment, 2; Acute stress group: received 6 footshocks on day 42, and exposed to the 
footshock box with the light stimulus only on day 43, 3; Recovery group: received 
footshocks daily for three weeks followed by a 3-week period with no footshock, and on 
day 43 exposure to the footshock box with only the light and no shock, 4; Chronic stress 
group: received footshocks daily for three weeks followed by 3 weeks of alternating 
days of exposure to the footshock box with footshocks and without receiving footshock, 
and on day 43 exposure to the footshock box with only the light (Fig.1). Because we 
have previously shown that isolation was a stressor for female rats, we had 2 extra 
socially housed groups of female rats: a social control group that was not exposed to the 
footshock box throughout the experiment, and a social acute stress group, in which rats 
received 6 footshocks on day 42 and were exposed only to the light on day 43. This was 
to determine whether isolation for 6 weeks resulted in a changed stress response.   
 
 








Figure 1. Schematic overview of the 43-day protocol. Control: rats were subjected 
to no footshock; Acute: rats received 6 footshocks on day 42, and were exposed to the 
footshock box with the light stimulus only on day 43; Recovery: rats received 
footshocks daily for three weeks followed by a 3-week period with no footshock, and on 
day 43 were exposed to the footshock box with the light only; Chronic: rats received 
footshocks daily for three weeks followed by 3 weeks of alternating days of exposure to 
the footshock box with footshocks and without receiving footshock, and on day 43 were 
exposed to the footshock box with the light only. 
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Stress procedure 
     The “footshock chamber” consists of a box containing an animal space positioned 
on a metallic grid floor connected to a shock generator and scrambler. Rats in the stress 
group were placed in a box and received variable (2-6) inescapable footshocks with 
randomized starting time (between 9:00 a.m. and 5:00 p.m.) and intervals during a 
30-120 min session (0.8 mA as maximum intensity and 8 s in duration) in order to make 
the procedure as unpredictable as possible. A light signal (10 s) preceded each footshock 
adding a ‘psychological’ component to the stressor. On the last day, the stress-exposed 
animals were subjected to the light stimulus only, which was crucial as it provided a way 
to create a stress condition without the unwanted side effects of direct physical or painful 
stimuli. Body weights were measured daily during the whole period. Blood samples 
were collected through the tail vein quickly on day 20 and stored at -20°C to determine 
plasma corticosterone levels. 
On day 43 rats were sacrificed using isoflurane anesthesia. Three rats from each 
group were transcardially perfused with 50 ml heparinized saline and 300 ml of a 4% 
paraformaldehyde solution in 0.1 M sodium phosphate buffer (pH 7.4), 2 hours after the 
start of the last exposure to the stress box, blood samples were taken by cardiac puncture. 
The brains were postfixed in the same fixative overnight at 4°C. The other five rats from 
each group were decapitated 30 minutes after the start of the last exposure to the stress 
box and the brains were removed immediately and put on dry ice and stored at -80°C, 
blood samples were also collected. The blood samples were centrifuged and plasma was 
removed and stored at −20°C. Adrenals and thymus were removed.  Adrenal and 
thymus weights, corrected for body weight, were calculated and used as indication of the 
amount of stress perceived.   
 
 
Open field test 
     Animals were subjected to a voluntary open field test (OF) for a period of 8 min. 
The open field test was performed under red-light conditions between 9 a.m. - 1 p.m. 
during the active period of the animals, at least 16 h after the last stress session and 
before the stress procedure of that day. The test was repeated 3 times, on days 1, 22, and 
40. Rats were gently placed in the tube which was connected with the open field at the 
start of the test. The open field consisted of a circular black arena with a diameter of 1.5 
m. The behavior of rats was recorded via a videotracking system (EthoVision 3.0®, 
Noldus information Technology, Wageningen, the Netherlands), with a sample rate of 
25 samples/s. Grooming frequency in the whole arena was analyzed.  
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Corticosterone radioimmunoassay 
  Blood samples were collected for corticosterone radioimmunoassay (RIA). The 
corticosterone fraction was extracted from the plasma (10µl) with Chromosorb (Alttech) 
and 30% dichloromethane (Rathburn 1001). Before the extraction a trace amount of 3H 
labeled (200 Bq) corticosterone (TRK-406 Amersham) was added to the samples to 
determine recovery which was 20%. A standard curve was determined by using 
non-labeled corticosterone, which was treated in the same way as the extracted plasma 
samples. For the quantification samples were mixed with 3H (500 Bq) labeled 
corticosterone and polyclonal antibody raised against corticosterone (rabbit nr 568 
UMCG). The tubes were incubated at 60°C for 30 minutes and the equilibrium reaction 
was established in a water/ice bath for 1 hour. The reaction was stopped by adding 
charcoal suspension and incubated for 15 min in the water/ice bath. The tubes were 
centrifuged for 15 minutes at 3000 g and 4°C to spin down the charcoal bound with free 
corticosterone. The supernatant was poured into 1 ml of scintillation fluid (Ultimagold 
XR, Canberra Packard) and samples were counted in a β-counter for 4 minutes or 4000 
preset counts. The amount of corticosterone was calculated from the standard curve. 
 
 
Western blot analysis  
  Serial 300 µm coronal sections of the cerebrum were made with a cryostat 
microtome (-15°C) and kept frozen on dry ice. Tissue samples were dissected from the 
DG and PFC (DG: bregma -2.45 to -2.85; Fig. 2) by using the "Palkovits Punch" 
technique (needle diameter 1.22 mm, Stoelting Co., Illinois, USA). Two punches per 
animal per area were taken and homogenized in 50 µl buffer (50 mM Tris pH 6.8, 1% 
SDS, 5% β-mercaptoethanol, 1 mM NaVO4, 10mM NaF, 1mM EGTA and complete 
protease inhibitors Roche). Brain tissue was homogenized and then heated for 2 min at 
96°C. The samples were stored at -80°C.  
      The expression of CREB, pCREB and β-actin as a loading control was estimated 
by Western blot analysis. Protein samples (5µl) were combined with SDS- bromophenol 
blue (5µl) reducing buffer with 100 mM DTT and then heated for 5 min at 96°C to limit 
the formation of high molecular weight receptor aggregates. Western blot analyses were 
carried out using 10% SDS polyacrylamide gels; gels were electroblotted (Supported 
Nitrocellulose Membrane, Biorad) for 1 h using a wet electroblotting system (Biorad, 
Mini Trans-Blot Electrophoretic Transfer Cell), and filters were blocked for 1 h in PBS 
buffer (pH 7.4) containing 0.5% non-fat dry milk. Blots were then incubated overnight at 
4 °C with primary polyclonal antibodies of CREB, pCREB (Upstate Biotechnology, 
Lake Placid, NY) and β-actin (Abcam, Cambridge, UK) (1:1000 for CREB and pCREB, 
1:10000 for β-actin) diluted in 0.5% non-fat dry milk-PBS solution. Blots were washed 
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three times for 10 min with PBS buffer and then incubated for 1 h with secondary 
antibodies (peroxidase-coupled anti-rabbit for CREB and pCREB and peroxidase- 
coupled anti-mouse for β-actin, Amersham Bioscience UK) diluted (1:5000) with 0.5% 
non-fat dry milk-PBS. Immunostaining was revealed by the enhanced ECL Western Blot 
analysis system (Syngene, Westburg, The Netherlands). The intensity of the bands was 
quantitated by image analysis. Membranes were washed and re-probed with the antibody 
to β-actin for loading control. The CREB and pCREB signals were normalized by the 
levels of β-actin and expressed as a percentage of the corresponding values for 
























 Figure 2. Atlas image represents the approximate brain level where dentate gyrus 
and prefrontal cortex was analyzed. A, dentate gyrus (dentate gyrus granule cell layer; 
DG-sg); B, prefrontal cortex (prelimbic; PL). The expression of CREB and pCREB was 
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Immunohistochemistry 
      Following an overnight cryoprotection in a 30% sucrose solution, serial 30 µm 
coronal sections of the brain were made with a cryostat microtome and collected in 0.02 
M potassium phosphate saline buffer (KPBS). CREB and pCREB immunostaining in 
DG and PFC was performed on free-floating sections. Sections were rinsed with 0.3% 
H2O2 for 10 min to reduce endogenous peroxidase activity, thoroughly washed with 
0.1M PBS and incubated with the rabbit anti-CREB antibody (1:300, Cell Signaling) or 
anti-pCREB antibody (1:1000, Upstate) diluted in 0.1 M PBS with 0.1% Triton X-100 
and 3% normal goat serum for 72 hours at 4˚C. After thorough washing, the sections 
were subsequently incubated for 2 hrs with biotinylated Goat-anti-Rabbit IgG (1:1000 in 
0.1 M PBS with 0.1% Triton X-100 and 3% Normal Goat Serum) and 
avidin-biotin-peroxidase complex (Vectastain ABC Elite Kit, Vector Laboratories). 
After thorough washing, the peroxidase reaction was developed with a DAB-nickel 
solution and 1% H2O2. Sections were washed for 15 min in buffer and mounted with a 
gelatine solution and air-dried, dehydrated in graded alcohol solutions and finally in 
Histoclear then coverslipped with DePeX mounting medium (BDH). To reduce staining 
artifacts or intensity differences the sections from all groups were processed 
simultaneously. 
      CREB or pCREB positive cells in the DG (dentate gyrus granule cell layer; 
DG-sg) (4 slices for each rat, bregma –2.45 to –2.85), and PFC (prelimbic; PL) (8 slices 
for each rat, bregma +3.20 to +2.15), were blindly quantified using a computerized 
imaging analysis system (Westenbroek et al, 2003a). The selected areas were digitized 
by using a Sony charge-coupled device digital camera mounted on a LEICA Leitz 
DMRB microscope (Leica, Wetzlar, Germany) at ×100 magnification. Regions of 
interest were outlined with a light pen, measured and the CREB or pCREB positive 
nuclei were counted using a computer-based image analysis system LEICA (LEICA 
Imaging System Ltd., Cambridge, England). The resulted data was reported as number 
of positive cells/0.1mm2. The DG and PFC was quantified bilaterally (no left-right 




  Data were expressed as means ± standard error (SEM) and analyzed with SPSS 
(version 12.0), P<0.05 was defined as the level of significance. Weight gain was 
analyzed separately for male rats and female rats with repeated measures ANOVA with 
days as within subject factors and treatment (control or stress) as between subject 
variables. Behavior was analyzed with a repeated measure ANOVA, with days as within 
subject variables and treatment (control or stress), gender (male or female) and housing 
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(individual or social) as between subject variables. Adrenal weight, plasma 
corticosterone levels, CREB and pCREB-ir were analyzed with an ANOVA with 
treatment (control or stress), gender (male or female) and housing (individual or social) 




Body weight gain 
   All rats continued to grow throughout the experiment, and there was a significant 
effect of day on male and female body weight gain (resp. F=1216.449, P<0.001; 
F=150.140, P<0.001), and a significant gender difference with male rats growing faster 
than female rats (F=490.839, P<0.001). Body weight gain was significantly affected by 
chronic stress in male rats (F=5.694, P=0.004) but not in female rats, and the significant 
effect of stress on male body weight appeared after six days (P=0.046). In male rats 
there was a significant interaction effect between day and treatment (F=10.096, 
P<0.001). When stress was stopped, the recovery male rats restored their body weight, 
and the significance appeared from day 32 (p=0.045) to day 43 (P=0.047) compared to 
chronically stressed male rats, while there was no significance between control male rats 
and recovery male rats (P=0.083) at the end of the procedure. Social housing had no 







































































































Figure 3. Effects of stress, recovery after long-term stress and social housing on 
body weight gain of male rats (A) and female (B) rats. Data were expressed as mean ± 
SEM, n=8. #P≤0.05, recovery group vs chronic stress group; ***P≤0.001 control group 
vs chronic stress group.  
 
 
Adrenal and thymus weight 
  Gender difference was found in relative adrenal weight, the female adrenal was 
significantly larger than the male adrenal (F=117.28, P<0.001). Although chronic stress 
induced an increasing trend in male and female adrenal weight, no significance was 
found. Social housing also had no significant effect on female adrenal weight compared 
to individually-housed control female rats. However, there was a significant increase of 
relative adrenal weight in recovery female rats compared to control female rats (P=0.029) 
(Fig. 4). Changes in thymus weight were not significant after acute and chronic stress 
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 Figure 4. Effects of stress, recovery after long-term stress and social housing on 
adrenal weight measured on day 43 in male and female rats. Data were expressed as 





Open field test 
 During the chronic stress procedure, there were no gender differences in the 
grooming frequency. The effect of day on grooming frequency was also not found. 
Exposure to stress for 3 weeks increased the grooming frequency compared to control 
group both in male rats (F=3.726, P<0.05) and female rats (F=4.126, P<0.05), which 
continued  to increase after 3 more weeks from stress exposure in male rats (F=5.263, 
P<0.01) and female rats (F=4.562, P<0.05). As shown in Fig. 5, grooming behavior in 
male rats restored to the baseline levels after the stress was stopped for 3 weeks 
compared with chronic male rats (P<0.01). Although recovery female rats showed a 
slight decrease in grooming frequency, there was no significant reduction compared with 
chronically-stressed female rats and it was still increased compared to control female 
rats. Social housing had no significant effect on grooming behavior compared to 































































































Figure 5. Effect of stress and recovery after long-term stress on grooming 
frequency in male and female rats. Chronically stressed male and female rats showed an 
increase in grooming frequency over time. Recovery after 3 weeks’ stress restored 
grooming frequency in male rats while not in female rats. Data were expressed as mean 
± SEM, n=8. *P≤0.05, **P≤0.001 within group, # #P≤0.001 vs male chronic group.  
  
 
Plasma corticosterone levels 
0.5h after stress or exposure to stress box 
     Gender difference in plasma corticosterone levels was found both on day 20 and 
day 43 (resp. F=13.460, P<0.001; F=26.318, P<0.001), female rats showing significantly 
higher plasma corticosterone levels than male rats. On day 20 a significant increase in 
corticosterone level induced by chronic stress was observed both in male rats (F=26.826, 
P<0.001) and in female rats (F=4.629, P=0.009). On day 43, exposure to the conditional 
stimulus only significantly increased the corticosterone levels in male and female rats in 
acute stress group (resp. P=0.001; P=0.002), recovery group (resp. P=0.002; P<0.001) 
and the chronic stress group (resp. P=0.008; P=0.008) compared to control male and 
female rats respectively. There was no significant difference among the acute, recovery 
and chronic male and female groups on day 43. Social housing had no significant effect 
on plasma corticosterone level on day 20 and day 43 compared to the individually- 
housed female rats. However, exposure to the stress box induced no significant increase 
in the plasma corticosterone levels in social acute female rats compared to social control 
female rats (Fig. 6).  
        







































2h after exposure to stress box  
Gender difference in plasma corticosterone levels was also found 2h after 
exposure to the stress box on day 43 (F=7.492, P=0.012). A significant decrease in 
plasma corticosterone levels was found in chronically stressed male rats (P=0.029) 
compared to control male rats. Furthermore, in acute group there was also a significant 
reduction in plasma corticosterone levels in individually-and socially- housed female 




























 Figure 6. Effects of stress, recovery and social housing on plasma corticosterone 
levels measured 0.5 h after stress on day 22 (n=8), 0.5 h (n=5) and 2 h (n=3) after 


















































































































































































mean ± SEM. *P<0.05, **P<0.01 ***P<0.001 vs control group; # # #P<0.001 vs male 
control group; $P<0.05 vs social female control group. 
 
 
CREB and pCREB expression in male and female PFC 
Protein expression 0.5h after exposure to the stress box 
 Acute and chronic stress both had no significant effect on the expression of 
pCREB and CREB in male and female PFC, although chronic stress induced a 
decreasing trend in the expression of pCREB and CREB. Social housing also did not 
affect CREB and pCREB expression in female PFC (Fig. 7).  
 
   
 
 











   
 






    
 
 
    Figure 7. Expression of pCREB and CREB measured by Western blot (n=5) in 
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footshock box with the light only on day 43. The intensity of Western bands was 
quantified with a densitometric scanner and each column represented the group 
means ± SEM of 4 determinations. Stress, recovery and social housing had no 
significant effect on the expression of pCREB and CREB in prelimbic 0.5 h after 
exposure to the footshock box.  
 
 
CREB- and pCREB- positive cells number 2h after exposure to the 
stress box 
     There was a significant decrease in the number of cells expressing pCREB 
(P=0.023), while no significant change in the number of CREB-positive cells in PFC of 
chronically stressed male rats compared to control male rats. Chronic stress also induced 
morphological abnormalities and irregularities in male PFC which were reflected by the 
“air bubbles”. After recovery there was no significant change in the number of cells 
expressing pCREB and CREB in male PFC. In female PFC no significant change in the 
number of cells expressing CREB and pCREB was found, also no “air bubbles” were 
examined (data not shown). Gender differences in the number of cells expressing CREB 
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Figure 8. Number of cells expressing pCREB and CREB in prefrontal cortex 
(prelimbic) measured by immunohistochemistry (n=3) in male and female rats 2 h after 
exposure to the footshock box with the light only on day 43. A, number of cells 
expressing pCREB and CREB 2h after exposure to the stress box on day 43 in male and 
female prelimbic, *P<0.05 vs control group. B, representative photomicrographs of 
pCREB-ir in the prelimbic of male rats exposed to chronic stress, air bubbles were 




CREB and pCREB expression in male and female DG 
Protein expression 0.5h after exposure to the stress box 
   In male rats, acute and chronic stress slightly decreased the expression of pCREB 
in DG, but the effect was not significant. Stress also had no significant effect on the 
expression of CREB in male DG. In female DG stress and social housing had no 





































































































































 Figure 9. Expression of pCREB and CREB measured by Western blot (n=5) in 
dentate gyrus (dentate gyrus granule cell layer) of male and female rats 0.5 h after 
exposure to the footshock box with the light only on day 43. The intensity of Western 
bands was quantified with a densitometric scanner and each column represented the 
group means ± SEM of 4 determinations. Stress, recovery and social housing had no 
significant effect on the expression of pCREB and CREB in dentate gyrus granule cell 
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CREB- and pCREB- positive cells number 2h after exposure to the 
stress box 
   In male rats, a significant effect of stress on the number of cells expressing 
pCREB was found in DG (F=8.673, P=0.007). The number of pCREB-positive cells was 
significantly decreased in acute (P=0.002) and chronically stressed male rats (P=0.008). 
Morphological abnormalities and irregularities were demonstrated by many “air 
bubbles” especially around the subgranule cell layer (SG) in male DG. However, in 
recovery male rats there was no significant change in the number of pCREB-positive 
cells compared to male control rats on day 43. Stress had no significant effect on the 
number of CREB-positive cells in male DG. In female DG there was no significant 
change in the number of CREB and pCREB-positive cells after acute and chronic stress, 
recovery and social housing compared to individually-housed control female rats (Fig. 
10). Acute and chronic stress also didn’t induce “air bubbles” in female DG (data not 
shown). Gender differences in the number of CREB- and pCREB-positive cells in DG 










































































































     
 
 
     Figure 10. Number of cells expressing pCREB and CREB in the dentate gyrus 
(dentate gyrus granule cell layer) measured by immunohistochemistry (n=3) in male and 
female rats 2 h after exposure to the footshock box with the light only on day 43. A, 
number of pCREB- and CREB-positive cells 2h after exposure to the stress box on day 
43 in male and female dentate gyrus granule cell layer, **P<0.01 vs male control group. 
B, representative photomicrographs of pCREB-ir in the dentate gyrus granule cell layer 
in male rats exposed to acute and chronic stress, air bubbles were clearly observed (red 




   Despite the striking gender differences in the prevalence of depression, attempts 
to identify corresponding gender differences in stress response in animal models have 
met with limited success (Altemus, 2006). In the present study gender differences in 
response to stress and recovery after long-term stress were further investigated. Our 
results demonstrated that male and female rats coped with stress and recovery in a 
different way.  
 
 
Effects of acute stress on individually-housed rats 
 Gender differences in the expression of CREB and pCREB in PFC and DG after 
acute stress were observed in this study. On the whole acute stress had no significant 
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impacted the expression of pCREB time-dependently and caused a significant reduction 
in pCREB-immunoreactivity (ir) while not CREB-ir in male DG 2h after exposure to the 
stress box. These results suggest that DG and PFC responded to acute stress in a 
different way.  
 The gender difference in the expression of pCREB in DG after acute stress may be 
related to the changes in corticosterone level. Acute stress induced a significant increase 
in plasma corticosterone levels both in individually-housed male rats and female rats. 
However, 2h after stress individually-housed female rats while not male rats showed a 
significant reduction in the plasma corticosterone levels which may be due to increased 
negative feedback (Gunderson et al, 2003), suggesting that in female rats a protective 
mechanism may have become activated. Rises in corticosteroid levels after acute stress 
impair synaptic plasticity in the rat hippocampus when compared with the situation 
where levels are basal under rest (Alfarez et al, 2003), for hippocampus is a prime target 
for glucocorticoid action (De Kloet, 1995). The changes of pCREB subsequently may 
result in the alterations in neurotrophin expression, for CREB and pCREB play a central 
role in mediating neurotrophin responses in neurons (Finkbeiner et al, 1997; Finkbeiner, 
2000). For examples, acute stress reduces neurotrophin expression in the hippocampus 
of male mice (Pizarro et al, 2004).  
 Activation of the infralimbic and prelimbic area of the PFC is necessary for 
stressor controllability (Amat et al, 2005). In a previous study acute stress was found to 
increase the expression of pCREB in PFC (Pardon et al, 2005), suggesting that 
protective effect of stressor controllability are mediated by the PFC. However, in the 
present study, although an increasing trend in the expression of pCREB in male PFC 
was observed, no significance was found. The differences from the previous study may 
result from the different breed of animal, stressor, methods used etc.  
 
 
Effects of chronic stress on individually-housed rats 
 Stress generated an inhibitive effect on male weight gain, while no such effect was 
found in female rats. These results were in accordance with previous preclinical data 
showing that stress exposure did not affect body weight gain in female rats as much as it 
did in male rats (Duncko et al, 2001). Chronic stress induced behavioral changes such as 
increased grooming frequency both in male rats and female rats while no gender 
difference was found. The behavioral changes indicated a depressive state in male and 
female rats. Stress for 21 days induced adrenal hypertrophy both in male and female rats 
(Westenbroek et al, 2003a), while no significance was found after 43 days’ stress in this 
study due to an unknown mechanism (Kioukia-Fougia et al, 2002; Kuipers et al, 2006).  
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 As expected (De Kloet et al, 1998), acute and chronic stress induced classical 
features of prolonged elevations of circulating corticosterone levels from the adrenal 
gland 0.5h after stress or exposure to stress box. However, female rats demonstrated 
higher plasma corticosterone levels than male rats not only under normal condition but 
also during stress (Rivier, 1999; Tinnikov, 1999). Interestingly, 2h after exposure to the 
stress box plasma corticosterone levels were significantly decreased through an 
unknown mechanism (maybe negative feedback, breakdown etc) in chronically stressed 
male rats. In our experiment chronic stress significantly reduced pCREB expression in 
male DG but no obvious effect on female DG. While CREB expression remained 
unaffected by chronic stress both in male and female DG, suggesting that CREB activity 
in the hippocampus was insensitive to chronic stress (Miller et al, 2006). Consistent with 
our results, chronic mild stress (CMS) was also found to result in a significant decrease 
in the expression of pCREB in male DG, while the expression of total CREB was 
unaffected by CMS (Gronli et al, 2006). In view of the importance of CREB and pCREB 
in neuroplasticity, our results were also consistent with other studies showing that 
chronically restrained female rats did not exhibit the severity of apical dendritic atrophy 
that was seen in stressed males (Galea et al, 1997), and that stressed male vervet 
monkeys showed evidence of hippocampal pyramidal neuron loss while females did not 
(Uno et al, 1989).  
  Besides the hippocampus, the male PFC also showed neurochemical changes in 
response to stress. As revealed in the present experiment, pCREB expression was 
reduced in male PFC. pCREB expression was also reported to be reduced by chronic 
stress in PFC in male rats (Laifenfeld et al, 2005). Significantly reduced pCREB 
expression in both cortical regions suggested reduced synaptic plasticity in male rats. 
Recent animal experiments showed that chronic stress resulted in altered dendritic 
morphology, and reduced spine density in the PFC (Cook and Wellman, 2004; Radley et 
al, 2004; 2006). Through down-regulating pCREB expression, chronic stress may thus 
compromise PFC plasticity required for proper response and/or adaptation to (stressful) 
stimuli (Kuipers et al, 2003). “Air bubble” in male PFC and DG after chronic stress were 
observed, which may be due to the dysfunction of HPA axis and prolonged elevation of 
corticosterone, for treatment with the synthetic glucocorticoid dexamethasone results in 
neuronal loss and atrophy in the mPFC as well as in the granule cell layer of the dentate 
gyrus (Cerqueira et al, 2005). The “air bubble” observed in the present study suggested a 
rate of the neuronal loss or an appearance of pycnotic cells. Interestingly, we did not find 
obvious changes in morphology (air bubbles) and expression of pCREB and CREB in 
female PFC and DG. Based on the results from the expression of CREB and pCREB and 
structural changes (air bubble) in PFC and DG, it may be concluded that female PFC and 
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DG was resistant while male PFC and DG was susceptible to the aversive effects of 
chronic and acute stress.  
 
 
Effects of recovery on individually-housed rats 
   Opposing effects of recovery were found in male and female rats justified by 
adrenal hypertrophy, behavior and neurochemical changes. The effects of stress on male 
rats were not permanent and once the stress was removed, different parameters applied 
in this study restored to the baseline level. McEwen also noted that the remodeling of the 
hippocampus in response to stress was largely reversible if chronic stress was terminated 
at the end of 3 weeks (McEwen, 2004). Surprisingly, recovery female rats showed even 
more adrenal hypertrophy and abnormal behavior, indicating female rats were still 
suffering of the consequences of stress and thus apparently exhibited a resistance to 
recovery. In a previous study of our research group, levels of accumulated ∆FosB in the 
mPFC of female rats had not returned to control levels following 21 days of recovery, 
which showed that the preceding stress period still had transcriptional consequences in 
this limbic area (Gerrits et al, 2006). All these data suggest that recovery for 21 days was 
not enough for female rats to recover.  
  In light of the effects of chronic stress and recovery, it seemed contradictory that 
on one hand female rats were resistant to these stress-induced neurochemical changes in 
DG and PFC, on the other hand female rats still showed stressed after recovery, 
suggesting that other factors are involved in females. Therefore, other proteins related to 
neuroplasticity or more brain regions besides DG and PFC in female brain should be 
investigated, especially brain regions containing estrogen receptors, such as amygdala 
and hypothalamus where ERα dominates and entorhinal cortex and thalamus where ERβ 
dominates, for compelling evidence now exists for estrogen's involvement in depression 
and schizophrenia (Ostlund et al, 2003). Estrogen and progesterone administration to 
ovariectomized rats resulted in elevated levels of pCREB and BDNF in hippocampus 
(Sharma et al, 2007; Franklin and Perrot-Sinal 2006). Furthermore, depression in 
females emerges especially at times of severe changes in plasma estrogen levels, like 
after pregnancy, prior to menses and during and shortly after menopause (Arpels, 1996; 
Halbreich and Kahn, 2001; Kessler, 2003), implying that gonadal hormones may provide 
protection in females during stress.  
 
 
Effects of social housing on female rats 
  In this study social housing prevented significant increases of plasma 
corticosterone levels after acute stress, suggesting that social housing maintained the 
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HPA axis at lower activity. Social housing was also found to help female rats to cope 
with chronic stress (Westenbroek et al, 2003a; 2003b), and has positive effects on 
neuronal survival (Westenbroek et al, 2004). All these results indicated that social 
housing had positive effects on female rats, whereas contradictory effects of group 
housing on males were reported (Gariepy et al, 2002; Karolewicz and Paul, 2001; 
Chourbaji et al, 2005). Oxytocin could be a possible mediator of the positive effects of 
social housing since social contact in rats was showed to increase oxytocin release 
(Uvnas-Moberg, 1997). In humans social contact is also associated with increases in 
plasma oxytocin levels and has been found to reduce plasma cortisol levels (Turner et al, 




   Male rats and female rats responded to stress and recovery in a different way. In 
female rats more evidences are needed to argue logically on one hand female rats were 
more susceptible to depression, and on the other hand PFC and DG was relatively 
resistant to stress in female rats, at least with the repeated footshock stress used here. 
Therefore our focus should be expanded to more proteins besides CREB and pCREB 
and more brain regions besides DG and PFC in female rats to clarify the neurobiological 
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124 / General discussion 
 The objectives of the studies comprised in this thesis were to explore whether 
BPRP is involved in the pathological process of depression induced by chronic stress. In 
addition, we further explored the gender difference in stress response and recovery after 
long-term stress in rats.  
     In the first experiment (Chapter 2), only male rats were exposed to chronic stress 
and then the changes in the expression of BPRP were examined. The results in the first 
experiment indicate that there may be a relationship between the glucose level and the 
expression of BPRP. Therefore, in the following experiment (Chapter 3) the effects of 
glucose, insulin and supernatant from pancreatic β-cells on the expression of BPRP were 
investigated.  
     In the third experiment (Chapter 4), male and female rats were subject to acute 
stress, chronic stress or recovery after long-term stress. Then a variety of parameters 
were used to investigate the impact of stress and recovery. Locomotor activity in an 
open field test was used to investigate the impact of stress on behavior. Weight gain, 
adrenal weight and plasma corticosterone levels served as physiological markers while 
neurobiological effects of stress and recovery were examined by measuring CREB and 
pCREB expression in response to the adverse environment of the footshock box. In 
chapter 4, the effects of stress on the expression of BPRP were also evaluated. However, 
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Animal model of depression 
 
   Numerous animal models of depression have been developed, frequently 
involving the analyses of stress effects. Many of these have received considerable 
attention and each has contributed to an understanding of specific aspects of this 
disorder. Among these models, chronic mild stress (CMS) model has many positive 
features, and is probably the most valid animal model of depression currently available. 
Therefore, in our experiment, we applied chronic stress to model depression pathology 
in rats. However, different stressors were used in our two different experiments. In one 
experiment (Chapter 2), rats were subject to different stressors which procedure were 
made unpredictable. While in the other experiment (Chapter 4) rats were subject to 
inescapable footshock with randomized starting time and intervals in order to make the 
procedure as unpredictable as possible. Electric shocks are used as the stressor because it 
is difficult to manipulate the behavioral control that an organism has over other stressors 
in a manner such that the animals with and without control are exposed to physically 
identical events (Bland et al, 2006). Although there are differences in two experiments, 
both protocols can induce depressive symptoms in male rats, and the models can be 
considered to be valid for the models met several criteria, they are: a) face validity: 
similarity in the symptom profile presented; (b) etiological validity: provocation by 
events thought to be important in eliciting the human disorder; (c) construct validity: 
involvement of similar neurochemical processes (Newport et al, 2002; Willner, 1985).  
   HPA axis responds to real or perceived stressors by secreting corticosterone, 
which in turn orchestrates the whole-organism response to a challenge by acting on 
numerous organ systems to modulate physiology and behavior. However, dysregulation 
of this key system may compromise the ability of the organism to successfully respond 
to stressors, thereby constituting a predisposing factor in the development of 
physiological and behavioral dysfunctions (Kuipers et al, 2006). Antidepressants protect 
against hippocampal volume loss in humans and reverse stress-induced atrophic changes 
in animals thus supporting the hypothesis that the pathophysiology of stress-related 
disorders such as depression involves reductions in neuronal connectivity. In the third 
experiment (Chapter 4), in male rats chronic footshock increased the activity of HPA 
axis reflected by adrenal hypertrophy and increase of corticosterone and decreased the 
expression of CREB and pCREB which are involved in the adaptation process in the 
brain. Chronic stress also had aversive effects on the structure of male PFC and DG 
which showed irregularities. Atrophy of DG was also demonstrated in the first 
experiment (Chapter 2). 
     One would expect “depressed” rats to be less active, similar as found in depressed 
patients. In our first experiment (Chapter 2), less activity was found in stressed male 
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rats compared to control male rats. Most studies also found a reduction in activity after 
stress exposure in rats. However, like Duncko and coworkers (Canli et al, 2002) in the 
third experiment (Chapter 4) we found a stress-induced increase in activity both in 
female and male rats. There are several possible explanations for the discrepancy. In the 
first experiment (Chapter 2) behavioral tests were performed shortly after the stressor, 
and thus showing an acute behavioral response to stress. While in the third experiment 
(Chapter 4) we were interested in the chronic effects of stress on behavior. Therefore, 
rats were tested about 16 hours after the previous stress session, before the stress session 
of that day. Since our rats in the third experiment (Chapter 4) were housed in reversed 
light-dark cycle, stress exposure and the open field test occurred during the active period 
of the rat, in contrast to the second experiment (Chapter 2). Most studies do not use this 
paradigm and study rat activity in the sleep period. Morever, in most studies male rats 
were used. All these factors may contribute to the differences in the behavior of rats. 
    Although chronic stress for 3 or 6 weeks can induced neurochemical changes in 
male rats, in female rats these neurochemical and structural changes in DG and PFC 
were not found. Apparently, the animal model made by chronic stress for 6 weeks in 
female rats is not robust according to the criteria which mention that involvement of 
similar neurochemical process. However, according to the open-field test which 
indicated that footshock did change the behavior in female rats, accordingly, it is 
reasonable to suppose that there may be neurochemical changes in the brain. The 
question which regions of the brain and which proteins are involved in the pathological 
process in females remains unknown. The similarity in the c-Fos response after 
first-time exposure on day 43 and after 6 weeks daily exposure suggests that habituation 
to the footshock paradigm is minimal (Gerrits et al, 2006). Thus it also may be 
reasonable to hypothesize that 3 or 6 weeks’ footshock is not chronic enough to induced 
neurochemical (CREB and pCREB) and structural changes in DG and PFC.  
    All in all, to study the gender differences in neurochemical changes after stress 
in females require novel neurobiological criteria for defining an animal model of 
depression. However, current diagnostic criteria for depression are based on symptom 
clusters rather than underlying neurobiology (APA, 1994). Charney et al provided a 
comprehensive overview of how neuroscience research should be applied to 
longer-term efforts to refine our current psychiatric diagnostic system as outlined in the 
Diagnostic and Statistical Manual of Mental Disorders, Version IV (DSM-IV) 
(Charney et al, 2002). Although the knowledge base is inadequate at this time, 
neurobiology and genetics are expected to play an increasingly important role in 
defining and validating diagnostic categories. Diagnoses based on neurobiological 
characteristics should lead to more targeted psychological, pharmacological, and other 
biological treatments. In addition, a more pathophysiologically based diagnostic 
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system will improve translation of investigations from animal to human studies and 
animal studies could play a greater role in definition of diagnostic categories. For 
example, girls with conduct disorder demonstrate more impulsive sexual behavior and 
boys engage in more interpersonal violence. If these behaviors are linked to similar 
biological processes, it would strengthen the argument for one diagnosis incorporating 
both behavioral profiles. 
 
 
Gender differences in stress response and depression 
 
  As stated in the introduction (Chapter 1), depressive illness occurs more 
frequently in females than in males by a ratio of 2-3:1. The higher prevalence of 
depression in females is most likely a combination of biological changes and social 
challenges of early adulthood (Piccinelli and Gomez, 1997). More and more evidence 
indicates that a depressive episode in women often occurs when hormonal levels are 
changing, like after pregnancy, prior to menses and during and shortly after menopause. 
Compared to men, women are subject to greater fluxes in reproductive hormones across 
the life span. Changes in reproductive hormones in utero, during puberty, the estrus 
cycle, pregnancy, and menopause clearly alter brain structure and function, and are 
likely to play a role in the increased prevalence of affective disorders in women. HPA 
axis responsiveness increases (Kirschbaum et al, 1999) and glucocorticod feedback 
sensitivity (Altemus et al, 1997) and brain GABA content decreases (Epperson et al, 
2002) in the luteal phase of the menstrual cycle, potentially destabilizing these 
homeostatic systems in vulnerable women (Epperson et al, 2002; Roca et al, 2003). In 
addition, both catecholamine and HPA axis stress response systems are suppressed 
during pregnancy (Barron et al, 1986) and lactation (Mezzacappa et al, 2003). Several 
brain neurochemical systems known to modulate anxiety and fear, including oxytocin, 
prolactin, norepinephrine, and GABA, appear to be altered in parallel during pregnancy 
and lactation (Altemus et al, 2004). Rapid weaning or lack of breastfeeding postpartum 
may precipitate more rapid decreases in these anxiolytic hormones, destabilizing stress 
responses and exacerbating anxiety and depression symptoms. Behavioral studies have 
demonstrated suppression of multiple fear behaviors and stress-induced gene responses 
in lactating rats and mice (Toufexis et al, 1999) and decreased anxiety and depression in 
breastfeeding compared to bottlefeeding mothers (Mezzacappa and Katkin, 2002). Until 
relatively recently, women spent much of their adult lives either pregnant or lactating, 
raising the possibility that longer life span, and reduced frequency of pregnancy have 
exposed modern-day women to relatively more activated stress response systems for 
much of their adult lives.  
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  Besides biological factors, there could be other factors that explain the higher 
prevalence of affective disorders found in women. Women appear to have a tendency to 
meet more criterion symptoms for depression than men, also some of the symptoms 
occur more frequently in women, which could underestimate the number of men 
suffering from a depression (Piccinelli and Gomez, 1997; Salokangas et al, 2002). 
However, when items that showed a gender effect were excluded, the gender differences 
were reduced but not eliminated, indicating that differences in symptomatology are not 
the cause for the observed gender difference in prevalence.   
  Although females show higher prevalence of depression, surprisingly, evidence 
from animal studies to date suggests that females are relatively resistant to the 
behavioral and neurobiological effects of acute and chronic stress. In our experiment 
(Chapter 4) female rats were resistant to the impact of stress in light of no obvious 
changes in the expression of CREB and pCREB and morphology in PFC and DG. 
Consistent with previous results, male rats that underwent 21 days of restraint stress 
showed significant apical dendritic atrophy compared to non-stressed controls 
(Magarinos et al, 1995). However, chronically restrained female rats did not exhibit the 
severity of apical dendritic atrophy that was seen in stressed males (Galea et al, 1997). It 
was also found that 30 days of daily cold swim stress caused a significant decrease in the 
number of CA3 and CA4 pyramidal cells in male rats, while no similar neuronal loss 
was observed in females (Mizoguchi et al, 1992). Males also had higher stress-induced 
c-fos gene expression in several brain areas compared to proestrus and diestrus females 
(Figueiredo et al, 2002). Consistent with these sex differences in structural responses to 
chronic stress, female rats did not show the impairment of spatial memory or object 
recognition memory after chronic restraint stress that was characteristic of males (Luine, 
2002). In addition, an acute stressor enhanced fear behaviors and impaired escape 
learning (learned helplessness) in males, but less so in females (Steenbergen et al, 1990; 
Heinsbroek et al, 1991). Moreover, in males, acute stress enhanced eyeblink 
conditioning (a reflex learning that does not involve fear), but in females it impaired 
eyeblink conditioning in proestrus and had no effect in diestrus (Wood and Shors, 1998). 
A similar sex difference in stress-induced enhancement of fear conditioning was recently 
reported in humans (Jackson et al, 2005).  
  Abnormalities in the regulation of the HPA axis and the sympatho- 
adrenomedullary system have been identified in depression which is clearly precipitated 
and exacerbated by stress (Gold and Chrousos, 2002). In humans, males seemed to have 
greater HPA axis responses to stress (Kudielka et al, 2004) and when circulating gonadal 
steroids were removed, men also had higher HPA axis responses than women (Roca et al, 
2005). Female rats had higher ACTH and total corticosterone responses to stress 
(McCormick et al, 2002), but it remained to be determined whether free corticosterone 
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responses were higher in female rats. The stress-induced rise in corticosterone levels was 
one factor that mediated the dendritic atrophy in repeatedly stressed males (Magarinos 
and McEwen, 1995). Thus, it is perhaps unexpected that despite the higher stress levels 
of corticosterone compared to males, stressed females did not show significant structure 
abnormalities and changes in the expression of pCREB and CREB. This suggests that 
there may be a protective mechanism in female rats that prevents the aversive effects of 
stress.  
  Firstly, corticosteroid binding globulin (CBG), which reduced the level of free 
corticosterone, was increased after repeated stress in female rats (McCormick et al, 
2002). Higher CBG levels also have been shown to decrease glucocorticoid receptor 
activation among rat strains differing in stress responsitivity (Dhabhar et al, 1995). 
Therefore, the higher levels of CBG in females may be a factor which has the 
‘‘protective’’ effect seen in females during stress.  
  Secondly, animal and human data were concordant in suggesting that 
physiological doses of estradiol suppressed HPA axis responses to stress (Young et al, 
2001). Therefore, a likely candidate to play a role in the occurrence of depression in 
women is estrogen. It has been reported that chronic 17β-estradiol treatment decreased 
stress response and improved the cognitive and morphological impairments relative to 
vehicle group. These data have important implications for cognition enhancing effect of 
estrogen treatment in postmenopausal women (Takuma et al, 2007). The 
ovariectomized/stress group showed a marked decrease in the number of pyramidal cells 
of the CA3 region and levels of BDNF mRNA in the hippocampus. While estradiol 
administration induced synaptogenesis between mossy fibers and CA3 neurons by 
enhancing BDNF release from DG granule cells (Sato et al, 2007). Plasma BDNF levels 
were influenced by hormonal status, modifications in BDNF circulating levels during the 
menstrual cycle suggested a potential role for gonadal sex hormones (estradiol and 
progesterone) in regulating neurotrophin expression (Begliuomini et al, 2007). Cyclic 
estradiol replacement attenuated stress-induced c-Fos expression in the PVN of 
ovariectomized rats, the dampening effect of estradiol on the excessive stress-induced 
activity in the PVN may be beneficial for the animal in its response to chronic recurrent 
stress by reducing the output of the PVN (Gerrits et al, 2005).  
  Last but not least, another way to reconcile relative resistance of females to 
neurobiological effects of stress with increased prevalence of affective illness in women 
is to consider the stress-induced neurobiological changes in males as adaptive, 
potentially preventing subsequent development of depression. For example, relatively 
impaired memory in response to 3 weeks of restraint stress may enable males to forget 
the stress and its associations more quickly (Altemus, 2006). In our experiment 
(Chapter 4), recovery can help male rats to recover, suggesting that male were able to 
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forget the stress and its associations, while female rats still showed effects of the prevous 
stressful events after 3 weeks’ recovery. 
 
 
What is BPRP? 
 
      BPRP which is mainly expressed in brain and pancreas is a protein found in our 
lab. BPRP was analyzed by peptide mass fingerprinting (PMF) and matrix-assisted laser 
desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS), which 
indicates that BPRP is a novel protein (Yao et al, 2003). A search of the protein database 
uncovered several proteins within the set parameters that possess significant matching 
relation to BPRP. These proteins are the microtubule-associated protein 1A (MAP1A) 
and protein kinase A anchoring protein 6 (AKAP6). These results suggest that BPRP 
may be MAP1A or AKAP6, or an analogous to MAP1A or AKAP6 (Yao et al, 2003).  
      AKAP6 is a member of a family of distinct but functionally homologous A 
kinase anchor proteins (AKAPs). AKAPs include two conserved structural modules: a 
targeting domain that serves as a scaffold and membrane anchor, and a tethering domain 
that interacts with PKA regulatory subunits (Feliciello et al, 2001). AKAPs have 
emerged as key regulators of PKA function. By tethering the holoenzyme at precise cell 
locations, in close proximity to their physiological substrate, AKAPs favor specific PKA 
phosphorylation events. PKA-dependent phosphorylation of nuclear and cytoplasmic 
substrates controls multiple cell functions, including motility, metabolism, 
differentiation, synaptic transmission, ion channel activities, growth and coordinate gene 
transcription (Montminy, 1997). Although AKAPs have been identified on the basis of 
their interaction with PKA, they also bind other signaling molecules, mainly 
phosphatases and kinases, that regulate AKAP targeting and activate other signal 
transduction pathways. Based on the present results, we hypothesize that BPRP is an 
essential cell factor for the normal functions of the β-cells of the islets and neurons of the 
brain. Especially, our results that BPRP may be involved into the process of diabetes 
(Chapter 2) and that high and low glucose level decreased the expression of BPRP in 
hippocampal neurons (Chapter 3) suggest there may be dysfunction of the signaling 
pathway of AKAP-PKA. Further research into the signaling pathway of AKAP-PKA in 
central nervous system diseases and diabetes will lead to new findings which will 
contribute to the therapy of these diseases.  
  MAP1A, one of the main MAPs in nerve cells, was a structural component 
involved in the filamentous cross-bridging between microtubules and other skeletal 
elements, and occured in equal amounts in both axons and dendrites (Bloom et al, 1984; 
Huber and Matus 1984). Structural neuronal plasticity, which is involved in the 
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pathophysiology of stress and depression, requires cytoskeletal molecular changes in the 
components of the microtubular system, which is a complex cellular machine formed by 
multiple components. It has been suggested that MAP1 was a main stabilizer of 
microtubules and was involved in dendritic plasticity (Schoenfeld et al, 1989; Vaillant 
et al, 1998; Tucker et al, 1989). MAP1A increased with development (Schoenfeld et al, 
1989). During plasticity events, the dynamic instability of microtubules was increased 
(Cornea-Hebert et al, 2002). Subchronic restraint stress upregulated the hippocampal 
expression of the acetylated form of α-tubulin, which was a marker of more stable 
microtubules (Bianchi et al, 2003). These data suggest that under conditions of 
subchronic restraint stress, the dynamic stability of microtubules was decreased that led 
to increased expression of the main stabilizers such as the acetylated form of α-tubulin to 
restore the stability of microtubules. The up-regulation of MAP1A in the hippocampus 
by repeated restraint stress supported this suggestion (Xu et al, 2004). However, in our 
experiment (Chapter 2), there was no changes in the expression of BPRP after 21 days’ 
stress, which suggests that BPRP is unlikely MAP1A. Furthermore, in the third 
experiment (Chapter 4), our primiary results showed that chronic stress for 43 days also 
had no obvious effect on the expression of BPRP in hippocampus and no gender 
difference was found (data not shown). In the future more studies are required to 
examine the effect of stress on the expression of BPRP in hippocampus, other brain 
regions and other tissues. And more studies are also required to confirm whether BPRP 
is an analogous to MAP1A or AKAP6 and involved in the pathopsychological process 
of depression and stress response. 
      
 
Stress and blood glucose level 
  
 In our experiment (chapter 2), glucose levels were elevated by chronic stress. 
Similarly, after 15 min exposure to forced swimming serum glucose levels were elevated 
(Armario et al, 1995). Several studies also have found that glycemic control was 
significantly worse in patients with depression compared to those who were not 
depressed (DeGroot et al, 1999; Lustman et al, 1997b; Mazze et al, 1984). Glucose in 
brain supplies energy which is essential for the maintenance and activities of nervous 
system cascade (Moley and Mueckler, 2000). The blood glucose level must be kept from 
falling below a certain threshold for normal brain function and may have to be raised 
acutely to satisfy a sudden need for energy. Epinephrine and glucagon appear to initiate 
the rapid, acute increase in blood glucose in response to stress, with a combination of 
glucocorticoid and growth hormone action prolonging the increase in blood glucose over 
hours (Munck and Naray-Fejes-Toth, 1995). However, deterioration in glucose 
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homeostasis that results from hypoglycemia or hyperglycemia can trigger neuronal 
injuries. High or low level of glucose both decreased the expression of BPRP, which is 
mainly expressed in brain and pancreas (chapter 3). Hippocampus which links with 
glucose and insulin is very responsive to local tissue glucose levels, and this brain 
structure also appears to be involved in peripheral glucose regulation. Hippocampus was 
also sensitive to the effects of diabetes (Magarin and McEwen, 2000). It was reported 
that the cerebral output of BDNF was highly significantly inhibited during 
hyperglycaemic clamp conditions in humans, suggesting that circulating levels of BDNF 
were regulated in response to plasma levels of glucose (Krabbe et al, 2007). When the 
hippocampus is damaged there is abnormal glucose regulation. These findings suggest 
that neural circuits involving the hippocampus play some roles in sensing glucose levels 
and regulating the peripheral metabolic response. 
 Stress-induced elevations of glucocorticoids increased glucose concentrations 
through multiple mechanisms, including synergy with other counter-regulatory 
hormones to stimulate glycogenolysis, gluconeogenesis, lipolysis, and inhibition of 
peripheral glucose utilization (Weinstein et al, 1995; Dimitriadis et al, 1997). 
Psychological stress was accompanied by release of counter-regulatory hormones (i.e., 
catecholamines, glucocorticoids, growth hormone, and glucagon) which counteracted 
the hypoglycemic action of insulin by raising blood levels of glucose (Sapolsky et al, 
2000). The metabolic actions of these counter-regulatory hormones are in a delicate 
interplay with those of insulin and other insulin-like factors in which a critical 
physiologic variable is the level of blood glucose. Patients with major depression 
exhibited insulin resistance during insulin tolerance tests (Casper et al, 1977) and 
intravenous or oral glucose tolerance tests (GTTs) (Winokur et al, 1988). Such 
abnormalities could contribute to insulin resistance and/or pancreatic β-islet cell 
dysfunction. As revealed in our experiment, chronic stress decreased the expression of 
BPRP in pancreas and the level of insulin was also decreased by chronic stress (Chapter 
2).  
 Alterations in glucose transport and utilization function was also demonstrated in 
depression which is associated with abnormalities in metabolically significant biologic 
pathways. Compared to nondepressed controls, depressed subjects displayed decreased 
glucose utilization and antidepressant treatment was associated with increased glucose 
metabolism (Martinot et al, 1990). Glucose is a necessary metabolic substrate of all 
mammalian cells, its entry into cells is facilitated by glucose transporters. Of the six 
isoforms of facilitative glucose transporters, glucose transporter-1 (GLUT1) and glucose 
transporter-3 (GLUT3) mediated the influx of glucose into endothelial cells and 
astrocytes, and neurons, respectively (Duelli and Kuschinsky, 2001). Glucose transporter 
3 (GLUT3) mRNA and protein expression, as well as the expression of insulin-like 
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growth factor receptor mRNA (IGF-Ir and IGF-IIr), were upregulated in the 
hippocampus of STZ diabetic rats subjected to stress (Reagan et al, 2000). Likewise, the 
recently described glucose transporter, GLUTx1 (GLUT 8), found exclusively in 
neurons, was upregulated in STZ diabetic rats at the mRNA but not protein level 
(Reagan et al, 2001). These molecular changes may represent compensatory responses in 
hippocampus to restore neuronal homeostasis, and could reflect an increased turnover of 
the protein. 
      Excessive glucose can be transported intracellularly and metabolized to change 
redox potential, increase sorbitol production via aldose reductase, or alter signal 
transduction pathways such as the activation of diacylglycerol and protein kinase C 
levels (Koya et al, 1998). Sequentially, the putative mechanisms involved in 
hyperglycemia neuropathy may be explained on the basis of excitotoxicity and oxidative 
stress hypothesis. Brain contains large amounts of polyunsaturated fatty acids (PUFA), 
which are particularly vulnerable to free radical attacks resulting in the formation of 
carbon and hydroxyl radicals (Halliwell and Aruoma, 1991). The latter initiates a chain 
reaction ultimately generating numerous toxic reactants that rigidifies membranes by 
cross-linking, disrupting membrane integrity and change membrane proteins (Coyle and 
Puttfarcken, 1993). These molecular, cellular and morphological changes induced by 
stress or diabetes may contribute to the cognitive deficits observed in elderly diabetic 
patients (Meneilly et al, 1993). Therefore, it is important to control the blood glucose 
level during depression, and it is may be a good idea to treat depression with 
antidepressants as well as hypoglycemic drugs. 
    
 
Neurotrophic factors secreted by pancreas 
 
  The mature pancreas is formed by exocrine tissue and by endocrine cells that are 
clustered into the islets of Langerhans. There are four main types of islet cells, each 
defined by the hormone produced. The insulin-containing β cells form the core of the 
islets; and the other three classical endocrine cell types, the α, D and PP cells, which 
synthesize glucagon (GLU), somatostatin (SOM), and pancreatic polypeptide (PP), 
respectively, are located in the periphery of the islet. In addition to the hormones, 
pancreatic endocrine cells express many neuronal properties (Le Douarin, 1988), such as 
the neurotransmitter biosynthetic enzymes tyrosine hydroxylase (TH) and glutamic acid 
decarboxylase (Teitelman and Lee, 1987; Baek keskov et al, 1990). Pancreatic islets are 
richly innervated by autonomic nerve fibers and are ensheathed by nonmyelinating 
Schwann cells (the neuroglial cells of the PNS) which can express GFAP and p75 (Fujita, 
1969; Teitelman et al, 1998). 
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  In the second experiment (Chapter 3), our results suggest that supernatant from 
pancreatic β-cells contained some neurotropic factors, including insulin, which can 
stimulate the growth of hippocampal neurons. When dorsal root ganglia (DRGs) were 
cultured with islets in the mixed medium, they were able to survive and merged with the 
islets to form a 3-dimensional complex of nerve cells and islet endocrine cells (Kozlova 
and Jansson, 2005). Thus, islet cells were likely to provide the cocultured DRG neurons 
with trophic factors, one of which was most likely insulin (Hooghe-Peters et al, 1981; 
Huang et al, 2005). Similarly, we found that insulin had beneficial effects on the growth 
of hippocampal neurons (Chapter 3). There is substantial evidence that brain insulin is 
derived from peripheral insulin, transferred in a transporter-regulated way through the 
blood-brain barrier (Banks, 2004). 
      Furthermore, it was found that pancreatic islet cells transiently expressed NGF 
during early development and that the level of this neurotrophin increased in both 
endocrine and exocrine cells following a toxic or autoimmune attack (Teitelman et al, 
1998). In addition to NGF, reactive Schwann cells of the nervous system secreted 
brain-derived neurotrophic factor (BDNF), another member of the neurotrophin family 
of molecules; insulin-like growth factors (IGF) I and II; acidic and basic fibroblast 
growth factors; and several cytokines (Raivich and Kreutzberg, 1993; Bunge, 1993; 
Einheber et al, 1995). Islet cells were found to contain NGF and Trk A (Teitelman et al, 
1998). Some of these components secreted by pancreas or Schwann cells may contribute 
the growth of hippocampal neurons observed in our experiment (Chapter 3). Therefore, 
it is important to screen which components are beneficial to the growth and 
differentiation of neurons, and then apply these components as the therapeutic targets of 
depression.  
           
 
Depression and diabetes 
 
  Chronic stress can raise the blood glucose level which is the common feature of 
diabetes. Therefore, it is reasonable to hypothesize that there is interaction between 
depression and diabetes. Patients with diabetes (PWD) experience disproportionately 
high rates of psychological disorders. Depression and anxiety disorders are the most 
common diagnoses, and occur far more often in PWD than in the general population. 
About 11-15% individuals with type 2 diabetes meet the criteria for major depression 
(Anderson et al, 2001). Some studies suggest that approximately 40% of PWD have 
significantly elevated levels of depressive symptomatology, although they are not all 
clinically depressed (Gavard et al, 1993). Gender differences also exist, which may 
interact with socioeconomic factors. Women with diabetes appear twice to experience 
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psychological distress than men (Peyrot and Rubin, 1997). Vascular disease and 
alterations in glucose, insulin, and amyloid metabolism may be underlying mechanisms 
that explain the link between diabetes and neuropsychiatric diseases (Biessels et al, 2006; 
Bruce et al, 2005). High blood sugars may produce some symptoms of depression, 
including fatigue and changes in sleep, weight, and appetite (Rubin and Peyrot, 2001). 
As summarized by Fisher et al (2001), diabetic patients at higher risk for depression 
have less education, are unmarried or have poor social support, and experience chronic 
stressors or negative life events. Indeed, education, functional impact of diabetes, and 
financial stress may contribute the most to depression (and anxiety) in patients with 
diabetes early in their disease. Depression is associated with important pathophysiologic 
alterations that may contribute to the increased vulnerability of depressed patients to 
type 2 diabetes and/or complications from both type 1 and type 2 diabetes. Therefore, 
when treating depression with or without diabetes selective serotonin reuptake inhibitors 
(SSRIs) have advantages over tricyclics because tricyclics such as nortriptyline have 
been shown to have hyperglycemic side effects, while SSRIs such as fluoxetine 
appeared to have no such impact (Lustman et al, 2000a) 
 Depressive episodes in PWD may be especially severe because depression and 
diabetes may exacerbate one another at a neuroendocrine level. It has been hypothesized 
that there may be a common hormonal disregulation in depression and poor glycemic 
control (Lustman et al, 1988). Moreover, depression can make diabetes self-management 
more difficult. The helplessness and hopelessness often associated with depression may 
contribute to a vicious cycle of poor self-management, worse glycemic control, and 
exacerbation of depression (Rubin and Peyrot, 1994). When depression is associated 
with increased rates of smoking and substance abuse, it can further compromise 
self-management, glycemic control, and diabetic complications. Even subclinical 
depression may be associated with diminished emotional and physical well-being. 
     Relief of depression may improve glycemic control, but depression and poor 
glycemic control are not synonymous, many persons with poor control are not depressed 
and many depressed people manage their diabetes effectively. Moreover, improvement 
of self-management and glycemic control is unlikely to relieve major depressive 






      Dysfunction of PKA pathway is involved in the pathological process of 
depression. However, no research was found to study the PKA-AKAP pathway during 
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depression. Our findings that BPRP in hippocampus was decreased by high level of 
glucose and BPRP may be an AKAP suggest that PKA-AKAP pathway is likely 
disturbed during depression. Therefore, PKA-AKAP pathway during depression and 
medication with antidepressants should be further explored. 
      Reduction in pancreatic BPRP expression induced by chronic stress and decrease 
in brain BPRP expression in diabetes induced by STZ (Communicate with my colleague 
Lu Tie) suggests an interaction between diabetes and depression, which is also 
confirmed by clinical results. Thus, studying depression in diabetes and screening the 
risk factors will lead to better treatment of depression. 
 Although women show higher prevalence in depression than men in clinics, 
female rats were relatively resistant to the effects of stress which plays an important role 
in the process of depression. These phenomena suggest that the underlying mechanisms 
dealing with stress may be different between male rats and female rats and there are 
protective factors which can prevent female rats from the impact of stress. Therefore, 
which factors in female rats, estrogen, CBG or others, are involved and how these 
factors interact with stress should be further investigated. Exploring these kinds of issues 
will further uncover the pathological process of depression, and thereafter design more 
effective antidepressants and raise the efficacy of antidepressants. 
     
           
References 
 
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of 
comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24: 
1069-1078. 
Altemus M, Redwine L, Leong YM, Yoshikawa T, Yehuda R, Detera-Wadleigh S, 
Murphy DL (1997) Reduced sensitivity to glucocorticoid feedback and reduced 
glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycle. 
Neuropsychopharmacology 17: 100-109.  
Altemus M, Fong J, Yang R, Damast S, Luine V, Ferguson D (2004) Changes in CSF 
neurochemistry during pregnancy. Biol Psychiatry 56: 386-392. 
Altemus M (2006) Sex differences in depression and anxiety disorders: Potential 
biological determinants. Horm Behav 50: 534-538. 
Armario A, Gavalda A, Marti J (1995) Comparison of the behavioural and endocrine 
response to forced swimming stress in five inbred strains of rats. 
Psychoneuroendocrinology 20: 879-890.  
APA (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. APA 
Press, Washington, D.C. 
Baekkeskov S, Aanstoot HJ, Christgau S, Reets A, Solimena M, Cascalho M, Folli F, 
                                         General discussion / 137     
Richter-Olesen H, Camilli PD (1990) Identification of the 64K autoantigen in 
insulin-dependant diabetes as the GABA-synthesizing enzyme glutamic acid 
decarboxylase. Nature 347: 151-156. 
Banks WA (2004) The source of cerebral insulin. Eur J Pharmacol 490:5-12. 
Barron WM, Mujais SK, Zinaman M, Bravo EL, Lindheimer MD (1986) Plasma 
catecholamine responses to physiologic stimuli in normal human pregnancy. Am J 
Obstet Gynecol 154: 80-84. 
Begliuomini S, Casarosa E, Pluchino N, Lenzi E, Centofanti M, Freschi L, Pieri M, 
Genazzani AD, Luisi S, Genazzani AR (2007) Influence of endogenous and 
exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod. 
22: 995-1002. 
Bianchi M, Heidbreder C, Crespi F (2003) Cytoskeletal changes in the hippocampus 
following restraint stress: role of serotonin and microtubules. Synapse 49: 188-194. 
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia 
in diabetes mellitus: a systematic review. Lancet Neurol 5: 64-74. 
Bland BH, Jackson J, Derrie-Gillespie D, Azad T, Rickhi A, Abriam J (2006) Amplitude, 
frequency, and phase analysis of hippocampal theta during sensorimotor processing 
in a jump avoidance task. Hippocampus 16: 673-681. 
Bloom GS, Schoenfeld TA, Vallee RB (1984) Widespread distribution of the major 
polypeptide component of MAP1 (Microtubule associated protein 1) in the nervous 
system. J Cell Biol 98: 320-330. 
Bruce DG, DavisWA, Starkstein SE, Davis TM (2005) A prospective study of 
depression and mortality in patients with type 2 diabetes: The Fremantle Diabetes 
Study. Diabetologia 48: 2532-2539. 
Bunge RP (1993) Expanding roles for the Schwann cell: ensheathment, myelination, 
trophism and regeneration. Curr Opin Neurobiol 3: 805-809.  
Canli T, Desmond JE, Zhao Z, Gabrieli JD (2002) Sex differences in the neural basis of 
emotional memories. Proc Natl Acad Sci USA 99: 10789-10794. 
Casper RC, Davis JM, Pandey G, Garver D, Dekirmenjian H (1977) Neuroendocrine and 
amine studies in affective illness. Psychoneuroendocrinology 2: 105-113. 
Charney D, Barlow D, Botteron K, Cohen J, Goldman D, Gur R, Lin KM, Lopez J, 
Meador-Woodruff J, Moldin SO, Nestler E, Watson S, Zalcman S (2002) A research 
agenda for DSM-V. In: Kupfer, D.J., Regier, D.A. (Eds.), A Research Agenda for 
DSM-V.M.F. American Psychiatric Press, Washington, DC: 31-84. 
Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative 
disorders. Science 262: 689-695. 
DeGroot M, Jacobson AM, Samson JA, Welch G (1999) Glycemic control and major 
depression in type 1 and type 2 diabetes mellitus. J Psychosomatic Res 46: 425-435.  
Dhabhar FS, Miller AH, McEwen BS, Spencer RL (1995) Differential activation of 
adrenal steroid receptors in neural and immune tissues of Sprague-Dawley, Fisher 
344 and Lewis rats. J Neuroimmunol 56: 77-90. 
138 / General discussion 
Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U (1997) 
Effects of glucocorticoid excess on the sensitivity of glucose transport and 
metabolism to insulin in skeletal muscle. Biochem J 321: 707-712. 
Diviani D, Scott JD (2001) AKAP signaling complexes at the cytoskeleton. J Cell Sci. 
114: 1431-1437. 
Duelli R, Kuschinsky W (2001) Brain glucose transporters: Relationship to local energy 
demand. News Physiol Sci 16: 71-76. 
Einheber S, Hannocks MJ, Metz CN, Rifkin DB, Salzer JL (1995) Transforming growth 
factor-beta 1 regulates axon/Schwann cell interactions. J Cell Biol 129: 443-458. 
Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, ZhangW, Weiss E, 
Rothman DL, Krystal JH (2002) Cortical gamma-aminobutyric acid levels across the 
menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a 
proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59: 851-858. 
Feliciello A, Gottesman ME, Avvedimento EV (2001) The biological functions of 
A-kinase anchor proteins. J Mol Biol 308: 99-114.  
Figueiredo H, Dolga C, Herman J (2002) Stress activation of cortex and hippocampus is 
modulated by sex and stage of estrus. Endocrinology 143: 2534-2540.  
Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA (2001) Contributors to 
depression in Latino and European-American patients with type 2 diabetes. Diabetes 
Care 24: 1751-1757. 
Fujita T (1969) Histological studies on the neuroinsular complex in the pancreas of some 
mammals. Z Zell-forsch 50: 94-107. 
Galea LA, McEwen BS, Tanapat P, Deak T, Spencer RL, Dhabhar FS (1997) Sex 
differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic 
restraint stress. Neuroscience 81: 689-697. 
Gavard JA, Lustman PJ, Clouse RE (1993) Prevalence of depression in adults with 
diabetes: An epidemiological evaluation. Diabetes Care 16: 1167-1178. 
Gerrits M, Grootkarijn A, Bekkering BF, Bruinsma M, Den Boer JA, Ter Horst GJ 
(2005) Cyclic estradiol replacement attenuates stress-induced c-Fos expression in the 
PVN of ovariectomized rats. Brain Res Bull 67: 147-155.  
Gerrits M, Bakker PL, Koch T, Ter Horst GJ (2006) Stress-induced sensitization of the 
limbic system in ovariectomized rats is partly restored by cyclic 17beta-estradiol 
administration. Eur J Neurosci 23: 1747-1756.   
Gold PW, Chrousos GP (2002) Organization of the stress system and its dysregulation in 
melancholic and atypical depression: high vs. low CRH/NE states. Mol Psych 7: 
254-275. 
Halliwell B, Aruoma OI (1991) DNA damage by oxygen derived species. Its mechanism 
and measurement in mammalian system. FEBS Lett 281: 9-19. 
Heinsbroek R, Van Haaren F, Van de Poll N, Steenbergen H (1991) Sex differences in 
the behavioral consequences of inescapable footshocks depend on time since shock. 
Physiol Behav 49: 1257-1263. 
                                         General discussion / 139     
Hooghe-Peters EL, Meda P, Orci L (1981) Co-culture of nerve cells and pancreatic islets. 
Brain Res 227: 287-292. 
Huang TJ, Verkhratsky A, Fernyhough P (2005) Insulin enhances mitochondrial inner 
membrane potential and increases ATP levels through phosphoinositide 3-kinase in 
adult sensory neurons. Mol Cell Neurosci 28: 42-54. 
Huber G, Matus A (1984) Immunohistochemical localization of microtubule-associated 
protein 1 in rat cerebellum using monoclonal antibodies. J Cell Biol 98: 777-781. 
Jackson E, Payne J, Nadel L, Jacobs WJ (2005) Stress differentially modulates fear 
conditioning in healthy men and women. Biol Psychiatry 59: 516-522. 
Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH (1999) Impact 
of gender, menstrual cycle phase, and oral contraceptives on the activity of the 
hypothalamic-pituitary-adrenal axis. Psychosom Med 61: 154-162. 
Koya D, King GL (1998) Protein kinase C activation and the development of diabetic 
complications. Diabetes 17: 859-866. 
Kozlova EN, Jansson L (2005) In vitro interactions between insulin-producing beta cells 
and embryonic dorsal root ganglia. Pancreas 31: 380-384. 
Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, 
Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, 
Bruunsgaard H, Pedersen BK (2007) Brain-derived neurotrophic factor (BDNF) and 
type 2 diabetes. Diabetologia 50: 431-438. 
Kudielka B, Buske-Kirschbaum A, Hellhammer D, Kirschbaum C (2004) HPA axis 
responses to laboratory psychosocial stress in healthy elderly adults, younger adults, 
and children: impact of age and gender. Psychoneuroendocrinology 29: 83-98. 
Kuipers SD, Trentani A, Westenbroek C, Bramham CR, Korf J, Kema IP, Ter Horst GJ, 
Den Boer JA (2006) Unique patterns of FOS, phospho-CREB and BrdU 
immunoreactivity in the female rat brain following chronic stress and citalopram 
treatment. Neuropharmacology. 50: 428-440. 
Le Douarin NM (1988) On the origin of pancreatic endocrine cells. Cell 53: 169-171. 
Luine V (2002) Sex differences in chronic stress effects on memory in rats. Stress 5: 
205-216. 
Lustman PJ, Griffith LS, Clouse RE (1988) Depression in adults with diabetes: Results 
of a 5-year follow-up study. Diabetes Care 11: 605-612.  
Lustman PJ, Freedland KE, Griffith LS, Clouse RE (2000a) Fluoxetine for depression in 
diabetes: A randomized double-blind placebo-controlled trial. Diabetes Care, 23: 
618-623.  
Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000b) 
Depression and poor glycemic control: a meta-analytic review of the literature. 
Diabetes Care 23: 934-942.  
Magarinos AM, McEwen BS (1995) Stress-induced atrophy of apical dendrites of 
hippocampal CA3c neurons: involvement of glucocorticosteroneicoid secretion and 
excitatory amino acid receptors. Neuroscience 69: 89-98. 
140 / General discussion 
Magarin AM, McEwen BS (2000) Experimental diabetes in rats causes hippocampal 
dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. 
Proc Natl Acad Sci USA 97: 11056-11061. 
Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar- Levy D (1990) Left 
prefrontal glucose metabolism in the depressed state: A confirmation. Am J 
Psychiatry 147: 1313-1317. 
Mazze RS, Lucido D, Shamoon H (1984) Psychological and social correlates of 
glycemic control. Diabetes Care 7: 360-366. 
McCormick C, Linkroum W, Sallinen B, Miller N (2002) Peripheral and central sex 
steroids have differential effects on the HPA axis of male and female rats. Stress 5: 
235-247.  
Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H (1993) The effect of improved 
glycemic control on cognitive functions in the elderly patient with diabetes. J 
Gerontol 48: M117-M121. 
Mezzacappa ES, Katkin ES (2002) Breast-feeding is associated with reductions in 
perceived stress and negative mood in mothers. Health Psychol 21: 187-193. 
Mezzacappa ES, Yu AY, Myers MM (2003) Lactation and weaning effects on 
physiological and behavioral responses to stressors. Physiol Behav 78: 1-9. 
Mizoguchi K, Kunishita T, Chui DH, Tabira T (1992) Stress induces neuronal death in 
the hippocampus of castrated rats. Neurosci Lett 138: 157-160. 
Moley KH, Mueckler MM (2000) Glucose and apoptosis. Apoptosis 5: 99-105.  
Montminy M (1997) Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66: 
807-822. 
Munck A, Naray-Fejes-Toth A (1995) Glucocorticoid action. Physiology. In: De Groot 
LJ, editor. Endocrinology. Philadelphia: W.B. Saunders Co, 1642-1656. 
Newport DJ, Stowe ZN, Nemeroff CB (2002) Parental depression: animal models of an 
adverse life event. Am J Psychiatry 159: 1265-1283. 
Peyrot M, Rubin RR (1997) Levels and risks of depression and anxiety symptomatology 
among diabetic adults. Diabetes Care 20: 585-590. 
Piccinelli M, Gomez F (1997) Gender differences in the epidemiology of affective 
disorders and schizophrenia, WHO/MSA/NAM/97.1 ed. Geneva: Division of 
Mental Health and Prevention of Substance Abuse, World Helath Organization: 
3-59. 
Raivich G, Kreutzberg G (1993) Peripheral nerve regeneration: role of growth factors 
and their receptors. Int J Dev Neurosci 11: 311-324.  
Reagan LP, Magarin˜os AM, Yee DK, Swzeda LI, Van Bueren A, McCall AL, McEwen 
BS (2000) Oxidative stress and HNE conjugation of GLUT3 are increased in the 
hippocampus of diabetic rats subjected to stress. Brain Res 862: 292-300. 
Reagan LP, Gorovits N, Hoskin EK, Alves SE, Katz EB, Grillo CA, Piroli GG, McEwen 
BS, Charron MJ (2001) Localization and regulation of GLUTx1 glucose transporter 
in the hippocampus of streptozotocin diabetic rats. Proc Natl Acad Sci USA 98: 
                                         General discussion / 141     
2820-2825. 
Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K, Rubinow DR 
(2003) Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis 
in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 88: 
3057-3063. 
Roca CA, Schmidt PJ, Deuster PA, Danaceau MA, Altemus M, Putnam K, Chrousos GP, 
Neiman LK, Rubinow D (2005) Sex-related differences in stimulated 
hypothalamic–pituitary–adrenal axis during induced gonadal suppression. J Clin 
Endocrinol Metab 90: 4224-4231. 
Rubin RR, Peyrot M (1994) Psychosocial problems in diabetes treatment: Impediments 
to intensive self care. Practical Diabetology 13: 8-14.  
Rubin RR, Peyrot M (2001) Psychological issues and treatments for people with 
diabetes. J Clin Psychol 57: 457-478. 
Salokangas RK, Vaahtera K, Pacriev S, Sohlman B, Lehtinen V (2002) Gender 
differences in depressive symptoms. An artefact caused by measurement instruments? 
J Affect Disord 68: 215-220. 
Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress 
responses? Integrating permissive, suppressive, stimulator and preparative actions. 
Endocr Rev 21: 55-89. 
Sato K, Akaishi T, Matsuki N, Ohno Y, Nakazawa K (2007) beta-Estradiol induces 
synaptogenesis in the hippocampus by enhancing brain-derived neurotrophic factor 
release from dentate gyrus granule cells. Brain Res 1150:108-120. 
Schoenfeld TA, McKerracher L, Obar R, Vallee RB (1989) MAP 1A and MAP 1B are 
structurally related microtubule associated proteins with distinct developmental 
patterns in the CNS. J Neurosci 9: 1712-1730. 
Steenbergen HL, Heinsbroek RPW, VanHaaren F, vandePoll NE (1990) Sex-dependent 
effects of inescapable shock administration on shuttleboxescape performance and 
elevated plus-maxe behavior. Physiol Behav 48: 571-576. 
Takuma K, Matsuo A, Himeno Y, Hoshina Y, Ohno Y, Funatsu Y, Arai S, Kamei H, 
Mizoguchi H, Nagai T, Koike K, Inoue M, Yamada K (2007) 17beta-Estradiol 
attenuates hippocampal neuronal loss and cognitive dysfunction induced by chronic 
restraint stress in ovariectomized rats. Neuroscience 146: 60-68.  
Teitelman G, Guz Y, Ivkovic S, Ehrlich M (1998) Islet injury induces neurotrophin 
expression in pancreatic cells and reactive gliosis of peri-islet Schwann cells. J 
Neurobiol. 34: 304-318. 
Toufexis DJ, Rochford J, Walker CD (1999) Lactation-induced reduction in rats' 
acoustic startle is associated with changes in noradrenergic neurotransmission. 
Behav Neurosci 113: 176-184. 
Tucker RP, Garner CC, Matus A (1989) in situ localization of microtubule-associated 
protein mRNA in the developing and adult rat brain. Neuron 2: 1245-1256. 
Vaillant AR, Muller R, Langkopf A, Brown DL (1998) Characterization of the 
142 / General discussion 
microtubule-binding domain of microtubule-associated protein 1A and its effects on 
microtubule dynamics. J Biol Chem 273: 13973-13981.  
Weinstein SP, Paquin T, Pritsker A, Haber RA (1995) Glucocorticoid- induced insulin 
resistance: Dexamethsone inhibits the activation of glucose transport in rat skeletal 
muscle by both insulin- and non-insulin-related stimuli. Diabetes 44: 441-445. 
Willner P (1985) Depression: A Psychobiological Synthesis. Wiley, New York. 
Winokur A, Maislin G, Phillips JL, Amsterdam JD (1988) Insulin resistance after oral 
glucose tolerance testing in patients with major depression. Am J Psychiatry 145: 
325-330. 
Wood G, Shors T (1998) Stress facilitates classical conditioning in males, but impairs 
classical conditioning in females through activational effects of ovarian hormones. 
Proc Natl Acad Sci USA 95: 4066-4071. 
Xu H, He J, Richardson JS, Li XM (2004) The response of synaptophysin and 
microtubule-associated protein 1 to restraint stress in rat hippocampus and its 
modulation by venlafaxine. J Neurochem 91: 1380-1388. 
Yao XH, Yu HM, Koide SS, Li XJ (2003) Identification of a key protein associated with 
cerebral ischemia. Brain Res 967: 11-18. 
Young E, Altemus M, Parkinson V, Shastry S (2001) Effects of estrogen antagonists and 
agonists on the ACTH response to restraint stress in female rats. 




                                   Summary / 143     
Summary 
Depression is a chronic, recurring and potentially life-threatening affective disease, 
with women having higher prevalence than men. Severe or chronic stress is an important 
factor responsible for the development of a depressive episode. Exposure of animals to 
stressors results in a series of coordinated changes in behavior, endocrine and 
neurochemistry, which leads to depressive-like symptoms in these animals.  
In view of that the pathological changes in hippocampus are involved in the 
process of depression, and that Brain-Pancreas Relative Protein (BPRP) is richly 
expressed in hippocampus and pancreas, we hypothesized that BPRP participates in the 
pathological process of depression (Chapter 2). Our results showed that chronic stress 
decreased the expression of BPRP in pancreas while not in hippocampus. This was 
accompanied by an increase in blood glucose levels and a reduction in insulin levels. 
Different responses in pancreas and hippocampus to hyperglycemia and 
hypoinsulinemia suggest that the BPRP in pancreas is more sensitive to the changes in 
levels of glucose and insulin than in hippocampus. With a full time course on BPRP 
levels and on measures of glucose tolerance and insulin sensitivity, it can be argued that 
the pancreas was affected after hyperglycemia developed. Therefore, we can determine 
that depressive-like symptoms in stressed animals are likely to be responsible for 
decreased pancreatic BPRP and that this change likely plays a role in onset of the 
diabetic condition. A depressive state induced by stress can thus lead to relatively 
advanced diabetic conditions (hyperglycemia and hypoinsulinemia). The interactions 
between stress and diabetes suggest that depression and diabetes may exacerbate one 
another at a neuroendocrine level, and that there may be a common hormonal 
dysregulation in depression and poor glycemic control. Thus, studying depression in 
diabetes, exploring the common hormonal dysregulation and screening the risk factors 
will lead to better understanding and treatment of depression.  
     The interaction between stress and diabetes prompted us to further investigate the 
effects of poor glycemic control on the expression of BPRP. Thus, in the following 
experiment we further studied the effects of glucose and insulin on the expression of 
BPRP in hippocampal neurons cultured in vitro (Chapter 3). Based on our results, we 
concluded that glucose deprivation as well as high levels of glucose both decreased the 
expression of BPRP in hippocampal neurons. This could not be explained by the 
presence of fewer hippocampal neurons. Although insulin had a positive effect on 
neuronal growth, it did not affect BPRP expression in cultured hippocampal neurons. 
Therefore, BPRP is a glucose-sensitive protein in brain. However, if the reduction in the 
expression of BPRP is a marker of disturbances in glucose homeostasis cannot be 
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substantiated at the moment. Our results also indicate that there were other neurotrophic 
factors besides insulin which can contribute to the growth of hippocampal neurons. It is 
therefore important to screen which components are beneficial to the growth and 
differentiation of neurons, and then apply these components as possible therapeutic 
targets for depression.  
BPRP is found to possess significant matching relation to protein kinase A 
anchoring protein 6 (AKAP6), suggesting BPRP is APAK6 or analogous to AKAP6. 
AKAP6 favors specific PKA phosphorylation events which thereafter impact the 
neuroplasticity. If this is true, then dysregulation of blood glucose level induced by 
stress or seen in diabetes may lead to the dysfunction of the pathway of PKA-AKAP. 
Dysfunction of the PKA-AKAP pathway may cause changes in expression of proteins 
like BPRP and other proteins involved in neuroplasticity. Accordingly, further study of 
the pathway of PKA-AKAP during depression will shed light on the pathological 
mechanism of depression. 
 Whereas women show a higher prevalence for depression than men, most of 
studies on depression were performed on male animals and the gender differences in 
stress response and recovery are poorly studied. The present study (Chapter 4) further 
investigated the gender differences in response to acute stress, chronic stress or recovery 
after long-term stress. Previously we have found that isolation is stressful for females, 
therefore two extra socially housed groups of females were added (control and acute 
stress groups). We used behavioral, endocrine and neurochemical parameters. Our 
results showed that the dentate gyrus of the hippocampus (DG) and prefrontal cortex 
(PFC) in male rats was susceptible to both acute and chronic stress reflected by the 
reduction in pCREB expression and abnormal morphology of these brain regions. 
Unexpectedly, expression of CREB and pCREB and the morphology in DG and PFC of 
female rats was relatively resistant to the aversive impact of footshock. Therefore, to 
elucidate the mechanisms responsible for the increased stress resistance in female rats 
studies should focus on more proteins besides CREB and pCREB and more brain 
regions besides DG and PFC. In addition, a gender difference in the effect of a recovery 
period was also found, male rats can recover while female rats still showed effects of the 
previous stressful events after 3 weeks’ recovery, such as adrenal hypertrophy, higher 
grooming frequency. Furthermore, we found an effect of social housing, which indicated 
that isolation was stressful for females. Overall, females appear to be quite different 
from males, and more research is needed to clarify the neurobiological mechanisms of 
stress coping in females. These findings also suggest that there are protective factors 
which can protect female rats from the negative influence of stress. Several factors, like 
estrogen and corticosteroid binding globulin, could be involved, but how these factors 
interact with stress in females should be further investigated. Exploring these kinds of 
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issues will further uncover the pathological processes underlying depression, and 
subsequently lead to the development of more effective antidepressants.  
     In conclusion, our findings show that male rats and female rats respond to stress 
and recovery in a different way. Depressive-like symptoms in stressed animals are likely 
to play a role in onset of diabetic condition. The link between these two illnesses likely 
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Nederlandse samenvatting 
   Depressie is een chronische ziekte met zich herhalende episodes, en een mogelijk 
levensbedreigende affectieve stoornis die vaker voorkomt bij vrouwen dan bij mannen. 
Heftige of chronische stress is een belangrijke oorzaak voor het ontstaan van een 
depressieve episode. Blootstelling van proefdieren aan stressoren resulteert in gedrags- 
endocriene- en neurochemische veranderingen die leiden tot depressie- achtige 
symptomen bij deze dieren.  
  Gezien het feit dat pathologische veranderingen in de hippocampus betrokken 
zijn bij depressie, en dat Brain Pancreatic Relative Protein (BPRP) tot expressie komt in 
de hippocampus en pancreas, was onze hypothese dat BPRP betrokken is bij de 
pathologische veranderingen die leiden tot een depressie (hoofdstuk 2). Wij hebben 
laten zien dat chronische stress de expressie van BPRP in the pancreas, maar niet in de 
hippocampus verlaagde. Dit ging samen met een toename van het plasma glucose niveau 
en een daling van het plasma insuline niveau. Deze verschillende reacties op 
hyperglycemie en hypoinsulinemia tonen dat de BPRP expressie in de pancreas 
gevoeliger is voor veranderingen in glucose en insuline niveaus dan BPRP expressie in 
de hippocampus. Aan de hand van een tijdscurve van de BPRP expressie en metingen 
van glucose tolerantie en insuline sensitiviteit lijkt het erop dat de BPRP expressie in de 
pancreas veranderde nadat de hyperglycemie zich ontwikkelde. Het is dus waarschijnlijk 
dat stress- geinduceerde depressie-achtige symptomen bij ratten correleren met 
verminderde BPRP niveaus in de pancreas en dat deze verandering onderdeel is van een 
moleculaire cascade die is betrokken bij het ontstaan van diabetes. Stress kan een 
depressie induceren en kan vervolgens leiden tot relatief vergevorderde diabetes 
(hyperglycemie en hypoinsulinemie). Interacties tussen stress en diabetes tonen dat 
depressie en diabetes elkaar wederzijds op neuroendocrien niveau zouden kunnen 
versterken. Het bestuderen van depressie bij diabetes, en verkenning van hun 
gemeenschappelijke hormonale disregulatie en risicofactoren, zou kunnen leiden tot een 
beter begrip van de pathobiologische mechanismen en uiteindelijk de behandeling van 
depressie. 
     De interactie tussen stress en diabetes was aanleiding voor verder onderzoek van 
effecten van slechte glycemische regulatie op de expressie van BPRP. In het volgende 
experiment hebben we daarom de effecten onderzocht van glucose en insuline op de 
expressie van BPRP in celculturen van hippocampale neuronen (hoofdstuk 3). Op basis 
van onze resultaten konden we concluderen dat zowel glucosedeprivatie als hoge 
glucose niveaus leidden tot een verlaagde expressie van BPRP in hippocampale 
neuronen. Deze reductie was niet een gevolg van een verminderde hoeveelheid neuronen. 
Hoewel insuline een positief effect had op neuronale groei, beïnvloede het niet de BPRP 
expressie in the gekweekte neuronen. BPRP is dus een glucosegevoelig eiwit in de 
hersenen, maar in hoeverre verminderde expressie van BPRP een indicatie is voor 
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verstoringen in de perifere glucosehomeostase kan op dit punt niet met zekerheid 
worden gezegd. Naast de betrokkenheid van insuline hebben we ook aanwijzingen 
gevonden voor de betrokkenheid van andere neurotrofe factoren bij de groei van 
hippocampale neuronen.       
      BPRP behoort waarschijnlijk tot de groep van “A-kinase anchoring proteins 
(AKAP)” en is mogelijk analoog aan het AKAP6, omdat dit eiwit significante 
structurele overeenkomsten heeft met BPRP. Disregulatie van glucose niveaus in het 
bloed geïnduceerd door stress of diabetes heeft dus mogelijk een verstoring van de 
neuronale PKA-AKAP cascade tot gevolg. Disfunctioneren van deze cascade kan leiden 
tot veranderingen in expressie van eiwitten die een rol spelen bij neuronale plasticiteit, 
onder andere BPRP. Verder onderzoek naar de PKA-AKAP cascade bij stress lijkt dus 
relevant voor een beter begrip van de pathofysiologie van depressie. 
      Hoewel vrouwen een grotere kans hebben op het krijgen van een depressieve 
episode worden de meeste studies naar depressie uitgevoerd met mannelijke proefdieren 
en worden geslachtsverschillen in de stressrespons en herstel nauwelijks onderzocht. In 
hoofdstuk 4 hebben we geslachtsverschillen in de respons op acute en chronische stress 
en het effect van herstel na langdurige stress onderzocht. Omdat we eerder hebben 
aangetoond dat isolatie stressvol is voor vrouwtjesratten hebben we twee extra sociaal 
gehuisveste groepen vrouwtjesratten toegevoegd (een controle en een acute stress groep). 
Onze resultaten lieten zien dat de dentate gyrus van de hippocampus (DG) en de  
prefrontale cortex (PFC) van mannetjesratten gevoelig was voor zowel acute als 
chronische stress gemeten aan een afname van de gefosforyleerde vorm van cyclic AMP 
response element binding protein (pCREB). Daarnaast toonden deze hersengebieden na 
stress een afwijkende morfologie. De BPRP expressie in de DG was onveranderd net als 
in onze vorige studies. Vrouwtjesratten bleken onverwacht resistent tegen de aversieve 
footshock stress. Om in vrouwtjesratten de mechanismen te achterhalen die 
verantwoordelijk zijn voor de verhoogde stressresistentie zal in vervolgonderzoek 
gefocusseerd moeten worden op andere eiwitten dan CREB en pCREB, alsmede op 
andere hersengebieden dan de DG en PFC. Ook een herstelperiode had een verschillend 
effect bij mannetjes en vrouwtjesratten, mannetjes zijn in staat om te herstellen in 3 
weken tijd, terwijl bij vrouwtjes na zo’n herstelperiode nog steeds effecten zichtbaar 
waren van de doorgemaakte stress. Ook vonden we in de vrouwtjes een effect van 
sociale huisvesting wat er op duidde dat isolatie stressvol was voor vrouwtjes. 
Samenvattend, vrouwtjesratten verschillen duidelijk van mannetjesratten in 
stressverwerking, en er is meer onderzoek nodig naar de stress-coping mechanismen van 
vrouwtjes. Al onze resultaten duiden erop dat de neurobiologische mechanismen die 
betrokken zijn bij het omgaan met stress verschillend zijn voor mannetjes- en 
vrouwtjesratten, en dat vrouwtjesratten beschikken over stress beschermende factoren 
mogelijk oestrogeen en corticosteroid binding globuline.  
      Onze resultaten tonen aan dat mannetjes- en vrouwtjesratten verschillend 
reageren op chronische stress en een daarop volgende herstelperiode. Stress- 
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geinduceerde moleculair biologische veranderingen die leiden tot depressieachtige 
kenmerken bij ratten zijn mogelijk ook betrokken bij het ontstaan van diabetes. De link 
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